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Abstract
Introduction: Infectious disease (ID) is an ongoing problem worldwide. In order to
manage this problem, it is important to have an integrated and effective surveillance
system that can be used to estimate the burden of ID. There is a scarcity of studies
published on the prevalence of IDs in the United Arab Emirates (UAE), both in
hospital settings and in the community. Infectious Intestinal Disease (IIDs) have
been one of the commonest IDs that have been studied in the community around the
world, there are no studies on prevalence of IIDs in Ras Al Khaimah (RAK).
Furthermore, while the UAE is a member state of the World Health Organization
(WHO) Eastern Mediterranean Region that is working toward a plan to fulfill the
implementation of the International Health Regulations, and has in recent years
started developing surveillance systems for several IDs, there are no publications
describing or assessing these systems.
Aims: The aim of this study is to estimate the burden of IIDs in the community and
to describe the surveillance system in the emirate of RAK.
Method: In the first part of this research, a population-based cross-sectional study
design using a telephone-based questionnaire was used to estimate IIDs in a
representative sample of the RAK population (N= 1254; 57.3% males; 25.2 % below
18 years) from all age groups. Participants completed the questionnaire collecting the
sociodemographic characteristics and information about IIDs during the four-week
period prior to the telephone interview.
The second part of this study was a descriptive scoping assessment of the core
activities and supportive functions of the ID surveillance system in government
health institutions in RAK based on the WHO guidelines.
Results: Overall prevalence of IIDs was 4.2% in the four weeks prior to the
interview. Multivariate logistic regression analysis identified that being female (odds
ratio (OR) 2.43, 95% confidence interval (CI) 1.16-5.07) and having a middle–range
monthly household income (~ USD 4080-<6800: OR 5.42, 95%CI 1.15-25.48; ~
USD 6800<9530: OR 7.13, 95% CI 1.47-34.57) were positively associated with IID.
Age≥ 6 years was negatively associated with IID (OR 0.95, 95% CI 0.90-0.99).
Nearly half (49.1%) of participants with an IID sought medical care and 20.8% took
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over-the-counter medication. ID surveillance systems in RAK exist at two levels: the
higher level of Preventive Medicine Department (PMD) and the lower level of the
hospitals. In the emirate of RAK, the basic structure, core functions and support
functions of the ID surveillance systems exist at the two levels, however further
development has been hampered by lack of standardization, limited training activities
and absence of a formal quality improvement process.
Significant contributions: This study provides the first population-based prevalence
estimates of IID in the UAE, which are similar to those reported in China (4%), but
lower than those reported in Canada (10%), the Netherlands (7%), and the USA
(6%). Furthermore, it is the first to describe the local ID surveillance system and
identify areas for improvement.
Gap filled: It provides baseline data for IIDs in the community and documentation of
the current surveillance system in RAK.

Keywords: Communicable diseases, disease notification, epidemiology, infectious
diseases, infectious disease surveillance, infectious diseases surveillance system,
infectious intestinal diseases, prevalence, Ras Al Khaimah, United Arab Emirates.
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)Title and Abstract (in Arabic

تقدير عبء األمراض المعوية المعدية ووصف نظام ترصد األمراض المعدية في رأس
الخيمة ،دولة اإلمارات العربية المتحدة
الملخص

المقدمة :تمثل األمراض المعدية أو السارية مشكلة مزمنة في جميع دول العالم .ومن أجل السيطرة
عليها ،فمن الضروري مراقبة وقياس األعباء التي تفرضها هذه األمراض على المجتمع مع ضرورة
إيجاد نظام فعال لمراقبتها .هناك ندرة في الدراسات التي تم نشرها حول مدى انتشار األمراض المعدية
في دولة اإلمارات العربية المتحدة ،سواء في المستشفيات أو في المجتمع .تعتبراألمراض المعوية
المعدية واحدة من أكثر األمراض المعدية شيوعا والتي تم دراستها في مجتمع حول العالم ،وال يوجد
دراسة عن مدى انتشارها في رأس الخيمة .ومع ذلك ،وبما أن دولة اإلمارات العربية المتحدة هي دولة
عضو في منظمة الصحة العالمية لمنطقة شرق البحر األبيض المتوسط فإنها تعمل جاهدة على وضع
خطط لتنفيذ وتطبيق اللوائح الصحية الدولية .وقد بدأت الدولة في السنوات األخيرة في تطوير أنظمة
لمراقبة العديد من األمراض المعدية السارية ،لكن ال توجد دراسات موثقة منشورة لوصف أو تقييم هذه
األنظمة.
األهداف :تهدف هذه الدراسة إلى تقدير عبء األمراض المعوية المعدية ( )IIDsلدى المجتمع ووصف
نظام الترصد في إمارة رأس الخيمة (رأس الخيمة).
الطريقة :الجزء األول من هذا البحث ،عبارة عن دراسة مستعرضة اجرية لتقدير نسبة انتشار
األمراض المعوية المعدية ( )IIDsوذلك باستخدام استبيان خاص لجمع المعلومات عن المشاركين عبر
الهاتف لتقدير نسبة انتشار ( )IIDsفي عينة تمثل سكان رأس الخيمة (العدد = 1254؛  ٪57.3ذكور؛
 ٪25.2أقل من  18سنة) وذلك من جميع الفئات العمرية .وقد أكمل المشاركون االستبيان الذي يجمع
الخصائص االجتماعية والديموغرافية ومعلومات حول اإلصابة باألمراض المعوية المعدية) لدى
المشاركين ،وذلك خالل فترة األربع أسابيع األخيرة السابقة للمقابلة الهاتفية.
وفي الجزء الثاني من هذه الدراسة ،تم تقييم األنشطة الرئيسية والوظائف الداعمة لنظام مراقبة
األمراض المعدية في المؤسسات الصحية الحكومية في رأس الخيمة بناء على معايير منظمة الصحة
العالمية.
النتائج :وجدت الدراسة بشكل عام أن معدل انتشار األمراض المعوية المعدية ( )IIDsخالل األربع
أسابيع السابقة للمقابلة الهاتفية هو .%4.2وقد أوضح تحليل االنحدار اللوجستي متعدد المتغيرات أن
اإلناث (  )OR 2.43, 95%CI 1.16-5.07و األفراد من ذوي الدخل الشهري المتوسط (~ USD
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4080-<6800: OR 5.42, 95%CI 1.15-25.48; ~ USD 6800<9530: OR 7.13, 95%
)CI 1.47-34.57
مرتبطين إيجابيا باإلصابة باألمراض المعوية المعدية .بينما وجد أن ذوي األعمار 6أو أكبر مرتبطة
سلبا باإلصابة باألمراض المعوية المعدية ( %49 .)OR 0.95, 95% CI 0.90-0.99من المشاركين
المصابين باألمراض المعوية المعدية تلقوا الرعاية الصحية و  %20.8تلقوا األدوية بدون وصفة طبية.
وأوضحت الدراسة وجود أنظمة لمراقبة األمراض المعدية بإمارة رأس الخيمة وذلك على مستويين:
المستوى األعلى المتمثل في الطب الوقائي والمستوى األدنى المتمثل في المستشفيات .وأوضحت
الدراسة أيضا وجود بنية أساسية ووظائف دعم خاصة بأنظمة مراقبة األمراض المعدية على كال
المستويين وأنها فعالة رغم أن هناك بعض األمور التي تعيق تطوير النظام مثل عدم توحيد طريقة
العمل بين المؤسسات المختلفة وعدم وجود تدريب الزامي يشمل جميع العاملين في هذا المجال .وعدم
تطبيق برامج تحسين الجودة على نظام ترصد االمراض المعدية في رأس الخيمة.
المساهمات الهامة للدراسة :هذه أول دراسة لتقدير مدى انتشار األمراض المعوية المعدية في مجتمع
بدولة اإلمارات العربية المتحدة ،وتماثل دراسة الصين ( )%4ولكن أقل من كندا ( ,)%10هولندا
( )%7والواليات المتحدة األمريكية ( .)%6وهي أول دراسة من نوعها لوصف نظام مراقبة األمراض
المعدية برأس الخيمة بغرض تحديد المجاالت المطلوبة لتحسين الخدمات.
سد الثغرات في المعرفة :كشفت الدراسة عن معلومات أساسية لمعدالت انتشار األمراض المعدية في
مجتمع رأس الخيمة ،كما وثقت لنظام مراقبة األمراض المعدية الحالي في إمارة رأس الخيمة.
مفاهيم البحث الرئيسية :اإلبالغ عن األمراض ،األمراض المعدية ،مراقبة األمراض المعدية ،نظام
مراقبة األمراض المعدية ،األمراض المعوية المعدية ،علم األوبئة ،مدى االنتشار ،رأس الخيمة،
اإلمارات العربية المتحدة.
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Chapter 1: Introduction and Literature Review
1.1 Introduction – infectious Diseases
Infectious Disease (ID) is defined as an illness which occurs because of the
presence of one or more infectious agents or its toxic product [1]. These agents
include: pathogenic bacteria, viruses, fungi, multicellular parasites, protozoa and
prions. They are able to cause animals and plant diseases, which manifest in different
ways. Infectious diseases are also called communicable diseases due to the ability of
the infectious agents to transmit from one person to another or from one species to
another. Routes of transmission include ingested food, liquids, body fluids,
inhalation, vector borne spread and contaminated objects [2].
IDs are an ongoing public health problem. IDs in humans have been
classified by the World Health Organization (WHO) as the second leading cause of
death, accounting for approximately 15 million deaths worldwide annually and in the
21st century these diseases still pose a serious problem to the public health [3].
In view of the fact the IDs have been of global concern, there has been
extensive research in this field. This research has taken on different focuses such as
clinical, microbiological and epidemiological aspects. The focus from a clinical
perspective is the organ system that is affected by the infection or by the clinical
manifestation of the disease, such as diarrheal diseases, respiratory diseases,
cardiovascular infection, central nervous system infection, and sepsis [4]. Commonly
the aim of such research is to optimize treatment regimens.
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On the other hand, the concern with microbiologists is related to the causative
organism characteristics and where applicable culture identification, sensitivity and
resistance patterns, and antimicrobial agents [4].
Epidemiological research on IDs is concerned with how the disease spreads,
how long the incubation period is, and how the disease is transmitted [4], to propose
acceptable, appropriate, and practical public health interventions to prevent and
control diseases in the community [5].
1.1.1 Burden of IDs
Burden of disease is a function of incidence and severity of a disease in a
target population, [6] and can be measured by a number of indicators such as
prevalence, incidence, financial cost, morbidity, and mortality. These indicators have
been used to quantify burden of disease by calculating Disability Adjusted Life
Years (DALYs) and Quality Adjusted Life Years (QALYs), all of which provide
information about health status of an individual [7].
The effect of all possible adverse events on health can be measured by the
DALYs [8], which is considered to be one of the measurements of the disease burden
and it can be obtained by the summation of Years of Life Lost (YLL) which is
defined as the number of years of life lost due to mortality of a specific disease in a
specific population and Years Lived with Disability (YLD) which is defined as the
number of years lived with a disability [9].
The DALYs best approach to measure the disease burden is by using the units
of time, which can be calculated using the prevalence or incidence measures. Both
prevalence and incidence have been used to calculate nonfatal health outcomes [7]
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and considered as predominant measures of the disease occurrence [6]. The time
lived with a disability can be measured either by taking the point prevalence
measures of disability, adjusting for the seasonal variation if available and then
expressing them as an annual prevalence, or by measuring the incidence of
disabilities and the average period of each disability [7].
Another way to measure the disease burden is by QALYs, which is a general
evaluation of health in terms of quality and quantity of life lived. A value can be
placed on the time lived in non-fatal health states. To quantify the social preferences
for different health states, the health state weights are used, and they are referred to
as QALY weights, disability weights or health state preferences. Such weights are
measured on a scale of 0-1, where zero corresponds to death while one indicates
perfect health [7].
It should be noted that the scores measuring QALY are inverted compared
with DALY; that is, in DALY a score of “1” indicates death and “0” indicates perfect
health, because DALY is measuring the loss of health. On the other hand, a QALY
score of “1” represents perfect health and a score of “0” means death, because QALY
is measuring equivalent healthy years lived [7].
There are a number of difficulties in estimating the burden of IDs. Firstly, a
long term chronic disease, which may be caused by symptomatic or asymptomatic
infections might not be recognized as originally caused by an infection, so it may not
be calculated when estimating the burden of the IDs. Secondly, IDs occur on very
different time scales. For example, the acute illness and sequelae for influenza
infection occur within a short period of time (weeks), but for Human
Immunodeficiency Virus (HIV) infection it may take a decade. These variations in
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time period require adding disease burden for the diseases that occur over long
periods of time. In some situations, a short-lived infection (such as Ebola virus or
hemorrhagic fever) causes more fatalities than a more wide-spread long-term
condition such as hepatitis C [8].
1.1.2 Increase in antimicrobial resistance
Antimicrobial resistance occurs when microbes become resistant to the
antimicrobial drugs that are used to treat the infections they cause [10]. Pathogenic
bacteria that are resistant to the common antimicrobial treatments and the emergence
of multidrug resistance bacteria are a huge challenge worldwide, that is associated
with a high mortality and morbidity [11].
One of the main factors causing antimicrobial resistance is the inappropriate
use of drugs. This includes unnecessary use of drugs (for example use of antibiotics
for treating illness caused by viruses like the common cold) and inappropriate choice
of drugs (such as use of a broad-spectrum antibiotic when an alternative narrow
spectrum antibiotic would be equally effective). In humans, the global consumption
of the antibiotics has increased by 36% between the year 2000 and 2010 [10].
Antibiotic resistance incurs extra health costs, because of increased drug use,
persistent infection and complications [10].
It is difficult to estimate the global burden of antimicrobial resistance,
because the data is not collected consistently and systematically, although some
factors like misuse of antibiotics and having less developed health systems increases
the antimicrobial resistance burden in many countries around the world. For example
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in India, E.coli bacteria resistance to certain types of antibiotics (third generation
cephalosporin) increased from 70% to 83% between the years 2008 and 2013 [10].
The accuracy of assessing the burden of diseases depends on the quality of
the data collected. There are two major ways of collecting data that can be used to
assess the burden of disease: surveillance and self-reported surveys.
1.2 Introduction – public health surveillance
Surveillance, commonly known as public health surveillance, is defined
according to the World Health Organization (WHO) as: "the systematic ongoing
collection, collation and analysis of data for public health purposes and the timely
dissemination of public health information for assessment and public health
response"[12].
Public health surveillance covers a wide range of health-related issues such as
obesity, cardiovascular disease, diabetes, injuries, adverse drug events, IDs and many
others [13]. From here onwards in this document, surveillance will be discussed
specifically in the context of infectious diseases. The term ‘infectious diseases
surveillance’ is used to describe a range of methodologies, concepts and actions
related to identification and management of IDs [14-17]. Surveillance systems vary
widely between countries, and sometimes within different regions in the same
country, and at different time points, depending on their scope and purpose. At the
national level, most countries have a system for dealing with infectious diseases,
although this varies greatly in terms of structure and function. At the global level,
Centers for Disease Control and prevention (CDC) and WHO are two main
authorities that coordinate a wide range of activities related to infectious diseases.
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1.2.1 CDC
The CDC is a United States (US) federal agency formed in July 1946. The
CDC works at the local state and national level to prevent disease outbreaks, control
environmental health threats, maintain national health statistics, control infectious
and chronic diseases (e.g. cancer) and improve the health of US people [18].
The CDC provides public health and healthcare facilities, with the leadership
and technical expertise needed to conduct the basic function of the public health
services. It has the office of IDs which aims to protect the population of US from
IDs. This protection comes by responding to the unusual health events and outbreaks
(including bioterrorism) rapidly. CDC focuses also on improving health state and
reducing the burden of diseases to reduce the health-related costs [19].
1.2.2 WHO
WHO is an international organization of the United Nations, which came into
force on 7 April 1948. This date is celebrated every year as WHO Day. The WHO
improves people's well-being by producing health guidelines, and by helping
countries in addressing their public health problems [20]. The WHO memberships
consist of 194 countries, that have agreed to follow WHO guidelines to combat the
health concerned events in that country [21].
Worldwide surveillance of infectious diseases has shown that the top disease
killers differ from one area to another. For example, in 2016, human
immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) was the
top disease in African region [22], while tuberculosis (TB) was the top killer in India
[23], and malaria top in sub-Saharan Africa countries [24].
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However, looking at the deadliest IDs across the world, the WHO reported
that lower respiratory tract infections caused 3.0 million deaths worldwide in 2016
[25]. Another important disease group is infectious intestinal Disease (IID), which
even in high income countries like the United Kingdom (UK) is associated with a
high disease burden [26]. In 2016 IIDs caused 1.4 million deaths worldwide [25], as
well as huge financial costs that were reported even from developed countries such
as US [27].
On May 23, 2005, the WHO adapted International Health Regulations (IHR),
which are an international legally binding instrument, which contains a decision
instrument that helps in identifying the health-related events that each country must
report to WHO, when that country agrees to be bound by the regulations and to
control the international spread of diseases [28]. The purpose of the IHR 2005 is to
prevent, control, protect, and to facilitate the responses to the international spread of
disease. It also makes disease surveillance central in order to guide public health
action against threats from cross border disease. IHR 2005 was developed to address
many limitations of the original IHR 1969, such as the narrow scope of application
which is only limited to three IDs, lack of international coordinated mechanism to
control cross border disease threats and focusing only on the emergencies caused by
ID agents.
The framework set by IHR involves several steps which should be carried out
at country level and then followed by reporting to the WHO (Figure 1.1 is modified
from the source) [28].
The IHR 2005 requires formal notification to the WHO by state parties, broad
scope of application and focusing on both the ID and non-ID disease events [28].
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Reporting or
notification

WHO

International
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Figure 1.1: ID surveillance structures and processes specified in IHR (2005)
1.2.3 Components of surveillance system
While surveillance systems vary greatly across different geographic regions,
certain minimal components need to be in place for the system to be effective [29].
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Necessary components include existence of a structure for the surveillance system,
core functions, support functions and mechanism for assessment [28].
1.2.3.1 Structure of the surveillance system
Any surveillance system needs to have a clear structure. The structure of the
surveillance systems in any country should be supported by regulations and
legislations of that country, and should involve the implementers (public health
practitioners, physicians, private healthcare providers, and healthcare facilities) and
other stakeholders (region/district public health department) and how they relate to
each other through different partnerships and networks [30].
The surveillance system can be simple or it can be complex. A simple
surveillance system may use few resources or whatever resources available as long it
performs the basic actions required to make it function. For example, in Tamil Nadu
(India) a paper-based reporting method is used in a tertiary care hospital for notifying
the IDs [31]. While a complex surveillance system may use web, computer-based
methods to notify their IDs of interest, such as in the US [32].
1.2.3.2 Core Function of surveillance system
The core functions of the surveillance systems can be broadly classified to
functions related to individual cases and to functions related to collated data.
The core functions associated with the individual cases include the early
detection (identifying outbreaks and cases), registration (recording the identified
cases), and confirmation of the case (capacity for confirming). Core functions related
to the collated data include data analysis, interpretation and then public health
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response including reports to stakeholders. The surveillance systems are useful only
if followed by proper response and control [30].
1.2.3.3 Support functions of the surveillance system
To facilitate the implementation of the surveillance core functions, the
following support functions should be included:
1) Policies and guidelines are essential supporting elements for the
surveillance system and they are important for monitoring and evaluating the
surveillance system to make sure that the systems are working according to what was
planned for. An example is the guidelines used for the investigation of the outbreaks,
which should define the priority diseases for the surveillance system. The policies
and guidelines also include the updated case definitions, which is vital for the IDs
case definition.
2) Training, which should happen at different levels, and should be tailored to
fulfill the set objectives. For example, at the clinical settings, the health professional
that is in direct contact with patients should have hands on training on prevention of
transmission of IDs. Laboratories personnel should be trained on different testing
methods. In addition to the previously mentioned training, the IDs control team
should be trained for reporting.
3) Financial resources and communication facilities (offices, paper, computer,
phone, fax, laboratories, equipment, vehicles) [30].
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1.2.4 Assessment of the surveillance system
The surveillance system of each country needs to be evaluated to ensure it is
operating efficiently and fulfilling its purpose. Assessment criteria may differ
depending on the context of the surveillance system and its aim.
CDC developed guidelines involving two steps that are important to evaluate
the quality of public health surveillance systems: The first step is describing the
elements, purpose and the operation of the surveillance system. The second step is
evaluation of the surveillance systems performance depending on the key attributes
(Table 1.1 modified from the source) [28]. The key attributes are: timeliness, positive
predictive value (PPV), representativeness, completeness, sensitivity, usefulness,
flexibility, simplicity, and acceptability [33].
Table 1.1: Attributes to evaluate public health surveillance systems
Attribute

Attribute details

Usefulness

Is the system providing data that can be used to prevent
and control adverse health related events?

Sensitivity

Is it able to detect the outbreaks and what is the
proportion of the true events detected by the system?

Timeliness

Are data collected and dispatched without delay?

Simplicity

Is the system easy to implement by the staff?

Flexibility

Could the system easily adapt to cope with the changes?

Acceptability

Are the persons and organizations willing to
participate?

Data quality

Are the recorded data valid and complete?

Positive predictive value

What is the proportion of the true events?

Representativeness

Is the data described the events over time and their
distribution (by person and place)?
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In reality, publications on assessment of surveillance systems have generally
not evaluated all of these components at once. In some studies, the assessment has
dealt with basic issues such as structure [33, 34]. With others, one or more quality
criteria have been evaluated, such as timeliness of reporting and completeness of
records [32].
1.2.5 Type of surveillance
Depending on the ways in which the data is collected, the surveillance of the
diseases can be passive or active [35].
1.2.5.1 Passive surveillance
Passive surveillance is compilation of information from data which is
routinely collected, exclusively from healthcare institutions. The specific
diseases/cases covered in this type of surveillance differs according to the facility;
for example, the diseases routinely collected in a health facility providing antenatal
care may be infections such as symptomatic or asymptomatic Urinary Tract Infection
(UTI), whereas in a surgical ward, post-operative wound infection might be more of
a concern. Once the data have been collected, it must be pooled and analyzed to
identify possible outbreak. It is used also to detect vaccine preventable diseases and
sometimes to report other diseases of interest [36].
Notification
Notification is the reporting of certain IDs to specific authorities (national
and/or international) [5]. The aim of notification reporting systems is to observe
disease trends, support epidemiological investigation, prevent disability and death
due to the spread of the diseases and assess disease prevention programs [34].

32
The notifiable disease reports serve as a source of data for the ID
surveillance, which consist of the mandatory reporting of a list of diseases by phone,
mail or fax, and demographics including data on birth, marital status, and data on
death [3].
The fluctuations in the prevalence and incidence of the pathogens over time
define the list of the diseases which is reported at the state or at the national level [3].
Notification of the IDs serves as an early warning about outbreaks and new
occurrences. It also provides information about disease frequency. The early
detection of disease outbreaks helps in the immediate control of its spread [31].
At present, the list of notifiable disease varies from one country to another
and each country should set their notifiable diseases list according to significant
diseases in that country. There are three diseases (yellow fever, cholera and plague)
that have been declared by WHO to be on every list, which means that any cases of
these diseases should be reported [37, 38]. All healthcare facilities should have a
mechanism for sending regular reports to the concerned authorities [36].
In many countries, IDs notification is an official duty of the medical
practitioner or physician and also of the healthcare institutions [31]. However, in
many developed countries like New Zealand, Ireland, Sweden and in some less
developed countries like Sri Lanka, reporting the diseases notification is not only
required from the clinicians, but also from laboratories [39].
Healthcare providers should have clear case definitions and the laboratories
should be able to perform the required laboratory diagnoses [40]. There are several
advantages associated with passive surveillance. Importantly, is not too demanding
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on resources, because much of the work is integrated into the ongoing clinical work
using existing resources [35]. It also covers large areas (provinces / countries) and is
less expensive than other surveillance types (e.g. active surveillance). However, it
can be hard to ensure the timeliness and completeness of the data, because it relies on
a large network of healthcare providers who are concurrently occupied with fulfilling
their basic duties [36].
1.2.5.2 Active surveillance
Active surveillance is non-routine collection of data about a specific disease
over a defined period of time, such as during an outbreak or after the exposure to the
disease in the community [5].
For example: it is useful in the procedure of case ascertainment during the
investigation of an outbreak, since it brings data from sporadic cases that could help
us getting information about how disease transmitted [40].
The advantage of active surveillance is that it is provides a more complete
reporting of the health events (e.g. disease outbreak). However, since it is nonroutine data collection, there may be a higher demand for resources and their related
costs [35].
Although many surveillance systems currently exist around the world, some
of which are well-developed, ID surveillance remains challenging [3]. Events such as
the Ebola outbreak in West Africa [41], the H1N1 influenza pandemic [42], severe
acute respiratory syndrome (SARS) outbreaks and Zika outbreak have demonstrated
that IDs can't be predicted [38].
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There are numerous ways in which active surveillance can be carried out,
such as conducting population based surveys [43], and self-reported illness surveys
[44].
1.2.5.3 Sentinel surveillance
Sentinel surveillance systems are a specialized type of surveillance that only
exist in certain centers. These sites are usually chosen because they are most likely to
be representative of the health concern in question [35]. The physicians notify the
public health authorities about cases with certain specific symptoms (e.g., influenza
like illness). Additionally, data from hospital admission and discharge records, and
data from absenteeism that are obtained from schools and work absenteeism
declarations can also be used in the detection of outbreaks.
Some of the data which is produced from the laboratories is valuable in
identifying IDs. The laboratories generate results that are necessary to confirm cases
of diseases or syndromes in population. The data generated from laboratories can
also be used in the epidemiological events investigation [3].
1.2.6 Source of data for ID surveillance
There are several sources from which data relevant to infectious disease
surveillance can be collected. Direct sources include patient health information that
is stored in paper or electronic medical records from hospitals, clinics, and
laboratories [3]. Additional information can be obtained from indirect sources that
can identify individual or spreading infection. For example, environmental data on
air and water pollution can potentially identify microbes in either of these sources.
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Sometimes data from telephone triage hotlines about people requiring quick
healthcare assistance due to an acute contamination problem can be the first flag
indicating a potential spread of infection.
Another source of data is from the drug prescribing patterns as well as sales
of (prescribed as well as over the counter) medications. However, drug utilization
data should be analyzed together with information about the patient’s health status
(either from medical records or self-reported symptoms). An example of selfmedication is when purchasing from a drugstore without prescription. Additionally,
data can be obtained from the medical records when physicians ask questions to
collect information about the patient's health status such as asking about their
symptoms [3].
1.2.7 ID surveillance strategies
The surveillance of IDs can be broadly divided into traditional (diseasespecific) surveillance, syndromic surveillance and event based surveillance [3].
1.2.7.1 Traditional (disease-specific) surveillance
This type of surveillance is based on the routine reporting of the notifiable
diseases. The building blocks of the traditional surveillance is any data coming from
routine reports such as laboratories (positive results), sentinel surveillance, and
reports which are sent from general practitioners.
The National Tuberculosis Surveillance System (NTSS) in United States of
America (USA) is an example for this type of surveillance. For example, when a
positive case for Mycobacterium tuberculosis is identified, a report to the NTSS will
be sent by the state health department, and this data will be published on CDC
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website. The advantage of this type of surveillance is that it can be used for a wide
range of pathogens, but before starting the surveillance, the targets such as diseases,
pathogens, populations and syndromes must be identified clearly [3].
1.2.7.2 Syndromic surveillance
Syndromic surveillance is defined according to the CDC as: an
investigational approach in which the health department staff use automated data
acquisition, monitor diseases indicators continually or at least daily to discover the
diseases outbreaks earlier [45]. In this type of surveillance, once the clinical features
(symptoms) of the suspected disease have been identified, appropriate action is taken
(such as isolation) even before the diagnosis (laboratories results) is confirmed [46].
These surveillance systems are being developed at local, regional, and
national levels [46]. Factors such as the outbreak size, the affected population
dispersion and the ability of healthcare providers to identify and report unusual cases
influence the ability of syndromic surveillance to identify outbreaks earlier than
conventional surveillance methods [47]. Syndromic surveillance systems are rapid to
implement and can help the public health leaders in making decisions in
implementing and evaluating programs for the prevention and control of IDs, but the
lack of human resources may affect the collection and sharing of the data. The
Electronic Surveillance System for the Early Notification of Community Based
Epidemics (ESSENCE I) is an example of syndromic surveillance in US. The
implementation of the ESSENCE started as a partnership between the Johns Hopkins
University Applied Physics Laboratory and the US Department of Defense. The
initial program (ESSENCE I) involved screening of the US army personnel [3].
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1.2.7.3 Event based surveillance
The data in the event based surveillance is not based on the routine collection
of data, but rather relies on the immediate reporting of events. Originally the
information can come from inaccurate sources or unreliable sources such as rumors,
reports, and even internet sources. This type of surveillance spots health related
events (infectious) worldwide. Program for Monitoring Emerging Diseases (ProMed)
[3], HealthMap, EpiSPIDER and BioCaster are examples of event based surveillance
and they are important to detect the true outbreaks globally [48]. Event based
surveillance is rapid in detecting and reporting the potential health hazards and it can
be used in countries with no public health surveillance system, such as in some lowincome countries. The events detected by this type of surveillance need to be
confirmed by reliable methods such as accurate clinical diagnosis and confirmatory
laboratory testing (where applicable) [3].
1.2.8 Types of surveillance programs/regional activities
Infection Control Committee
Infection Control Committee is group of professionals or personnel in a
healthcare facility whose aim is to monitor and supervise the infection control
activities within the healthcare facility.
The committee should be multidisciplinary, and include physicians as well as
representatives from: administration, clinical microbiology, training services,
pharmacy, housekeeping and maintenance. This committee must be able to meet
quickly in emergency situations (such as an outbreak) and whenever required.
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Some of their tasks are, reviewing the epidemiological surveillance data,
ensuring that the staff is getting appropriate training in safety and controlling
infections and investigating of epidemics [49].
Regional programs
To reduce the risk of the infections in the healthcare facilities, the health
authority is responsible of establishing a regional program which must develop the
guidelines for healthcare surveillance, practice and prevention, and must be updated
continually to ensure it is fulfilling its goals. In order to have effective regional
programs, it is essential to have adequate staffing and appropriate training,
appropriate equipment (chemical reagents, kits), and proper isolation facilities [49].
Self-reported surveys
There are different methods to assess the burden of infectious diseases. One
method is routine collection of data from healthcare facilities, and this is generally
known as passive surveillance (Figure 1.2 is modified from the source) [44].
The other way to collect data that is not available or not collected routinely
from the healthcare facilities is by using surveys, in which the data is collected
directly from the population of interest (self-reported). Such data is valuable to
estimate the burden of disease in people that are not likely to visit the healthcare
facilities for their illness [6].
An example for such illness is Infectious Intestinal Disease (IIDs), which is
described as diarrhea or vomiting caused by microorganisms and it is one of the most
common IDs in the world [50]. The high annual costs due to the burden of this illness
are making IIDs an important public health issue [44]. Some data on IIDs can be
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obtained from outbreak surveillance, activities of the routine public health
surveillance and laboratory based communicable disease reporting [6].
Self-reporting IID is useful in several situations. People in remote
communities are unlikely to visit health facilities because travelling may be
cumbersome. People with chronic diseases may have difficulties in visiting the
health facilities, because of the nature of their disease, so it will not be captured in
the routine health monitoring surveillance system. Since many cases of IIDs are
tolerable and self-limiting, they often are not identified unless captured in a selfreported survey [6].
Usually such self-reported disease surveys contain a questionnaire which may
collect information about the symptoms that are reported by the respondents. In
addition, the participant may be required to undergo laboratory, physical or
radiological examination. For example, in studying the self-reported IIDs, a stool
sample may be collected [6].
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Data appear in
national statistics

Positive lab test results

People who provide stool
sample requested by GP

People with IIDs and go to their
GP

Population with IIDs in the community
Figure 1.2: Surveillance of IIDs, showing the data flow at each level
Standard based case definition needs to be used for studies on IIDs [51].
Although IID has been the topic of many studies [52-55], the different symptom
based case definitions and the different terms for the same illness that have been used
in these studies make it hard to draw comparison between such studies, despite the
fact that in these studies the same illness is being evaluated (Table 1.2 is modified
from the source).
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Table 1.2: Symptom based case definitions for gastroenteritis to population data from
United States, Ireland, Canada, Norway, and RAK
Definition
name/ Ref
FoodNet
(United
States)
[52]

Illness

Definition

Diarrhoeal illness

≥ 3 D in 24 h
lasting > 1 day,
or resulting in
activity
restriction

Irish
(Ireland)
[53]

Acute
gastroenteritis

NSAGI
(Canada)
[54]

Acute
gastrointestinal
illness

Norwegian
(Norway)
[55]

RAK

Prevalence/
Incidence
Prevalence=6%

The definition is
more specific
Incidence=0.75 after interview
episodes per person confirmed cases
per year

≥ 3 D: or bloody
The definition is
D: or V with one
more specific
of D,
Incidence= 0.60
cramps/abdomin episodes per person
al pain, fever in
per year
24 h
D or V

Prevalence=10%

The definition is
very general

Incidence=1.3
episodes per person
per year

≥ 3 D in 24 h: or
at least 3 of the
following: V,
Incidence=1.2
nausea,
episodes per person
abdominal
per year
cramps, fever
Infectious
≥ 3 D in 24 h: or Prevalence=4.23%
Intestinal Diseases
V in 24 h
Gastroenteritis

Remarks

The definition is
general and only
excluded chronic
cases

FoodNet, United States Foodborne Diseases Active Surveillance Network; NSAGI,
National Studies on Acute Gastrointestinal Illness; D, diarrhea (loose stool); V,
vomiting, in all studies the time period for observation was 4 weeks prior to
interview
To estimate the true level of morbidity, prevalence and the incidence of the
IIDs in the community, many studies have been conducted using different
methodologies like retrospective and prospective study designs [51, 56]. These
studies using retrospective cross sectional studies and prospective cohort studies
methodologies have collected information about self-reported IID data from their
target population such as information about the demographics, possible causes of this
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illness, symptoms and their severity, healthcare use and secondary symptoms [51,
56].
The retrospective cross-sectional studies are based on contacting the
participant, usually by the phone, to ask about their symptoms in the recent past. By
contrast, cohort prospective studies recruit the participants and asking them to record
their symptoms in a form of a diary over a period of several weeks or months [44].
An important advantage of prospective cohort studies is that the pathogens
causing the IIDs can be determined by requesting stool samples from the participants
who report illness, thereby confirming the diagnosis through laboratory testing [44].
However, such study designs suffer from information bias in which the outcome
assessment can be affected by knowledge of exposure, take longer time and are more
expensive. Additionally, there is the risk of selection bias due to loss of follow up,
which may lead to under estimation the true burden of the disease [6].
Using the retrospective cross-sectional method has many advantages over the
prospective cohort method. For example, it is less expensive and can be performed
over a relatively short period of time, which enables use of a large sample size,
thereby reducing type II error. Also, since it is not relying on those who attend the
healthcare facilities, this method is able to capture cases that do not make their way
to a doctor [56].
However, the retrospective cross-sectional method has some disadvantages
such as not including microbiological information on the cases of illness [44] and
suffers from a number of biases. For example, recall bias (telescoping) occurs when
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the participants have a tendency to displace events in time and includes the
inaccuracy in recalling the symptoms onset date, severity and duration [44, 51].
Recall bias will give an over estimate of the IID frequency [6, 56]. An
example is in an IID study, the incidence of IID was 0.55 episodes per person-year
when using the retrospective cross-sectional method, while it is 0.19 episodes per
person-year using prospective cohort method even after using the same case
definition in both methods [26].
1.3 Literature review – ID surveillance system
Search of the published articles on the surveillance system showed that the
majority of the literature that was published involved different aspects of surveillance
systems, either providing a description or an assessment or an intervention expected
to improve the system.
1.3.1 ID surveillance systems – worldwide
The surveillance systems around the world are very different with regards to
how developed and efficient they are [37]. Since the distribution and the magnitude
of the IDs vary by region, each country needs to develop its own strategies and
surveillance system for their particular situation [57].
1.3.2 ID surveillance system – developed countries
ID surveillance is usually based on notifiable disease reporting systems and
these diseases are required to be reported to government health authorities by law
[31]. Most developed countries have a well-established system which is functional.
Publications in the literature about this topic give some information about issues of
concern in these surveillance systems. For example, developed countries tend to
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focus on how efficient their surveillance systems are (quality) and their main
challenges in the areas related to timeliness [32] and completeness [58] (Table 1.3).
Table 1.3: Main issues addressed in studies published of ID surveillance system in
developed countries
Country

Year of
Hospital or System
publication

Main issues

System

Single or
national
level
National

Australia

2017

Canada

2016

Canada
(Ontario)

2018

Germany

2017

ID surveillance system

National

Quality issues

[64]

Italy

2015

National

Quality issues

[63]

Korea

2009

Acute viral hepatitis
surveillance system
Notifiable diseases
surveillance system
System
SSI surveillance system

National

Quality issues

[57]

National
National

2012

ID surveillance system

National

Quality issues
[66]
Core elements and quality [62]
issues
Quality issues
[65]

2002

Notifiable surveillance
system
ID Surveillance system

National

Quality issues

[58]

National

Quality issues

[32]

Netherlands 2011
Norway
2016
United
Kingdom
United
States
United
States

2004

Ref

Quality issues
[59]
(completeness
&timeliness)
Pneumococcal surveillance National
Quality issues: [1[60]
system
Effectiveness (usefulness,
data quality) 2-Feasibility
(simplicity, acceptability,
timeliness)]
ID surveillance system
Ontario
Core elements, Quality
[61]
(provincial) issues

Many European countries assess national surveillance systems that cover a
large region. For example, US evaluated the quality issues of their national ID
surveillance system such as completeness [58] and timeliness [32]. Australia also
focused on completeness and timeliness (quality issues) when evaluating their
national ID surveillance system [59]. In Korea and Canada, the national ID
surveillance systems were evaluated focusing on quality issues such as effectiveness
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(usefulness, data quality) and feasibility (simplicity, acceptability, timeliness) [57,
60].
It is important to evaluate not only the quality issues of a surveillance system,
but also the core elements. A recent Canadian publication in 2018 evaluated the
existing ID surveillance system, focusing on both the core elements and the quality
issues of their system [61]. Similarly, in Norway in 2016, a published article
evaluated the core elements and the quality of their national ID surveillance system
and found that the completeness of their surveillance system is improving over a
time, and also found that the computer based surveillance systems gives good
accuracy when analyzing the data [62].
Italy [63], Germany [64], UK [65], and the Netherlands [66] published
articles on evaluation of their national ID surveillance systems, focusing on the
quality issues. Italy, Germany and Netherlands evaluated the timeliness of their
surveillance system, while UK assessed the completeness of their reports.
1.3.3 ID surveillance system – developing countries
By contrast, publications on ID surveillance systems from developing
countries are different from those from developed countries in terms of the issues
they deal with.
In general, the focus is on issues related to the basic structure of the
surveillance systems, such as the core elements and the support functions. For
example, in an Iranian study evaluating the support functions of their surveillance
system; it was found that combining the computerized surveillance systems with the
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use of the internet is useful to ensure that updated surveillance information is always
available at any time [29].
Tanzania identified gaps related to core functions in their surveillance
system; standardized case definitions were unavailable for the majority of IDs they
were reporting (only 3 of 21 IDs were with standardized case definitions) and require
improvement in the reporting, analysis and feedback [33]. Pakistan found that most
practitioners were noncompliant towards reporting the notifiable diseases, because of
the lack of time (difficult reporting system) and poor knowledge about the
importance of reporting such diseases [67].
In India, the non-reporting and the incomplete reporting of notifiable
diseases were because of the lack of information or unawareness about the reporting
system [21, 68]. In Sri Lanka, improvement of the system through computerization
and enhancement of laboratories were seen as steps to improve the surveillance
system [69]. Improvement of the surveillance system in Brazil was proposed to be
through training of health professionals [70].
China found when evaluating their national surveillance system that the early
warning (early detection) is an essential element for their ID surveillance system to
be more efficient [38].
Some developing countries have been working on improving their
surveillance system. In Pakistan a publication evaluating the core elements of their
national ID surveillance system [67], was followed by a second publication several
years (2016) later focusing on quality issues of a national ID surveillance
system [71].
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Similarly, Ghana evaluated the core elements and support functions of their
national ID surveillance system first in 2015 [72], then focused on evaluating the
quality issues of their national ID surveillance system in 2016 and found that their
surveillance system improved in completeness and timeliness [73].
Several other African countries have recently started evaluating the quality
issues of their national ID surveillance system. For example, Nigeria (Enugu) in
2018, published an article focusing on the quality issues (timeliness and
completeness) when evaluating their national ID surveillance system and found that
their surveillance system needs to be improve focusing on completeness and
timeliness issues [74]. Also Madagascar (southern coast of Africa) published an
article in 2017 evaluating the quality of their ID surveillance system and found that
their surveillance system is performing very well especially in terms of its simplicity
and acceptability [75].
In Afghanistan, an article published in 2013, focused on evaluating the
quality issues of their ID surveillance system. Their surveillance system was poor in
terms of timeliness and acceptability [76] (Table 1.4).

48
Table 1.4: Main issues addressed in studies published of ID surveillance system in
the developing countries
Country

Year of
publication

Hospital or System

Single or
national
level

Main issues

Ref

Afghanistan

2013

TB surveillance
system

National

Quality issues

[76]

Brazil

2012

ID surveillance
system

National

Core elements

[70]

China

2017

ID surveillance
system

National

Core elements,
support functions

[38]

Enugu (Nigeria)

2018

System

Regional

Quality issues
(timeliness and
completeness of data
reporting)

[74]

India (Mumbai)

2012

System

National
(city)

Core and support
functions

[68]

India

2017

ID surveillance
system

National

Core and support
functions

[21]

Iran

2010

ID surveillance
system

National

Core and support
functions

[29]

Madagascar (low 2017
income)[Southern
coast of Africa]

Influenza sentinel
surveillance system

National

Quality issues

[75]

Northern Ghana

2015

ID surveillance
system

National

Core and support
functions, quality
issues

[72]

Northern Ghana

2016

ID surveillance
system

National

Quality issues

[73]

Pakistan

2014

ID surveillance
system

National

Core elements

[67]

Pakistan

2016

Acute respiratory
surveillance system

Gilgitbaltistan
(single)

Quality issues

[71]

Sri Lanka

2011

ID surveillance
system

National

Core elements,
support functions

[12]

Sri Lanka

2013

Notifiable disease
surveillance system

National
(Jaffan city)

Advantage and
disadvantage of the
surveillance/ support
functions

[69]

Tanzania

2002

ID surveillance
system

National

Core and support
functions

[33]
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1.3.4 ID surveillance system – Middle East and North Africa (MENA)
Publications in the literature about the ID surveillance system in the MENA
region are limited (Table 1.5). In Iraq (Mosul), the ID surveillance system was
evaluated focusing on issues related to core elements and support functions, which
was at the regional level. Their surveillance system was in general poor in issues
related to the core functions [77].
Qatar published an article in 2014 that was conducted during 2012-2013
which evaluated the ID surveillance system focusing on quality issues in a very small
newly build hospital (75 beds), the core elements and the support functions was not
evaluated which are the building blocks of any surveillance system and must be
evaluated first [78].
Kingdom of Saudi Arabia (KSA) published an article in 2000 evaluating their
ID surveillance systems focusing on quality issues in several hospitals from (Jeddah)
in the year 1999.Their surveillance system found to be good in reporting the
cases [79].
Kingdom of Saudi Arabia (KSA)
Hajj issue in our region
The IDs are important issue especially in a situation of mass gathering,
because it may result in outbreaks. The WHO defined mass gatherings as "events
attended by a sufficient number of people to strain the planning and response
resources of a community, state or nation"[80]. Every year, the KSA hosts the Hajj,
which is the largest religious mass gathering in the world [81], in which 2-3 million
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pilgrims [82] coming from over 180 countries around the world are present in an area
of 356,000 square kilometers [83].
In the crowded Hajj conditions, the infections of the respiratory tract, such as
TB, spread rapidly through sneezing and coughing. Food poisoning by toxins
produced by some microorganisms like Staphylococcus aureus or gastroenteritis due
to viruses and Salmonella spp also is a common during the Hajj [81].
For any mass gathering, there are three core areas that are important: the risk
assessment for the things that may happen, surveillance to predict when a disease
appears, and the action in the cases of the disease outbreak [80].
The KSA always prepares for the Hajj season by: regular updating of the
health regulations and updates the Hajj travel advice through international public
health agencies such as WHO and CDC as well as Hajj travel agencies.
Additionally, 25000 health workers are deployed during the Hajj season.
Healthcare services for acute conditions are offered free to Hajj pilgrims. There are
additional preventive measures such as: mandatory vaccination prior to travelling for
Hajj and prohibition of bringing agricultural products or fresh food into KSA) [81].
Table 1.5: Main issues addressed in studies published of ID surveillance system in
the MENA region
Country

Year of
publication

Hospital or System

Iraq

2008

System

Single or
national
level
Mosul

Qatar
Saudi
Arabia

2014
2000

One hospital – new
Hospitals – several

Single
Jeddah

Main issues

Ref

Core elements
and function
Quality issues
Quality issues

[77]
[78]
[79]
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United Arab Emirates (UAE)
ID is a particularly important public health issue in the UAE due to the tourist
influx from all over the world and also due to a high migration of expatriates [84].
Nevertheless, the rates of infectious disease are low due to the regular screenings of
expatriate residents, immunization program, strict legislation regarding certain
diseases and the high standard of living [85].
The UAE is a relatively small country, spanning an approximate area of
83,000 square kilometers. It was established in December 1971 and comprises seven
Emirates: Abu Dhabi (capital of the UAE), Dubai, Sharjah, Umm Al Quwain,
Fujairah, Ajman and Ras Al Khaimah (Figure 1.3) [86].

Figure 1.3: Map of United Arab Emirates showing the seven Emirates
According to the 2015 censes, the total UAE population was 9,154,000 [87].
RAK is one of the seven emirates and the fourth largest emirates that's cover 2,478
square kilometers of the total land area of the UAE with a population of
231,000 [88].
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An effective surveillance system is one of the important keys to control
spread of IDs, and inadequate surveillance and response capacity in a single country
can endanger national populations and the public health security of the entire
world [89].
1.4 Literature Review – IIDs
1.4.1 IIDs – Worldwide
Few studies have attempted to measure the burden caused by all types of
infection in a single study, but many studies that have measured the burden of
specific infectious diseases such as IIDs [50].
IID is one of the commonest IDs, and it is the most frequently studied in the
community studies, because it gives information about intestinal illness which is not
detected by passive surveillance.
In developing countries, the mortality due to IID is high, especially in
countries with limited health facilities. By contrast, the mortality due to such illness
is low in developed countries, but the morbidity and the economic impact are
substantial [54]. Much of the burden due to IID is overlooked by passive surveillance
systems, because many of these cases do not present to the healthcare system, and
remain at home until the self-limiting condition resolves on its own or is managed
with home remedies or self-medication [50] and most of the people don't try to
obtain medical attention, so it is hard to determine the incidence of this disease using
routinely collected data [26]. In order to fill this gap, researchers have used
community based surveys to obtain information about IID [90].
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The epidemiology of IID has showed big differences between countries as
shown below. Incidence/prevalence have varied cross countries in deferent parts of
the world. It is important to be aware of different methodologies to be used.
1.4.2 IIDs – Developed countries
Data on infectious intestinal diseases can give us important information on
the burden of disease, which may be otherwise missed by traditional surveillance
systems. However, when examining such data, it is important to be aware of the
methodology behind it.
For example, studies that use a general definition that also encompasses
respiratory infectious diseases are likely to report a higher prevalence than those
reporting on intestinal diseases only such as: in Italy the IIDs incidence is 1.08
episodes per person-year without excluding those with respiratory symptoms and it is
0.76 episodes per person-year when excluding the respiratory symptoms [90].
Several studies around the world have looked at incidence or prevalence
through telephone based surveys, these studies generally do not focus on specific
agent (bacteria, viruses and parasites), but rather depending on participants reporting
their symptoms to be considered a positive case. For example: a study conducted in
the UK estimated the incidence of symptomatic IIDs in 2016 without confirmatory
laboratory testing to identify the causative agent [26]. Two US studies were
conducted to investigate all types of causative agents that may cause IIDs [43, 52].
Ireland and Canada both published articles in 2004, studying all types of
causative agents causing IIDs in their target population [53, 54]. Other studies from
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Malta [56, 91, 92] and Australia [93] also did the same by studying all the causative
agents causing the IIDs in their target population.
The incidence/ prevalence of the IIDs may increase, decrease, or it may
remain almost constant over a certain time interval in the same country. For example,
in the Netherlands, the incidence of IIDs increased from 0.283 episodes per personyear (prospective cohort) in the 2001 [94] to reach 0.964 episodes per person-year
(retrospective) in 2012 [50].
By contrast, in Malta, the prevalence of the IIDs decreased from 5% (during
2003) in 2006 [56] to 3.18% (during 2004-2005) in 2007 [92]. In the US, the
incidence and the prevalence remained almost constant over a time. The incidence in
2002 (during 1996-1997) was 0.75 episodes per person-year (prevalence 6%) [52]
and in 2004 (during 1998-1999) it was 0.72 episodes per person-year (prevalence
6%) [43].
Comparing the incidence of IIDs over the same time period has highlighted
differences within the same continent. For example, data from the Netherlands and
Italy in 2012, estimated similar incidences (0.964 and 1.08, episodes per person peryear respectively) [50, 90]. In both of these studies the authors suggest that it is
important to note that telescoping may have inflated the incidence reported. Another
example is Canada and US which are considered to be in the same continent, while
showing differences in the prevalence and incidence even during a relatively similar
duration of time. The incidence in Canada 2004 (during 2001-2002) was 1.3 episodes
per person-year and the prevalence was 10% [54], while in the US the incidence in
2004 (during 1998-1999) was 0.72 episodes per person-year and the prevalence was
6% [43]
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Studies of IIDs provide important information, but using different case
definitions, different study designs, and including respiratory tract infection cases
have made the comparisons between studies done in different countries difficult
(Table 1.6).
Table 1.6: Epidemiological studies on IIDs from different developed countries
Country/

Disease

Study design

Target

Size

Australia
(2005)

Diarrhea

-Cross
sectional
telephone
survey

All ages N=6087

Canada
(2004)

Acute
-Retrospective All ages N=3500
gastrointestinal cross sectional
telephone
illness
survey (selfreported)

Year of pub

Outcome
Associated factors Ref
Prevalence/Incidence*
-Prevalence=6.4%

-Age

[93]

-Gender

-Prevalence=10%

-Incidence rate=1.3
episodes per person
year

-Medications
(antibiotics)

[54]

-Season
-Age
-Gender

Ireland
(2004)

Acute
-Population
All ages N= 9,903 -Prevalence= 4.5%
gastroenteritis based
telephone
-Incidence= 0.6
survey (2000episodes per person
2001)
per year

-Presence of a
child in a
household

[53]

Italy

Acute
-Retrospective All ages N=3490
gastrointestinal telephone
survey (selfillness
reported)

-Occupational
status

[90]

(2012)

-Prevalence=8.9%

-Season
-Citizenship
-Gender
-Age

Malta

IIDs

(2006)

Malta
(2007)

IIDs

-(Pilot study) All ages N=2652
Age stratified
retrospective
cross sectional
telephone
survey

-Prevalence=5%

-Age stratified All ages N=3504
retrospective
cross sectional
telephone
survey

-Prevalence=3.18%

-Demographic
data

[56]

-Symptoms
-Burden of illness

-Working/school
days lost
-IID cost
(direct/indirect)

[92]
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Table 1.6: Epidemiological studies on IIDs from different developed countries
(Continued)
Country/

Disease

Study design

Target

Size

IIDs

-Age stratified All ages N=3504
retrospective
cross sectional
telephone
survey

Year of pub
Malta
(2010)

Outcome
Associated factors Ref
Prevalence/Incidence*
-Prevalence=3.18%
Data on specific
pathogens which are
not shown in this table

-Pathogens
[91]
causing the illness

-Incidence=0.421
episodes per person
per year
Netherlands Gastroenteritis -Prospective
population
(2001)
based cohort
study

All ages N=4860

-Incidence= 283 per
1000 person-years

-Age

[94]

-Gender
-Degree of
urbanization
-Region
-Level of
education

Netherlands IIDs
(2012)

-Retrospective All ages N=1975
cross sectional
study (selfreported)

United
Kingdom
(2016)

IIDs

-Retrospective All age
telephone
survey (selfreported)

United
States
(2002)

Acute
Diarrheal
illness

-Population
based
telephone
survey

United
States
(2004)

Acute
Diarrheal
Illness

-Population
based
telephone
survey

-Prevalence=7.4%

-Season
-Age, -Gender

N=14,813 -Incidence=0.533
-Age
episodes per person -Gender
year

All ages N=8624

[50]

-Prevalence=11%

-Age, -Gender

[26]

[52]

-Residence
-Incidence=1.4
episodes per person
per year
All ages N=12,075 -Prevalence=6%

-Education
- Income, -Race
-Education level

[43]

-Area
-Incidence=0.72
episodes per person
per year

-Ethnicity
-Age, -Gender
-Season

*Some studies reported prevalence only and some studies reported incidence only
and some reported both; the values presented in the table were as reported by the
authors in the original paper.1.4.3 IIDs – Developing countries

57
Some developing countries have reported different incidence/prevalence of
the IIDs within the same geographic and even within the same country. For example,
in Iran different prevalence of the intestinal parasitic infections were reported in
three different cities, Gorgan, Boyer Ahmad, and Tehran, with the prevalence of
28.8%, 37.5%, and 32.7% respectively [95, 96, 97]. Although it must be
acknowledge that other factors may contribute to these differences.
When comparing published research from developed and developing
countries, it is clear that the main focus of the developing countries is on intestinal
parasitic infections (Table 1.7). Furthermore, studies in some developing countries
have included all types of causative agents causing the IIDs such as Malaysia [98]
and China [99], while many other developing countries studies focused on studying
intestinal parasitic infections such as West Africa (Burkina Faso) which found a high
intestinal parasitic infection (86.2%) of parasites in a school children age from 8-14
years [100]. Iran reported a low prevalence of parasites (3.7%) causing IIDs in food
clerks (4612 samples) in Tabriz city, although it must be noted that the study sample
was very specific sample of adults [101]. In Pakistan (Karachi) prevalence of
parasites in children aged 1-5 years was 52.8% [102]. In Ethiopia 34.2% of children
from grade 1-8 had parasites causing IIDs [103].
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Table 1.7: Epidemiological studies on IIDs or parasitic infections in developing
countries
Country/ Disease
(Year of
pub)
China
IIDs
(2013)

Study Design

Target

Sample
size

-Retrospective
cross sectional
From
July/2010July/2011

All ages

N=39686 -Prevalence=4.2%

Malaysia IIDs
(2011)

Outcome
Associated factors
Prevalence/Incidence*

-Nationwide
All ages
cross sectional
survey
From Apr/2006mid Aug/2006
West
Intestinal -Cross sectional Age 8-14
Africa, parasitic survey
years
Burkina infections In Feb/2015
Faso
(2016)

N=56710 - Four week
incidence=5%

Ethiopia Intestinal -Cross sectional Grade1(2013) parasitic survey
grade8
infections From Apr/2012Jun/2012

N=304

N=385

-Prevalence=86.2%
(parasites)

-Prevalence=34.2%
(parasites)

Pakistan, Intestinal -Cross sectional Children
N= 350
Karachi parasitic From
aged 1-5
(2008) infections Feb-June/ 2006 In town in
Karachi

-Prevalence= 52.8%
(Parasites)

Iran
(2012)

-Prevalence= 28.8%
(Parasites)

Iran
(2016)

Iran
(2016)
Iran,
Tehran
(2017)

Intestinal -Cross sectional
parasitic survey
infection Between
Oct/ 2010March/ 2011

Primary
N= 800
school of
Gorgan
City Age 8
to 12 years
old
Intestinal -Cross sectional All ages
N=1025
parasitic population
(Boyer
infections based survey. ahmad
From
distract)
Jun-Dec/ 2014
Intestinal -Descriptive
Food clerks N= 4612
parasitic study
in Tabriz
infections In 2014
City
Intestinal -Cross sectional All ages
N= 561
parasites From
residents of
Jun-Dec/ 2014 Roudehen
area

-Gender
-Age
-Ethnic group
-Education
-Days off
-Causes of their
illness.
-Seeking healthcare
-Age, Ethnicity,
Gender
-Education, Locality
-Household Income
-Gender
-Ethnicity
-Hand hygiene
-Exposure to fresh
water
-Quality of drinking
water
-Age
-Gender
-Hand hygiene
-Education
-Family monthly
income
-Gender, -Age
-Mother education
status
-Monthly family
income
-Pathogens
-Hand hygiene
-Household Income
-Education level
-Family size
-Animal contact

Ref

[99]

[98]

[100]

[103]

[102]

[95]

-Prevalence= 37.5%
(Parasites)

-Pathogens
[96]
-Contact with animals
-Education status

-Prevalence= 3.73%
(Parasites)

-Pathogens

[101]

-Prevalence=32.7%
(Parasites)

-Gender, -Age
-Occupation,
Education
-Water source
-Animal contact

[97]

*Some studies reported prevalence only and some studies reported incidence only
and some reported both; the values presented in the table were as reported by the
authors in the original paper.1.4.4 IIDs – Gulf Cooperation Council (GCC)
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Six countries closely related geographically and culturally, make up the GCC.
These are Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and UAE [85]. Studies of
IIDs are very limited in the Gulf region (Table 1.8), and it is notable that the majority
of them focused on parasitic infections.
The prevalence of the intestinal parasitic infections has been shown to vary in
different cities of KSA. A community based study conducted in (Riyadh) in 1999
reported that 32.2% infected with the intestinal parasites infections [104]. The only
study of IID was reported in (Jeddah), where the one-month incidence of diarrhea
was 14.9 % (during 2004-2005) [105]. Intestinal parasitic infections were reported in
44.2% from the study population in (Madinah) during 2012 [106].
In Bahrain, the first and only published community based study was
conducted from 1984-1986 and found that 739 persons (34.8%) had intestinal
parasitic infections from a total number of 2123 participants [107].
In Qatar, over a three-year period from 2005-2008 it was found that 10.2%
of the study population (N=9208) were found positive when tested for intestinal
parasitic infections [108].
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Table 1.8: Epidemiological studies on IIDs from different MENA region
Country/Year Disease
of pub
Bahrain
Intestinal
(1995)
parasites
infections

Study design Target

First
community
based study
From 19841986
Dubai (2015) Infectious From 1995Diseases 2013

All ages

Size

Outcome
Associated factors Ref
Prevalence/Incidence*
N=2123 -Prevalence=34.8%
[107]

-Data about 21 ID were
included, of which 5
diseases were intestinal
diseases
KSA, Riyadh Intestinal Household All ages
N=6012 Prevalence=32.2%
-Area
(2001)
parasites survey
(Riyadh)
-Gender
infections
-Age
-Education
-Nationality
-Environmental
factors
KSA (2009) Diarrhea Cross
Boys public N=1064 -Prevalence= 14.9%
-Children under 5.
diseases sectional
School in
-Sewage spillage
survey (self- Jeddah
near household.
reported)
7-12 years
-Eating out after
-From
school
Oct/2004-Not drying hands
Feb/2005
after washing
-Using reusable
cloths to dry
dishes.
-Eats in traditional
restaurants
KSA
Intestinal Prospective Workers in N= 120 Prevalence=44.2%
-Gender
Madinah
parasites cross
Madinah
-Nationality
(2015)
infections sectional
(Asia,
-Age
Africa)
Qatar (2010) Intestinal Hospital
Subjects of N= 9208 - Parasites increase in -Region
parasitic records
all age
prevalence (almost
(nationality)
infections
groups
doubling) over the
-Age
From 2005- from28
period 2005-2008
-Gender
2008
nationalities
- prevalence= 10.2%
and resident
in Qatar
Sharjah
Intestinal (laboratories Patients of N=10514 -Prevalence=7.7%
-Nationality
(2010)
parasitic investigation) all age
intestinal parasitic
infections -From
(native &
infections
(Protozoa) Jan/2008expatriate)
Dec/2009
attending
MoHAP
hospitals in
Sharjah

[84]

[104]

[105]

[106]

[108]

[109]

*Some studies reported prevalence only and some studies reported incidence only
and some reported both; the values presented in the table were as reported by the
authors in the original paper. In the United Arab Emirates (Sharjah), the prevalence
of the intestinal parasitic infections was 7.7% (15.7% native and 3.2% expatriate)
from the study population of all ages attending Ministry of Health hospitals in the
emirate of Sharjah (N=10514); the rate of infection in males was 58% and 42% in
females (from Jan 2008-Dec 2009) [109].
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The only study published from the UAE on IIDs, is a study conducted in
UAE (Dubai) that represented retrospective hospital data about 21 different IDs
including some selected intestinal diseases. This study found that in more recent
years (2014-2016), the forecasted Crude Incidence Rate (CIR) of Amoebic
Dysentery, Bacillary Dysentery and Food Poisoning was much higher than the
calculated CIR in previous years [1997-2013] (Table 1.9) [84].
Table 1.9: Change in the mean of CIR associated with one year increase in time
every 4 years starting by 1997 and ending by 2013, and forecasted changes from
2014-2016
Change in
time

Forecasted values

1997-1998

2002-2003

2007-2008

2012-2013

2014

2015

2016

Amoebic
Dysentery

-0.33

0.47

1.27

2.07

17.12

19.51

22.06

Bacillary
Dysentery

-2.35

-1.25

-0.15

0.95

3.29

4.68

6.29

Food
poisoning

-1.47

0.53

2.53

4.53

41.53

46.86

52.59

Salmonellosis

-4.1

-1.9

0.3

2.5

-

-

-

Typhoid

-4.75

-2.35

0.05

2.45

-

-

-

Diseases

1.5 Statement of problem
The UAE has worked on developing its health services which have now
become comparable to international standards. The UAE also works closely with the
WHO on several areas that aim to improve the public health situation, with IDs being
one of the top priorities. The UAE is a member state with the WHO Eastern
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Mediterranean that is working towards a plan to fulfill the implementation of the IHR
[110].
There is very limited published data about both active IIDs and passive IIDs
surveillance systems in the UAE. Considering that community based surveillance of
IIDs is an example of active surveillance, there is a lack of studies in the UAE,
therefore there is a need for further studies to better understand intestinal disease in
UAE. Most data available is hospital based data, which does not reflect the true
burden of IIDs in the community.
Regarding health system based surveillance, there are no publications
describing the core capacities and structure of surveillance systems in the UAE.
Neither has there been any published evaluation of the associated support functions
nor quality issues related to the surveillance system such as timeliness of reporting
and completeness of records.
In UAE, this is the first attempt to examine IIDs in the RAK community to
understand the burden of IIDs in this emirate. And it is also the first attempt to
describe some components of ID surveillance system in RAK using the core criteria
setup from the IHR.
1.6 Research question
What is the IIDs burden in RAK community and what are the main
characteristics of the local ID surveillance system?
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1.7 Aims
The aim of the study is to estimate the burden of infectious intestinal disease
in the community and to describe the surveillance system in the emirate of RAK.
1.8 Objectives
1. To measure the self-reported prevalence of infectious intestinal disease in a
representative population-based sample using a standardized interviewer
assisted questionnaire.
2. To describe the burden of intestinal infections and explore some of the
associated factors.
3.

To describe the structure, core functions and support functions of the
infectious disease surveillance system in RAK.

1.9 Expected benefits
This study estimates the burden of intestinal infection amongst the population
of RAK. With it being the first community study on infectious diseases in Ras Al
Khaimah, this study will identify the practical challenges in doing this type of study
in the local setting. Furthermore, the findings will help identify the magnitude of the
problem and associated factors. This work can help in development of the
infrastructure and public health staff, so that it is possible to identify those who are at
risk of intestinal infections in RAK population. Furthermore, since this is the first
published description of the surveillance system in RAK, it can be used as part of
future quality improvement projects.
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Chapter 2: Methods
2.1 Introduction
In this chapter, the methods used to estimate self-reported infections in RAK
and the methods used to describe the existing surveillance system in RAK are
presented.
2.2 Part 1: Community survey to estimate self-reported IIDs
This section has been written in accordance with the Strengthening the
Reporting of Observational Studies in Epidemiology (STROBE) guidelines [111].

2.2.1 Study design, population and setting
A population-based telephone survey (cross-sectional design) was conducted
from 07 January 2017 to 31 September 2017 in the Emirate of RAK. The target
population was all residents of RAK and those who were no longer living in RAK
were excluded. The UAE Federal Competitiveness and Statistics Authority provided
the sampling frame, which was a list of all residential addresses and telephone
numbers in RAK.
2.2.2 Estimation of sample size
From previous studies, it was estimated that four weekly prevalence of IID
was 6% [43]. This estimate was used in the following equation:
Sample size n = [DEFF*Np(1-p)]/ [(d2/Z21-α/2*(N-1)+p*(1-p)] [112].

Where, N = Population size (RAK population 231000)

p = prevalence (0.06) 6%
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d = Precision (0.015) = (0.045 – 0.075)/2 = 0.015 from CI (4.5% - 7.5%).

DEFF = Design effect (1): usually 1 except for stratified or cluster sampling.
Z1−α/2 = 1.96n = [1*231000*0.06(1−0.06)]/
[(0.0152/1.962)*(231000−1)+0.06*(1−0.06)] = 13028.4/13.586 = 959

Then a sample of 959 will give an estimate of the population proportion of
4.5%-7.5% with 95% confidence. It should be noted that this sample would consist
exclusively of adults, and therefore the only way to include children in the study was
for them to be reached through the adult participants (see below).
The UAE Federal Competitiveness and Statistics Authority provided the
sampling frame, which is the only authority with information on the UAE population
in all Emirates. This authority compiles data on the population, through its database
that covers all geographic areas in each emirate according to households in each area.
Each residential address is covered; however only a single mobile number is noted
for each address. Furthermore, the majority of the numbers were registered under a
male name, regardless of which member of that household or other person associated
is using it.
In order to recruit a representative sample of females and children in our
sample we aimed to recruit one male, one female, and one child from each
household. For example, if a male respondent answered the telephone call then his
spouse (or other adult female if spouse not available) and a child was recruited into
the study. The next birthday method was used to select one child (<18 years) from
each household. Considering the unique family and social hierarchical characteristics
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of our population, we expected this recruitment method to at least provide a
representative study sample that comprised adult males, adult females and children.
Based on a previously published study in the UAE, it was assumed that the
response rate in the current study would be 65% [113]. A more conservative
response rate of approximately 50% was assumed. As per the policies of the UAE
Federal Competitiveness and Statistics Authority provided a list of 1728 residences
with a mobile number for the head of the household, stratified by geographical
location and nationality.
All telephone numbers were provided by the Federal Competitiveness and
Statistics Authority, Abu Dhabi branch, based on their database of numbers which
were according to 108 geographical areas into which the emirate of RAK was
divided. Their sampling method ensured that representation was from all areas of
RAK, since their database included information about where the person is living.
Additionally, information about living area was collected to account for
people changing accommodation. Anyone no longer living in RAK was excluded.
Those who were in RAK, even if their accommodation was changed from one area to
another were included. To ensure that all areas of RAK were covered, the final
location of all study participants were once again mapped against the geographical
areas in municipality, to ensure no area was neglected.
2.2.3 Recruitment method
Each of the mobile numbers in the list of 1728 contacts given by the authority
was called. Numbers for which there was no response on the first call had repeat
calls to a maximum of 4 times in total.
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Along with the list of 1728 potential participants, the names, mobile numbers
and residential area were provided.
2.2.4 Data collection procedures
The initial plan for the study was to divide the list of 1728 numbers by 12,
with the aim of having an equal number of potential participants to be contacted
every month. As such, there were around 145 numbers to be contacted per month,
from which it was anticipated to get a response from around 100 participants. The
response rate improved after the second month and as a result the study period was
reduced to 9 months (January to September).
2.2.5 Research team and training workshop
The research team consisted of three research personnel experienced in
performing questionnaire based studies.
There was an initial meeting held on 07 January 2017, to go through the
protocol with the research team and explain to them their responsibilities. Specific
instruction was given on how to collect the information needed to fill the
questionnaire from the participants, how to respond to the possible questions from
participants and how to address any concerns that the participants may have. A chart
was produced to guide the research personnel on how to recruit females and children
(Figure 2.1).
In the questionnaire, there were no options for the interviewers to elaborate
on the questions as the majority was closed ended multiple choice questions.
Researchers had to ensure that forms were complete, and in case there was missing
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data or other issue related to the form, it was immediately raised to the principal
investigator to resolve.
Prior to initiating the study, the researchers were trained on the study
procedures including how to go through the questionnaire with the participants
without influencing the responses and how to document the responses on the form.
Definitions that were relevant to the research were covered in detail (see definition
section below).

Participants *

Family
accommodation

Married

(1) Run the
questionnaire on the
adult participant after
taking his/her consent.
(2) Ask about his/her
child < 18, with the next
birthday if it’s possible.
(3) Take parent consent
to interview the child.
(4) Ask for the other
parent's phone No.

Other (single, divorced,
widowed)

Non-Family
accommodation

(1) Run the
questionnaire on the
participants after
taking his/her
consent.

(1) Run the questionnaire on the
adult participant after taking
his/her consent.
(2) Ask about his/her child < 18,
or any child live in the same
house hold with the next
birthday if it’s possible.
(3) Take the consent to
interview the child.
(4) Ask for other adult ≥ 18
phone number (opposite gender
of the participants).

Figure 2.1: Chart to outlining the recruitment strategy
The plan was that for each household 3 questionnaires would be completed: two
adults and one child
(1) Male (≥ 18), (2) Female, (3) Child
*Participants from the initial list given by the Statistics Authority of Competitiveness
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For each family household, the aim was to recruit both parents and one child.
For single parents, the aim was to enroll the parent of the child, another adult in the
household and a child.
Non-Family household included individuals living alone as well as laborers
living in communal accommodation. For the latter group, only the first contacted
participant was included. This was because all individuals living in these premises
are male and recruitment of more than one participant would introduce a gender
imbalance in the study sample.
Research personnel used mobile phones with research study numbers that
were provided to conduct all study related calls. Monitoring of progress was done
through monthly meetings in which all members of the research team got together.
The purpose of these meetings was: 1) to submit the hard copies of the completed
questionnaire from the previous month 2) to discuss any difficulties encountered in
the previous month 3) to assign each member with a new set of participants numbers
for the next month as well as the blank forms that were to be completed for the next
month.
The principal investigator was available to meet with one or more members
of the research team to discuss and resolve any urgent study related issues that
emerged.
2.2.6 Questionnaire development and administration
The final versions of the questionnaire that were used in three languages in
this study (Arabic, English and Urdu) are provided (Appendix 1, 2, 3 respectively).
All versions were pre-tested before finalization.
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The questionnaire was developed by modifying questions from an existing
questionnaire that has been used in a similar study in Holland [50]. The authors of
that study approved the use and adaptation of their questionnaire for this study.
The questionnaire was initially developed in English and translated to Arabic
by a professional translator. The Arabic version was sent to a second professional
translator who reviewed it and back translated from Arabic to English. The English
version of the questionnaire also was translated into Urdu by two independent
translators whose mother tongue is Urdu and the two translations were checked side
by side and reconciled by a third person.
For each participant, information regarding socio-demographic characteristics
such as age, education, employment status, monthly income, and type of
accommodation was collected. Furthermore, information about the occurrence and
severity of IID symptoms such as diarrhoea and vomiting in the 4-week period prior
to the interview was collected.
Three trained research personnel explained the questionnaire to the
participants before the interviews and gave them the opportunity to ask questions.
Parents were asked to complete the questionnaire on behalf of their children. Once
consent was obtained and documented, the research personnel went through the
questionnaire with the participants and wrote the responses they provided on the
form.
Definitions
The Definition of the IIDs that was used was that of the International
Collaboration on Enteric Disease 'Burden of Illness' studies, which defined IID as a
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condition where a person has three or more loose stools or any vomiting in 24 hours,
that was not because of the consumption of alcohol, pregnancy, or drugs and
excluding those with cancer of the bowel, irritable bowel syndrome, ulcerative
colitis, Crohn's disease, celiac disease or other chronic illnesses with symptoms of
diarrhea or vomiting in the 4 weeks prior to the day of the interview [50]. This case
definition was chosen because of its acceptability, simplicity and the symptoms midrange severity, all of which are important especially when considering the research in
developing countries [51].
Diarrhea was defined as stool with abnormal liquidity or loose stool [54].
Symptoms of IIDs may include nausea, abdominal pain, vomiting, abdominal
cramps, fever, diarrhea and other systemic symptoms [114].
In the current study a potential participant was considered to be a nonresponder if four independent contact attempts were made with no response in each
time.
Pilot study
The questionnaire was tested face-to-face before finalization on fifty
participants working in a governmental hospital in RAK to ensure that the questions
in the questionnaire are cultural and context appropriate. The majority of the
participants were Emirati adults, because the Emirati population generally has less
exposure to telephone based surveys and it was necessary to ensure that the
questionnaire that is being used will be culturally acceptable.
The participants took between 8 to 13 minutes to complete the questionnaire.
All participants agreed that the questions were clear and easy to understand, although
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almost two thirds thought that some of the questions were a little too long, such as:
The types of food they consume (more vegetables or more meats or both) and
medications they currently take. Based on the findings from the face to face testing
and taking into consideration the method of the questionnaire administration (as a
phone questionnaire) that needs to be straightforward and simple, some of the
questions were shortened and some others were deleted. For the purpose of
comparison, basic questions were added on the end of the questionnaire to detect the
occurrence of other infectious disease such as respiratory tract infection, eye ear nose
mouth infections, skin infections and urinary tract infections.
The final questionnaire comprised 60 questions, the majority of which were
closed ended multiple choice and some questions were open ended like questions on
age, name of the country they traveled to in the last two weeks before their illness
and name of the animals they were in contact with. Participants were given the
choice to share their comments in the end of the questionnaire.
Finally, the revised questionnaire was pretested by phone on a sample of 7
individuals, to check for the average time needed to complete the questionnaire over
the phone (which was 3-5 minutes) and to ensure that the participants go through all
the questions during the field calls.
2.3 Part 2: IDs surveillance system in RAK
For this part of the study, a descriptive retrospective design was used. The
study sample consisted of all active infectious diseases units in RAK:
1) Lowest level which is at the level of hospitals.

In RAK there are three

government hospitals, but only two hospitals were included (Saqr and Ibrahim Bin
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Obaidullah), because, at the time of the current research, a third government hospital
was closed for renovation.
2) Higher district level. The information from this level was obtained from the
preventive medicine department (PMD), which is responsible for overseeing ID
reporting from the hospitals.
The survey tool that was used was based on the WHO guidelines to
monitoring and evaluating communicable disease surveillance systems [30]. The
survey tool was designed so as to obtain information about core functions (case
detection, registration, case confirmation, reporting, data analysis, outbreak
preparedness and response) and supportive functions (communication, training,
supervision, resources) of the current surveillance system.
All information was collected through face to face interviews by the principal
investigator with various personnel working at different levels within the concerned
department during the first half of 2018. In addition to the interviews, samples of
notification forms, zero reporting forms, surveillance forms, case investigation
forms, education materials used, and the guidelines used were examined.
In UAE, the top most authority in the healthcare system is the MoHAP,
through which a variety of health services are provided across the different Emirates.
The MoHAP headquarters are located in Dubai, while each emirate has its medical
district that serves as the local health authority for that emirate, and reports back to
the MoHAP. Each emirate has hospitals, primary health centers and PMD, all under
the jurisdiction of the local medical district and ultimately the main MoHAP.
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From RAK, the PMD and two government hospital were included: Saqr
hospital (Hospital 1) and Ibrahim Bin Obaidullah hospital (Hospital 2).
Only questions that were deemed to be relevant to the specific site were
asked. In gathering information to describe the surveillance system the main areas
from the WHO guidelines: Structure, core functions and support functions were
followed.
Within each area several questions were asked to either hospitals alone or
PMD alone or both see (Table 2.1).
Since the study sample in this part of the research was small, data from each
site was presented separately, since it was considered that it would be misleading to
expresses the results as percentages.
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Table 2.1: Questions from the semi structured questionnaire about the ID
surveillance system
Preventive
Medicine
Department
(PMD)

Hospitals

Structure of the IDs surveillance system
1) Can you share with me your surveillance structure?

✓

✓

2) Can you share with me the guidelines that you are using in your work?

✓

✓

3) What kind of surveillance and for which type of diseases?

✓

✓

4) What is the urgent notification? Do you have your own notification list?

✓

✓

5) Do you have regular meetings with other hospitals Infection Control
Committee (ICC) members? How often?

✓

✓

6) Do you have regular meetings with PMD members? How often?

*

✓
✓

✓

1) What case definitions do you use? Are they updated?

✓

✓

2) How the data that you receive is handled/ processed?

✓

✓

3) Is laboratory testing done locally or in collaboration with reference
laboratories?

✓

✓

4) Who reports to you? In what format and frequency is it done?

✓

✓

5) Do you have prevalence data that helps you identify trends in ids and/ or
areas to improve the surveillance system?

✓

✓

6) What kind of feedback do you get and what feedback you give?

✓

✓

7) What are the most recent outbreaks or emergencies and the procedures that
were in place to deal with them?

✓

✓

7) Do you collaborate with other sectors such as municipality?
Core function of the IDs surveillance system

Support function of the IDs surveillance system
1) Do you update the guidelines? How often the guideline updated?

✓

✓

2) Describe the training activities related to the surveillance system?

✓

✓

3) How many persons are working on each surveillance?

✓

✓

4) What training do the healthcare professionals get on notifications?

✓

✓
*

5) Do you visit any of the healthcare facilities? For what?

✓

6) Describe the means of communication used with the stakeholders?

✓

✓

7) Describe quality control measures implemented?

✓

✓

8) After evaluation, if there is a gap what is the action?

✓

✓

9) What other activities you have?

✓

✓

1) Do you feel that the healthcare professionals need to train to be able to fill
the notification? Are they trained?

✓

✓

2) How the samples transfer from your facility to others? Is the protocol from
you or from the hospital or from MoHAP?

✓

✓

3) Do you have any published statistics? How is the annual data published?

✓

✓

4) Do you have any publications about the surveillance system? About
evaluating any of its components (structure, core elements and support
functions)?

✓

✓

5) How do you see the development of your department?

✓

✓

6) If you were to place a development program for your department, what
priority issues you will focus on?

✓

✓

Miscellaneous
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2.4 Ethical approval
2.4.1 Ethical considerations
The principal investigator ensured that this study is conducted in accordance
with the principles of the Declaration of Helsinki. The protocol, participant
information sheet and questionnaire were revised and approved by the Social
Sciences Ethics committee of the United Arab Emirates University with the reference
number: ERS_2015_3207. The survey questions were tested to ensure ethical and
cultural sensitivity. All research personnel went through the consent process with the
participants and ensured their willingness to participate and documented it in writing
before proceeding with the interview.
For the informed consent process, written versions of the information sheet
and informed consent were presented verbally to each participant. These describe the
nature of the study and what it means to take part. The participants were informed
that their participation is voluntary and they can withdraw at any time if they did not
wish to take part in the questionnaire without any consequences. Participants who
gave a verbal consent had this consent documented by the interviewers who then
proceeded to ask the participants the questions (Appendix 2).
The document linking the names and phone numbers of potential participants
was kept with the principal investigator who ensured that this was stored separately
from all study data throughout the duration of the study. No participant identifier was
documented on the questionnaire. Participant's anonymity was maintained in the
electronic database since it could be identified only by a participant ID number.
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The research personnel stored the hard copies of the questionnaires in a
locked place which was only accessible by them, until they were handed over to the
principal investigator. Data from the hard copies were entered into an electronic
database on a personal computer which could only be accessed by password. There
are no direct benefits to the individuals involved, other than the satisfaction of
contributing to research.
2.4.2 Regulatory approval
As per the laws and regulations of the UAE, regulatory approval needed to be
obtained from RAK Medical District as well as the administration of the institutions
included in Part 2 of the study. All approvals were obtained prior to initiation of the
study (Appendix 4).
2.4.3 Data management and security
Participants were assigned a unique research number, which was used on the
questionnaires. The questionnaire responses are maintained under a unique research
number, in a secure location. No individually identifiable information was included
in the research database. The research number link to personal identifying
information is maintained in a secure server physically separate from the research
database, which is accessible only by the research personnel.
2.5 Variables
Independent and dependent (outcome) variables
In Table 2.2, the summary of the independent variables and the dependent
(outcome) variables is shown.
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Table 2.2: Summary of independent and dependent variables
Variables

Variable type

Categories

A. Demographic characteristics
Age

Continuous

--

Gender

Binary

Male, Female

Nationality

Binary

Nationals, Non-Nationals

Marital status

Categorical

Single, Married, Separated, Divorced,
Widowed

Residential
address (area)

Categorical

Urban, Suburban

Type of
residence

Categorical

Arabic house, Villa, Apartment, Workers

Living
Condition

Categorical

Alone, Spouse, Family, Non-Family

Employment

Categorical

At work, Unemployed, Student, Retired,
Looking after home or family, Long term
sick or disabled, Other

Job type

Categorical

Armed forces occupations, Managers,
Professionals ,Technicians and associate
professionals, Clerical support workers,
Service and sales workers, Skilled
agricultural forestry and fishing workers,
Craft and related trades workers, Plant and
machine operator and assemblers,
Elementary occupations

Monthly income Categorical

<5000, 5000-14999, 15000-24999, 2500034999, >35000

Education level

Did not attend school, Completed primary
school, Completed intermediate school,
Completed secondary school, Completed
College or university, Completed Master or
PHD

Categorical

B. History of infectious disease in
past four weeks

Intestinal infections, respiratory infections,
eye ear nose mouth infections, skin
infections, urinary tract infections, other
infections
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2.6 Statistical analysis
Data were entered, coded and cleaned in Microsoft Excel 2007 and
transferred to Stata version 15.0 for analysis.
2.6.1 Descriptive Analysis
The categorical variables (gender, nationality, marital status, residential address
(area), type of residence, employment, job type, education level) were described using

frequencies and percentages. Four weekly prevalence of infection were calculated for
specific infections. Comparisons were made between groups based on plausible
independent variables such as age, gender, work status and season.
2.6.2 Inferential Analysis
The data analysis was conducted using Stata version 15.0. Participants
considered as having had an episode of infection (IID or respiratory) were compared
with asymptomatic participants regarding several characteristics and exposures,
including age, sex, marital status, living condition, living area, family income, work
status, nationality category, and level of education. The Chi-square test or Fisher’s
exact test was applied to compare the prevalence of infection for categorical
variables. The two-sample t-test was applied to compare the prevalence of infection
for continuous variables. Univariate and multivariate logistic regression analysis
were performed to ascertain the association between various socio-demographic
variables and infection (IID and respiratory each of these done separately). A p-value
of ≤0.05 and 95% confidence intervals (95% CI) were chosen to determine statistical
significance.
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Chapter 3: Results
3.1 Introduction
In Part 1 of this chapter, the estimated prevalence of self-reported infections
in the RAK community is presented. In Part 2, a description of the existing
surveillance system in RAK is presented.
3.2 Part 1: Community survey to estimate self-reported IIDs
3.2.1 Description of the study sample
A total of 1728 households were contacted by telephone, of which 822
responded to the telephone call (47.6% initial response rate) and were invited to take
part in the study. Of these, 547 households agreed to participate (31.7% participation
rate) and 275 refused. All household participants completed the consenting process
before answering the questionnaire. Participants living in a family setting were asked
if the interviewer could have access to the spouse and a child. In this way, the final
study sample was 1254 individuals, with 391 being spouses and 316 being children
(Figure 3.1).
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Total number of potential
participants (n=1728)

Didn’t respond to the call (n=906)

Responded to the call (n=822)

(n=547) from
the original list
agreed to
participate

(n=275)
refused to
participate

(n=493)
responders
from family
accommodation

(n=54)
responders
from nonfamily
accommodation

+

+

(n=391)
Spouses

(n=316)
Children

Figure 3.1: Description of the participants recruited.
Total study sample was (493+54+391+316) all shown in bold
The overall response rate of the individuals who responded and agreed to
participate was 31.7%. The participation rate for UAE nationals was higher than for
non-nationals (52.3% and 47.7%, respectively; p = 0.044). The participation rate was
higher for male than for female subjects (57.3% and 42.7%, respectively; p < 0.001).
Details of the study sample are summarized Table 3.1.
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Table 3.1: Summary of those who participated and did not participate in the study

All

Number of
participants
contacted
initiallya

Number
participated
from initial listb

1728

547***

Did not
participatec **

Response
rate

p-values

(%)
1181

31.7*
Proportion

Nationality***
Nationals

656

175

52.3

Non-Nationals

598

100

47.7

Male

718

256

57.3

Female

536

19

42.7

0.044

Gender***

*

<0.001

Initial response rate=b/a * 100 (547/1728 * 100)

**

Either refused to participate or couldn't be contacted

***

1254 questionnaires came from 547 initial responders + 391+316 (b/1254 * 100)

3.2.1.1 Characteristics of study participants
One quarter of the study sample were children (25.2%), almost half of the
participants (47.7%) were non-nationals, and almost half of the participants (49.0%)
were from urban areas. Sixty-nine percent of participants were married and only
5.4% of participants live in non-family (bachelor accommodation). The majority of
the participants are workers (employee) forming 41.9%. Most of the participants
completed secondary schooling (29.9%) or college/ university (27.3%). Only 6.4%
of the participants were with the average monthly Household income ≥ AED 35000.
Details of the demographic characteristics are presented in Table 3.2.
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Table 3.2: Demographic characteristics of the study sample (n=1254)
Characteristics
Age (years)
0-5
6-17
18-59
≥60
Gender
Male
Female
Marital Status
Single
Married
Separated/Divorced
Widowed
Living Conditions
Alone
Spouse
Family (living with extended family)
Non-Family (bachelor accommodation)
Employment Status
Currently working
Unemployed
Student
Retired
Looking after home/Family (care giver)
Long term sick/Disabled
Work details unknown
Geographical Location
Urban
Suburban
Nationality
Nationals
Non-Nationals
Level of Education
No formal schooling
Completed primary schooling
Completed intermediate schooling
Completed secondary schooling
Completed college or university
Completed Master or PhD
Contact with Animals
No
Yes
Monthly Household Income, AED (USD)*
AED <5000 (~USD <1360)
AED 5000-14999 (~USD 1360-<4080)
AED 15000-24999 (~USD 4080-<6800)
AED 25000-34999 (~USD 6800-<9530)
AED ≥35000 (~USD ≥9530)

Participants n (%)
Total 1254 (100.0)
89 (7.1)
227 (18.1)
856 (68.3)
82 (6.5)
Total 1254 (100.0)
718 (57.3)
536 (42.7)
Total 1253 (100.0)
370 (29.5)
864 (69.0)
5 (0.4)
14 (1.1)
Total 1245 (100.0)
64 (5.1)
797 (63.6)
325 (25.9)
68 (5.4)
Total 1248 (100.0)
523 (41.9)
4 (0.3)
252 (20.2)
64 (5.1)
330 (26.4)
2 (0.2)
73 (5.9)
Total 1254 (100.0)
614 (49.0)
640 (51.0)
Total 1254 (100.0)
656 (52.3)
598 (47.7)
Total 1236 (100.0)
169 (13.7)
209 (16.9)
131 (10.6)
369 (29.9)
338 (27.3)
20 (1.6)
Total 1254 (100.0)
1006 (80.2)
248 (19.8)
Total 1048 (100.0)
231 (22.0)
355 (33.9)
232 (22.1)
163 (15.6)
67 (6.4)

* Note. AED denotes Emirati Dirham; USD denotes United States Dollar †Based on USD 1.00  AED
3.67.
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3.2.2 Prevalence of IID
The overall prevalence of participants reporting an IID in the 4- week period
preceding the telephone interview was 4.2% (n = 53). IID were more prevalent in
children than in adults (prevalence 9.8% compared with 2.3%; p<0.001). IID were
significantly more prevalent in UAE nationals compared with non-nationals
(prevalence 69.8% and 30.1%, respectively; p≤0.05). Prevalence of IID for each
month was calculated from the number of the IID cases reported from that month
divided by the number of participants recruited that month, for each month from
January to September. No data from October, November and December was
collected. Higher prevalence’s of IID were noted in February and March, during
which prevalence was at least triple that seen in other months. The prevalence in
August was zero although the recruitment (n=59) was almost same as month of
January (n=57) (Figure 3.2). There is a significant difference between prevalence of
IID infections in different months (p=0.008).
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Figure 3.2: Prevalence of IID for each month from January to September 2017

85
Univariate analysis and multivariate analysis were done using logistic
regression analysis, to explore the factors associated with IID.
3.2.2.1 Univariate analysis of IID
From the univariate analysis, the prevalence of IID was significantly higher
in nationals than non-nationals (p≤0.05). Furthermore, those aged 18–59 years were
significantly less likely to report an IID than participants aged 6–17 years (p≤0.05),
and being married was protective from IID (p≤0.05). It is important to note that
being married does not necessary mean that they are living with their spouse, since
it's possible to be married but are living alone, especially among those from the
migrant population.
Students were significantly more likely to report an IID (p≤0.05) and
participants with an average monthly income of AED 15 000 (~USD 4080) were
significantly more likely to report an IID than those with a lower average monthly
household income (p≤0.05) as shown in (Table 3.3).
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Table 3.3: Univariate analysis of factors associated with IID, RAK, 2017
95% CI

p – value

0.43

0.20-0.92

0.030

18-59

0.13

0.06-0.27

0.000

≥60

0.06

0.00-0.51

0.010

Gender
Male

Ref
0.18-2.44

0.220

Variables
Age (year)
0-5

OR

6-17

Ref

Female
Marital Status
Single

1.41

Married

0.18

0.10-0.34

0.000

Separated/Divorced/Widowed
living conditions
Alone

1.85

0.51-6.68

0.346

Spouse

1.29

0.30-5.53

0.726

Family
Employment Status
At work

1.92

0.43-8.47

0.387

Student

4.23

2.00-8.92

0.000

Retired

1.50

0.32-6.93

0.602

Looking after home/Family (care giver)

1.00

0.38-2.62

0.986

Other*
Geographical Location
Urban

8.33

3.53-19.63

0.000

Suburban
Nationality
Nationals

1.75

0.99-3.11

0.054

Non-Nationals
Level of Education
No formal schooling

0.45

0.25-0.83

0.000

Completed primary schooling

0.62

0.33-1.21

0.149

Completed secondary/intermediate schooling
Completed college or university
Contact with Animals
No

0.31
0.43

0.14-0.72
0.23-0.90

0.006
0.018

Yes
Monthly Household Income, AED (USD)**
AED <5000 (~USD <1360)

1.63

0.88-3.03

0.115

AED 5000-14999 (~USD 1360-<4080)

4.00

0.88-18.06

0.071

AED 15000-24999 (~USD 4080-<6800)

6.24

1.38-28.22

0.017

AED 25000-34999 (~USD 6800-<9530)

7.48

1.61-34.62

0.010

AED ≥35000 (~USD ≥9530)

7.26

1.30-40.60

0.024

Ref

Ref

Ref

Ref

Ref

Ref

Ref

Ref

*"Other" category refers to all these categories combined [work details unknown, long term
sick/disabled, unemployed]
**Note. AED denotes Emirati Dirham; USD denotes United States Dollar †Based on USD 1.00 
AED 3.67.
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3.2.2.2 Multivariate analysis of IID
All variables were initially included in the model (age, sex, marital status,
living conditions (family, non-family), employment status, degree of urbanization,
nationality, level of education, contact with animals, and average monthly household
income). Variables that were not statistically significant (i.e., p>0.05) were then
removed one at a time and only the variables with a p-value of ≤ 0.05 were retained.
Age, sex, employment status, and average monthly household income were the
significant determinants in the final model. In the multivariate analysis, being female
and having a middle-range monthly household income (AED 5000– 14,999 or AED
15 000–24 999) were positively associated with reporting an IID, while age ≥ 6 years
was negatively associated with reporting an IID.
Furthermore, care givers [those who are looking after their home or family]
are significantly associated with the IID (p≤0.05) as shown in (Table 3.4).
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Table 3.4: Multivariate analysis of factors associated with IID, RAK, 2017
Variables
Age (year)
Gender
Male
Female
Employment Status
At work
Student
Retired
Looking after home/Family (care giver)
Other*
Monthly Household Income, AED (USD) **
AED <5000 (~USD < 1360)
AED 5000-14999 (~USD 1360-<4080)
AED 15000-24999 (~USD 4080-<6800)
AED 25000-34999 (~USD 6800-<9530)
AED ≥35000 (~USD ≥9530)

95% CI

p – value

0.90-0.99

0.048

Ref
2.43

1.16-5.07

0.018

Ref
0.38
4.32
0.23
0.83

0.04-3.30
0.71-26.25
0.06-0.90
0.08-8.61

0.387
0.111
0.035
0.880

Ref
3.99
5.42
7.13
6.16

0.85-1870
1.15-25.48
1.47-34.57
1.02-36.88

0.078
0.032
0.015
0.046

Multivariable
OR
0.95

*"Other" category refers to all these categories combined [work details unknown, long term
sick/disabled, unemployed]
**Note. AED denotes Emirati Dirham; USD denotes United States Dollar †Based on USD 1.00 
AED 3.67.

Out of the 53 participants with an IID, only half (49.0%) sought medical care
and 13.2% asked pharmacists for advice on how to manage their condition. Of those
who sought medical care, less than a fifth (18.9%) provided a stool sample and 5.7%
of them were hospitalized. The majority of individuals who had an IID took
medication (69.8%), of which 20.8% were without a prescription (i.e., over-thecounter medication). The IID affected the daily routine of many participants. For
example, it stopped 11.3% of affected participants from going to work or to school.
Of the 53 participants with an IID, 35.8% had additional concomitant infections
(respiratory tract infection, skin infection, urinary tract infection, and/or eye, ear,
nose and mouth infections). The most suggested causes of illness provided by the
participants with an IID were the consumption of contaminated food (47.2%) and
infection from another person (26.4%). The prevalence of IID showed seasonal
variation, with the highest prevalence in February and March (p ≤0.05) (Table 3.5).
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Table 3.5: Source of infection and management of IID infections (n=53)
Variables
Sought medical care
Yes
No
Submit a stool sample
Yes
No
Take medicine
Yes
No
Hospitalized
Yes
No
Medicine without prescription
Yes
No
Illness affected anyone else
Yes
No
Illness from consumption of food
Yes
No
Illness stop work/school
Yes
No
Other infections in past 4 weeks
Yes
No
Accommodations
Arabic house
Villa
Apartment
Group accommodation for labourers

IID (n=53)
n (%)
26 (49.1)
27 (50.9)
10 (18.9)
43 (81.1)
37 (69.8)
16 (30.2)
3 (5.7)
50 (94.3)
11 (20.8)
42 (79.2)
14 (26.4)
39 (73.6)
25 (47.2)
28 (52.8)
6 (11.3)
47 (88.7)
19 (35.8)
34 (64.2)
16 (30.2)
29 (54.7)
8 (15.1)
0 (0.0)

3.2.3 Participants with other infections
For comparative purposes, information on prevalence of other infections was
collected. The most common other infection was the respiratory infections with
prevalence of 14.2%. The prevalence for other infections was too small for
performing further analysis (0.8%).
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3.2.3.1 Prevalence of respiratory infections
The prevalence of respiratory infection was (14.2%), with the majority
occurring in January, February, March and April, from which 37.5% alone were
found in February (Figure 3.3). There is a significant difference between prevalence
of respiratory infections in different months (p=0.01).

Respiratory Infections Prevalence vs. Month
37.5

Respiratory Infection Prevalence

40
35

27.8

30

25
19.3
20

14.9

15
9
10

6.3

Respiratory Prevalence

8.2

5

0

1.6

0

Month

Figure 3.3: Prevalence of respiratory tract infection for each month from January to
September 2017
The univariate and multivariate analysis were conducted using logistic
regression analysis, to explore the factors associated with the respiratory tract
infection.
Univariate analysis of respiratory infections
From the univariate analysis, compared with 0-5 age group, other age groups
were significantly less likely to get respiratory infections (p≤0.05). Being married
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was associated with a lower likelihood of getting respiratory infections (p≤0.05).
Furthermore, respiratory infections were significantly high in students and in the
“other” category (p≤0.05).
Compared to those with no formal schooling, participants in all the other
education status categories were less likely to get respiratory infections (p≤0.05).
From the monthly household income, the following categories were
positively associated with the respiratory infections (AED 5000-14999, AED 2500034999 and AED ≥35000) p≤0.05 as shown in (Table 3.6).
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Table 3.6: Univariate analysis of factors associated with respiratory tract infection,
RAK, 2017
Variables
Age (year)
0-5
6-17
18-59
≥60
Gender
Male
Female
Marital Status
Single
Married
Separated/Divorced/Widowed
Living conditions
Alone
Spouse
Family
Employment Status
At work
Student
Retired
Looking after home/Family (care giver)
Other*
Geographical Location
Urban
Suburban
Nationality
Nationals
Non-Nationals
Level of Education
No formal schooling
Completed primary schooling
Completed secondary/intermediate schooling
Completed college or university
Contact with Animals
No
Yes
Monthly Household Income, AED (USD)**
AED <5000 (~USD <1360)

OR

95% CI

p – value

Ref
0.42
0.24
0.17

0.24-0.73
0.14-0.39
0.07-0.42

0.002
0.000
0.000

Ref
0.99

0.72-1.37

0.989

Ref
0.46
0.99

0.33-0.64
0.32-3.09

0.000
0.998

Ref
0.67
1.09

0.34-1.33
0.53-2.21

0.260
0.809

Ref
1.86
0.94
0.88
4.23

1.23-2.81
0.41-2.17
0.56-1.38
2.48-7.22

0.003
0.899
0.595
0.000

Ref
1.14

0.83-1.57

0.404

Ref
0.85

0.62-1.17

0.341

Ref
0.61
0.37
0.47

0.38-0.97
0.22-0.60
0.29-0.77

0.040
0.000
0.002

Ref
0.69

0.44-1.06

0.097

AED 5000-14999 (~USD 1360-<4080)

1.89

1.10-3.25

0.021

AED 15000-24999 (~USD 4080-<6800)

1.62

0.89-2.94

0.108

AED 25000-34999 (~USD 6800-<9530)

2.00

1.07-3.72

0.029

AED ≥35000 (~USD ≥9530)

2.78

1.32-5.87

0.007

Ref

*"Other" category refers to all these categories combined [work details unknown, long term
sick/disabled, unemployed]
** Note. AED denotes Emirati Dirham; USD denotes United States Dollar †Based on USD 1.00 
AED 3.67.
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Multivariate analysis of respiratory infections
Multivariate analysis was carried out to identify the determinants of the
respiratory infections. All the variables (age, gender, marital status, living conditions
(family, non-family), employment status, degree of urbanization, nationality, level of
education, contact with animals, and average monthly household income) were
initially included in the model. The insignificant variables were removed one at a
time and only the variables with a p value of ≤0.05 was retained. Age, living
condition and average monthly household income were the significant determinants
in the final model.
Multivariate analysis showed that being ≥60 years old and living with spouse
were both significantly negatively associated with respiratory infections p≤0.05.
Those having middle range household income (AED 5000-14999, AED 2500034999 and AED ≥35000) were significantly more likely to get respiratory infections
p≤0.05 as shown in (Table 3.7).
Table 3.7: Multivariate analysis of factors associated with respiratory tract infection,
RAK, 2017
Variables
Age (year)
0-5
6-17
18-59
≥60
Living conditions
Alone
Spouse
Family
Monthly Household Income, AED (USD)*
AED <5000 (~USD <1360)
AED 5000-14999 (~USD 1360-<4080)
AED 15000-24999 (~USD 4080-<6800)
AED 25000-34999 (~USD 6800-<9530)
AED ≥35000 (~USD ≥9530)

Multivariable OR

95% CI

p – value

Ref
0.35
0.22
0.10

0.10-1.22
0.03-1.65
0.01-0.89

0.101
0.143
0.039

Ref
0.37
0.70

0.16-0.88
0.29-1.69

0.025
0.441

Ref
1.95
2.04
2.73
3.50

1.04-3.64
0.91-4.53
1.16-6.44
1.31-9.32

0.035
0.080
0.021
0.012

*Note. AED denotes Emirati Dirham; USD denotes United States Dollar †Based on USD 1.00  AED
3.67.
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3.2.4 Comparisons of IIDs with other infections
Some comparisons between IID and respiratory infections were drawn,
because it was the most common and the numbers of other infections was too small
to be able to make any comparison. In contrast with IIDs, the prevalence of
respiratory infections in males was similar to females (14.2%).
The prevalence of both IID and respiratory infections was found to be higher
in children as compared to adults. For IIDs (9.8% vs 2.3%and respiratory infection
(22.2% vs 11.5%) (see Table 3.8).
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Table 3.8: IID vs. Respiratory infections
Infection (Total)
Nationality
Nationals
Non – Nationals
Gender
Male
Female
Age
Children
Adults
Marital Status
Single
Married
Separated/Divorced
Widowed
Degree of urbanization
Urban
Suburban
Contact with animals
No
Yes
Sought medical care
Yes
No
Take medicine
Yes
No
Took Medicine
Yes with prescription
Yes without prescription
No Medicine

IID (n= 53)
n (%)

Respiratory (n= 178)
n (%)

37 (69.8)
16 (30.2)

98 (55.1)
80 (44.9)

26 (49.0)
27 (51.0)

102 (57.3)
76 (42.7)

31 (58.5)
22 (41.5)

73 (41.0)
105 (59.0)

34 (64.1)
16 (30.2)
1 (1.9)
2 (3.8)

78 (43.8)
96 (54.0)
0 (0.0)
4 (2.2)

17 (32.1)
36 (67.9)

73 (41.0)
105 (59.0)

38 (71.7)
15 (28.3)

154 (86.5)
24 (13.5)

26 (49.1)
27 (50.9)

91 (51.1)
87 (48.9)

37 (69.8)
16 (30.2)

145 (81.5)
33 (18.5)

11 (20.7)
26 (49.1)
16 (30.2)

54 (30.0)
91 (51.0)
33 (19.0)

*All percentages (written in brackets) were calculated by the number of cases in that specific group
divided by the total number of cases for that specific infection ie: 53 for IID, 178 for respiratory
infections.

Participants with IIDs infections were less likely than those with respiratory
infections to take medicine, both with or without prescription (Figure 3.4).
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Total number of
participants (N= 1254)

Total cases with
infections (N= 241)

IID
(N= 53)

Respiratory
infections (N= 178)

Sought medical
care

Sought medical
care

Yes, and
took
medication
(N= 26)
49.1%

No
(N= 27)
51.0%

Took medication
over the counter
(N= 11)
20.8%

Yes and took
medication
(N= 91)
51.1%

Other
infections
(N= 10)

-Ear, Nose, Mouth (N= 5)
-Skin infections (N= 2)
-UTI (N= 1)
-Others (N= 2)

No
(N= 87)
48.9%

Took medication
over the counter
(N= 54)
30.3%

Figure 3.4: Overview of participants with infections and management
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3.3 Part 2: ID surveillance system in RAK
This section presents a description of the surveillance system at the two levels
of RAK: lower and higher. 1) The lower level is at the level of hospitals in which
two government hospitals were included and 2) higher level (PMD) oversees the ID
notifications from all healthcare settings in RAK and it is also responsible for
screening of anyone coming to work in UAE, as per UAE law.
In the UAE, a pre-requisite for applying for a residency visa is to undergo
certain laboratory tests. These include screening for Tuberculosis (TB), Hepatitis,
certain Sexually Transmitted Diseases (STD) and (HIV/AIDS), which should be
negative in order to be able to proceed with applying for the residency visa.
The information below was collected through several visits in person to PMD
and the two government hospitals.
3.3.1 Government healthcare services in RAK – PMD
The PMD in RAK is under the jurisdiction of the MoHAP which has its
headquarters in the emirate of Dubai (Figure 3.5). The PMD has both clinical and
administrative services.
The clinical services include: clinics (for medical examination), vaccination
department, laboratory, radiology department and infectious disease department. The
administrative services include: human resource management, birth registration and
death registration. It is at the district level that oversight of the hospitals is done, and
that is reported to the higher levels (at the federal level).
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Ministry of Health &
Prevention (MoHAP)

Figure 3.5: MoHAP covers: RAK, Ajman, Umm Al Quwain, Al Sharjah, Al
Fujairah, Dubai
: The Medical District,
Medicine Department

: Government hospitals,

: Preventive

The activities of PMD are in line with the surveillance programs initiated by
the MoHAP and the guidelines they use are provided by MoHAP. The pathway of
reporting the ID cases in RAK is outlined in Figure 3.6.
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Ministry of Health
and Prevention
(MoHAP)

RAK Medical
District

1
-Guidelines of
ID surveillance
programs
-ID Notification
list & forms

3
ID notification
reports

RAK outbreak
cases
3

RAK Preventive
Medicine Department
(PMD)

2

1

RAK Government Hospitals:
Hospital (1), Hospital (2)

Figure 3.6: The pathway of reporting the ID cases in RAK.
Pathways: 1) Guidelines of ID surveillance programs, 2) ID notification reports, 3)
Exclusive for outbreak cases. Solid lines indicate communication from higher level;
Dotted lines indicate communication from Lower level.
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3.3.1.1 Structure of the ID surveillance system:
1) Surveillance structure
The guidelines used in PMD (under UAE Federal Ministry of Health and
Prevention) are the most updated version of those provided by MoHAP. Currently,
the PMD is working on 6 main surveillance programs which are: (1) TB (2)
HIV/AIDS (3) Measles (4) Acute Flaccid Paralysis (AFP)/Poliomyelitis (5) Hepatitis
(6) Severe Acute Respiratory Infections (SARI) with a seventh category (Other) that
encompasses all other diseases mentioned in the ID notifiable list which are under
the category ''Other''.
While these diseases are the main focus, other notifiable cases also need to be
reported to MoHAP (Table 3.9). Only in cases of outbreaks at the level of RAK is it
necessary to report to the local (RAK medical district) as well as the MoHAP.
2) Notification
The PMD receives IDs notifications from all healthcare settings in RAK.
Some infections are required to be reported to PMD immediately (on the day of
identification), while others are reported each week depending on the instructions on
the IDs notification list from MoHAP (Table 3.9).
Table 3.9 is constructed based on the MoHAP Notifiable ID form in Appendix 5.
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Table 3.9: Diseases which are "Immediately reportable and weekly reportable"
Immediately Reportable Diseases

Weekly Reportable Diseases

- AFP/Poliomyelitis

- Amoebiasis

- Anthrax

- Chickenpox

- Botulism

- Giardiasis

- Cholera

- Hepatitis A, B, C, D, E

- Diphtheria

- Influenza

- Encephalitis

- Intestinal Worms, Ascaris, Taeniasis

- Food poisoning

- Malaria

- Heamophilus influenzae b:
Epiglottitis, Meningitis

- Mumps

- HIV / AIDS
- Legionellosis
- Leprosy
- Measles
- Meningitis: Meningococcal
- Plague
- Rabies
- Relapsing fever
- Rubella, Congenital rubella syndrome
- Tetanus, Neonatal Tetanus
- Tuberculosis – Pulmonary
- Typhoid / Paratyphoid fever
- Typhus
- Viral haemorrhagic fevers
- Yellow fever

- Pertussis
- Scabies
- Scarlet fever
- Schistosomiasis
- Sexually Transmitted Infections
(STIs): Chlamydia, Gonorrhea,
Syphilis
- Shigellosis
- Tuberculosis – Extra – pulmonary
- Zoonotic Diseases: Brucellosis,
Hydatid disease

102
3.3.1.2 Core functions of the ID surveillance system
1) Case Detection
A number of diseases from the ongoing surveillance programs had guidelines
that were available at the time of data collection. These guidelines were complete,
included clear case definitions and were updated by MoHAP. However, for several
other surveillance programs that the UAE is working on, the MoHAP guidelines
were not readily available at the time of visiting the site in RAK.
Completion of the notification and reporting are integrated into the daily
work of health professionals. Learning is done hands on, since health professionals
are not required to undergo specific training about ID surveillance.
2) Case confirmation
The ID notification forms (Appendix 5) and Weekly Zero Reporting Forms
(Appendix 6) are reported from all RAK healthcare settings to the PMD. The ID
notifications are reported monthly from PMD to the MoHAP. No ID notification
cases are routinely reported to RAK medical district.
When a suspected case of infectious disease has been admitted to the hospital
(children are admitted in government hospital number 1 and adults are admitted in
government hospital number 2), personnel from PMD initiate the case investigation
and contact tracing.
PMD personnel investigate the notifiable cases using investigation forms
which are provided by the MoHAP. The investigation may involve a visit to the
hospitals that hold the notifiable case in the isolation room. The purpose of the visit
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is to ensure all basic information documented is complete and accurate and that
appropriate referrals have been made.
PMD then follows up the case with regards duration of treatment, success of
treatment, and any other action, such as investigating contacts as appropriate, until
discharge.
For each type of infection there is a specific investigation form which
contains questions related to the individual infection. Examples of these forms can be
found at Appendix 7, which shows the meningitis case investigation form and
Appendix 8, which shows the cholera case investigation form. The ICD personnel
take appropriate and necessary action depending on the circumstances of the case.
For example, in the case of measles, the action taken may be immunization of all the
persons who were in contact with the affected individual.
The protocol of transferring laboratory specimens is not included in the PMD
guideline. The protocol and the guideline of transferring the samples is only found in
one of the governmental hospital’s laboratories in RAK (in government hospital
number 2), while the other laboratories do not have written guidelines, but rather
follow locally established procedures that are passed on to new staff verbally.
In cases of outbreaks, a multidisciplinary team (from all relevant
municipalities and other authorities) is formed to investigate, follow the cases and
report to RAK medical district, who in turn reports to MoHAP.
When investigating the suspected case, the preliminary testing is done in
local laboratories and confirmatory testing often involves sending microbiological
samples from the patient to reference laboratories in the adjacent emirate of Sharjah
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(Al Qassimi Hospital laboratory) and laboratories in emirate of Abu-Dhabi (Sheikh
Khalifa Hospital). These reference laboratories have more advanced identification
techniques like Polymerase Chain Reaction (PCR) that are not available in any of the
microbiology departments in RAK.
3) Data analysis
Raw data from the hard copy notification forms is entered electronically into
an excel spreadsheet, which in turn is sent to the higher federal authority (MoHAP)
on a monthly basis. Pooling, processing and analyzing of raw data are done only at
the level of the MoHAP. In the event of outbreak, cases can be reported from any
area by any person in RAK by calling the PMD call center. Details of each case are
forwarded to MoHAP where the data were processed.
The MoHAP is responsible for publishing ID data. This is regularly done in
the form of incidence and prevalence of infectious diseases that form part of the
annual health report.
4) Epidemic/ Outbreak preparedness and response
While there is no permanent team that it is dedicated for the outbreak
management, whenever an outbreak occurs, the PMD immediately contacts the RAK
medical district to form a team consisting of some of the PMD personnel, laboratory
technician and some staff from the area (such as schools, restaurants) who reported
the outbreak. This team is assigned to be responsible for managing, investigating and
reporting the outbreak to the MoHAP through RAK medical district.
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5) Quality monitoring activities
The external monitoring of the surveillance system is done by MoHAP which
sends a team that may visit the PMD in order to check that this surveillance system is
functioning as required. This includes evaluation of the forms which are used for
different diseases and how they are filled, prevision of updated guidelines and
discussion of any challenges. Most issues that immerge are addressed during the
visits.
The monitoring team from MoHAP assesses the core elements of each ID
surveillance system in the PMD by checking if the case definitions are applicable and
the notifications are according to the guidelines. This team also evaluates the support
functions of the system by checking the documented activities of each staff of PMD
working on ID surveillance system such as their training of healthcare personnel.
However, there is no evaluation of the key attributes that are used to assess
surveillance system such as timeliness and completeness, since the data needed for
such evaluation is not routinely documented. For example, the time of initial
identification and time of notification of PMD are not documented to allow
assessment of timeliness.
The internal monitoring is done by a team from the PMD to evaluate the
work flow at the district level, measure the process that leads to specific outcome and
finally identify any gaps or opportunity for improvements.
Findings are shared with the head of the PMD, after which a meeting is held
with the concerned personnel to resolve issues and make progress. This PMD team
also sometimes evaluates the surveillance system at the level of RAK government
hospitals. The main purpose of these monitoring activities is their use for continuous
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quality improvements. The internal monitoring is done on as needed basis and is not
restricted to certain time and format.
3.3.1.3 Support functions of the ID surveillance system:
1) Guidelines
Development and update of guidelines is the responsibility of the MoHAP.
The guidelines used by the PMD and hospitals at the district levels are those
provided by the MoHAP.
2) Supervision
Since the PMD oversees the ID surveillance programs in RAK, it routinely
receives reports from the hospitals and any healthcare setting and is responsible for
resolving issues related to the surveillance ID at the level of RAK.
3) Training
Whenever a new ID program is presented from the WHO, the MoHAP
organizes a training workshop for PMD staff from different emirates including RAK.
Trained personnel are responsible for utilizing and passing on the training
information as needed.
The training has a clinical component that focuses on how to manage cases
and control spread of diseases, and an administrative component that is concerned
with the reporting to the relevant authorities and stakeholders as appropriate. The
PMD has an internal training program for its own staff that is run twice a month in
the form of lectures related to IDs. The PMD may collaborate with other healthcare
institutions to conduct some lectures after taking the approval and the lecture
material from the MoHAP.
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4) Resources
The PMD is working on 6 ID surveillance programs in which 2-3 staff are
allocated for each program. Each team that is assigned to a program has the
responsibility of gathering all relevant details of this disease in the investigation form
and following up the cases (notification or outbreak) until treated. The transportation
department provides transport for the samples as well as personnel during work
related missions whenever needed.
Reporting at the level of the PMD is done by using a combination of
computer and paper resources: All the notifications are initially completed on paper,
on a unified format that is provided by the MoHAP. Outbreak cases differ from other
cases in that the initial reporting is done by the phone. A computer is used to enter
the notification data and then to send it (in an excel spreadsheet) to MoHAP by email.
5) Coordination
The PMD collaborates with any stakeholders in RAK in order to fulfill its ID
surveillance tasks. For example, it may coordinate with the hospitals’ ICC members
in investigating and discussing some of the ID notifiable cases. Coordination is
necessary and evident during times of outbreak with the formation of a
multidisciplinary team with the member of the health sector, municipalities and other
stakeholders.
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3.3.2 Government healthcare services in RAK – Hospitals
Hospital number 1
This hospital is the main public hospital in RAK. It is a tertiary care hospital
which has 226 beds, 116 doctors and 318 nurses, which offers a full range of clinical
services through its many specialist departments.
Within the hospital, infection prevention and control is the responsibility of
the Prevention and Control of Infection Committee (PCIC) whose members are
drawn from all relevant departments including clinical and non-clinical departments.
Hospital number 2
This hospital has a total of 158 beds covering a variety of specialties
(medical, psychiatry, infectious diseases, intensive care unit and an isolation unit).
The hospital has 32 doctors and 182 nurses. This Hospital specializes in internal
medicine and geriatric care. Within the hospital, infection prevention and control is
the responsibility of the PCIC.
3.3.2.1 Structure of the ID surveillance system:
1) Surveillance structure
Within the two government hospitals, infection prevention and control is the
responsibility of the PCIC whose members are drawn from several relevant
departments including administration, quality control, clinical departments,
laboratory, pharmacy, supplies, engineering, housekeeping and continuous
professional development department. Most of PCIC work is done by two nurses
(members of the PCIC), which includes the daily monitoring of infectious cases that
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are admitted in the hospital, writing monthly reports and contributing to teaching
activities.
At the hospital level, ID surveillance focuses on the need, depending on the
types of infections in different departments. For example, the IDs surveillance in
hospital number 1 focuses on five infections which are: surgical site infections (SSI),
methicillin

resistant

staphylococcus

aureus

(MRSA),

ventilator

associated

pneumonia (VAP), urinary tract infection (UTI) and bloodstream infection (BSI).
With the exception of MRSA, guidelines for these infections are prepared by the
MoHAP and circulated to the hospitals. The MRSA guidelines are prepared by PCIC
members in each hospital. While the MoHAP guidelines are used at the hospital
level, they can be customized to meet the individual hospital needs. This seemed to
be done regularly in hospital 2.
2) Notification
The infectious diseases case notification form is distributed by PMD to all
RAK healthcare settings. The PCIC is responsible for ensuring that the form is
available in the various hospital departments (Appendix 5).
3.3.2.2 Core function of the ID surveillance system:
1) Case detection
The PCIC of the two hospitals adopted the guidelines for their ID
surveillance from the MoHAP, however made changes to them to better suit their
settings, using CDC as a reference.
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2) Case Confirmation
The ID notification form is completed for any patient who has an infection
which is confirmed with a positive culture result conformation. This is done using
the notification form, which is completed by the physicians and the ward nurse
(Appendix 5). The completed notification is then sent immediately to the Infection
Control Nurse (ICN), who makes the necessary documentation and then sends it to
PMD. All the IDs notifiable cases forms and the weekly Zero reporting forms are
sent to PMD after completion.
For cases of notifiable diseases coming to the hospital, continued
management of the patients (especially laboratory testing) can only be done after the
PMD has been notified and in turn communicates with the clinical team to proceed,
which can sometimes cause a delay in patient treatment.
In both hospitals, the samples come from different hospital departments and
wards, and are transferred in biohazard bags to the laboratory. In hospital number 1
there is no locally prepared guideline for transfer of samples, however the CDC
guidelines are used. In some cases, the PMD collects the sample and performs the
initial analysis in their laboratories before sending it to reference laboratories for
further testing, in the emirates Sharjah and Abu-Dhabi. Positive results from the
hospital laboratories are forwarded electronically to the ICN. The ICN checks these
results and decides on the appropriate action.
3) Data analysis
The raw data collected on each notification form includes name, age, sex,
nationality, ward and type of disease. However, at the hospital level this data only
exists on the hard copy of the notification form, which is sent to the PMD.
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At the PMD, data is entered into an excel spreadsheet which is sent by e mail
to the MoHAP at the end of the month.
For other cases which do not fall in the ID notifiable list, each hospital sends
summarized data to the ICD in the MoHAP by e mail.
The ID data analysis that is done in the hospitals is to understand what
microbes are spreading, in which ward they are spreading and resistance patterns.
This is very different from the analysis done in the context of surveillance programs
and notifiable infections, which is done at the higher level.
4) Epidemic/ Outbreak preparedness and response
In the two government hospitals, any outbreak (within the hospital) or other
positive results such as SSI, MRSA, VAP, UTI and BSI are considered to be
important and require immediate action. When an infectious agent is detected in any
sample, the microbiology department sends the positive culture results to the ICN
office. When the ICN comes to the office, she screens the positive reports to decide
the action that will follow. Since the screening can be done only using the office
computer, there could be a time delay between the sending the report and taking
action.
The PCIC in each hospital reports directly to the hospital executive director
or his designee via the PCIC chair after their investigation and action. This
arrangement seems to be effective in allowing infection-related problems within the
hospital to be quickly brought to the attention of the senior management for whom
hospital infection prevention and control is a priority.
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When forming a team for the cases of outbreak in RAK (outside the
hospitals), a laboratory technician will be included in the team and sometimes a
member of PCIC.
5) Quality monitoring activities
Evaluation of the ID surveillance systems is done internally by PCIC
members. The core functions (availability of case definitions) and support functions
(availability of papers and computers) are evaluated every three months using custom
developed tools. In case any gap is found in their surveillance system (e.g. timeliness
of reporting), then the members of the PCIC meet to find solutions.
3.3.2.3 Support function of the ID surveillance system:
1) Guidelines
The two hospitals may customize the guidelines

in order to meet their

specific need, while ensuring that they are consistent with national and international
guidelines. The PCIC of the hospitals would meet to discuss revisions of the
guidelines and approve updates.
2) Supervision
The PCIC checks all the ID surveillance of the hospital and makes sure that
the case definition used is according to their guidelines which are updated from
MoHAP. PCIC also make sure to collect all the ID notifiable cases forms from all
hospital departments.
3) Training
All healthcare personnel in the MoHAP need to complete mandatory
competency training on a variety of topics that are related to their department at least
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once a year. However, training on ID surveillance is not a component of the
competency training programs.
Professional development of healthcare personnel working with IDs in the
two hospitals is in the form of attending conferences, participating in training
workshops and infection control programs, which include surveillance and
management of medical waste.
4) Resources
Both computer and papers are used in the two hospitals: 1) computer to enter
the hospital ID surveillance data and to send reports to the MoHAP, 2) papers such
as notifications and zero weekly reports which are sent to the PMD. The
transportation department supports the hospitals by transporting samples as well as
transporting PCIC staff during work related missions.
5) Coordination
In each of the two hospitals, the respective PCIC meets quarterly, however in
an emergency (such as an outbreak) it could meet more frequently. PCIC
coordinates/ collaborates with PMD and may meet with them to help in controlling
an outbreak case or to help in their investigation of some cases of notifiable diseases.
PCIC also coordinates with RAK municipality to dispose their office waste and with
Waqaya (a company that specializes in disposing medical wastes).
Miscellaneous
RAK infectious disease data is published as part of a bigger publication
prepared by the MoHAP, which is the quarterly annual statistical report. There have
been no peer-reviewed publications about the ID surveillance system in the UAE.
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Table 3.10 shows the assessments of the ID surveillance system (structure,
core functions and support functions) at different levels in RAK.
Table 3.10: Assessment of the ID surveillance system (structure, core functions and
support functions) at different levels in RAK
PMD
Clinical
services

Government Hospitals

Administrative
services

Hospital 1 Hospital 2

Structure
Surveillance structure
Availability of the structure

NA

✓

✓

✓

Training on surveillance

NA

✓

ND

ND

NA

✓

✓

✓

NA

✓

*

*

✓

NA

✓

✓

✓

NA

**

**

✓

NA

✓

✓

NA

ND

✓

✓
✓
✓

NA
NA
NA

*
✓
✓

*
✓
✓

*

NA

*

*

ND
ND

NA
NA

ND
ND

✓
ND

ND

NA

ND

✓

Notification
Availability of notifiable disease
list
Collaboration
Collaboration with other sectors
Core Function
Case Detection
Availability of standard case
definitions
Knowledge of programs that are
under surveillance
Case Confirmation (of notifiable
diseases)
Capacity to transport specimens
to higher level
Presence of specimen collection
guideline
Follow up of specimen results
Data reporting
Availability of reporting form (ID
notification)
Presence of zero reporting system
Data Analysis
Performing trend analysis
Calculate incidence and
prevalence of diseases
Epidemic/ Outbreak preparedness
and response
Manual for standard case
management

ND
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Table 3.10: Assessments of the ID surveillance system (structure, core functions and
support functions) at different levels in RAK (Continued)
PMD

Compare present and previous
data
Involved in an outbreak
investigation
Presence of epidemic rapid
response team
Quality monitoring
Quality monitoring from a higher
level
Support Functions
Guidelines
Presence of guidelines
Supervision
Presence of supervisory visits to
the lower level
Training
Training of the rapid response
team
Basic training on ID surveillance
system
Post basic training on ID
surveillance system
Resources
Presence of office
Presence of functioning telephone
Presence of functioning computer
Presence of functioning means of
transportation
Coordination
Coordination mechanism
Miscellaneous
Healthcare personnel need
training on ID surveillance
Publications about surveillance
system
Published statistics

Clinical
services
**

Government Hospitals

Administrative
services
NA

Hospital 1 Hospital 2
**

✓
*

✓

NA

*

*

NA

ND

*

NA

✓

NA

*

NA

ND
✓

*

✓

✓

✓

✓

NA

*

ND

ND

NA

✓

*

*

NA

*

ND

ND

NA
NA
NA
NA

✓
✓
✓
✓

✓
✓
✓
✓

✓
✓
✓
✓

NA

*

*

*

NA

✓

✓

✓

NA
NA

✓ Applicable.
* To some extent.
** Not clear/ insufficient information.
ND: Not Done
NA: Not Applicable

ND
*

ND
*

ND
*
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Chapter 4: Discussion
This is the first population-based study using a representative sample on the
prevalence of and factors associated with IID in the UAE.
4.1 Prevalence of IID in the community
4.1.1 Comparison of the IID prevalence with other studies
In UAE
This cross-sectional telephone based survey has estimated the prevalence of
IID caused by all pathogens to be 4.2% in a sample of the RAK community. It is
difficult to compare the findings with other data from UAE, because there are no
previous community studies about IID prevalence in UAE. The only two
publications on IID found in UAE are hospital-based studies where data collection
was from patients attending the health facility complaining of gastrointestinal
symptoms. Although it is not possible to make a direct comparison between those
hospital based studies and the RAK community based study, certain aspects which
are relevant to both will be discussed.
The first study was conducted in the emirate of Dubai and reported crude
incidence rate (CIR) of 21 IDs obtained from retrospective data from the Preventive
Services and Communicable Disease Department of Dubai Health Authority during
the period 1995-2013. The authors noted that, the overall CIR for IDs in Dubai
decreased from 1486.82 in 1995 to 307.43 in 2013, possibly due to the improvement
in the healthcare system. However, focusing on the IID as a subset of the total IDs,
different trends could be seen.
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Over the same time period from 1995 to 2013, the CIR for certain IIDs
decreased (Bacillary Dysentery, Salmonellosis, Typhoid) however, for others (food
poisoning and Amebic Dysentery) there was more than a 3-fold increase, and was
expected to increase further [84]. The increasing CIR of certain IIDs may be due to
the changes in the lifestyle, where more are eating outside the home or maybe
spending more time outside the home which makes them more susceptible to
diseases. The lesson learned from this study is that the general trends for IDs may not
applicable to all IDs, and that by pooling all the data together, certain important
issues may be overlooked.
The second study, conducted in the emirate of Sharjah, was a hospital based
study that focused on intestinal parasitic infections over a one-year period from
2008-2009. The reported prevalence in the study sample (n=10514) was 7.7%. The
higher rates of parasitic infections were found in the native Emirati population
(15.7%) as compared with the expatriates (3.2%) [109]. Although this data does not
reflect what is happening in the community, it is reasonable to expect that many
asymptomatic cases did not seek medical care, and hence remained undetected [115,
116]. Similarly, in the current study no stool samples were collected, and hence no
information about parasitic infection could be obtained, although it is likely that there
are cases of parasitic infection in the community that were not identified.
In GCC countries
Only one community study on prevalence of IID in the GCC could be found. In
KSA, a cross-sectional study involving school children age 7-12 years old reported
that 14.9% of 1064 respondents (children) had diarrhea in the previous month [105].
In the current RAK study, prevalence IIDs in children 7-12 was 9.4%. One of the
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differences that exist in the current RAK study is that the prevalence of IID in all
ages was calculated where the KSA study the entire study sample comprised of
children. It is possible that if more than one child per household were recruited, the
prevalence would have been higher.
There is generally very limited number of studies on IID in the GCC, with
most studies generally focusing on intestinal parasitic infections. The following
section presents the findings and trends from those studies, with the understanding
that no direct comparison between IID and intestinal parasitic infections were drawn.
Some of the GCC studies focused on comparing the prevalence of parasitic
infections in expatriates and natives, because of the influx of migrants to these
countries. In Qatar, a study investigating prevalence of intestinal parasitic infections
in expatriates who had recently arrived for employment in food handling jobs
between 2005-2006 reported prevalence of 33.9%. Those workers were believed to
have carried the intestinal parasitic infections on arrival to Qatar [117]. Although the
current study did not explore parasites, the UAE also has a high influx of workers
who could be parasite carriers, making this a potentially relevant topic for future
research.
In Kuwait, a study conducted on patients visiting hospitals reported the
prevalence of intestinal parasitic infections to be 67%. In contrast with the study
from Qatar a higher prevalence was found in Kuwaiti nationals than expatriates
[118].
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These findings are in agreement with a study conducted in Sharjah (UAE)
investigating the parasitic infection that reported a higher prevalence in native
Emiratis (15.7%) compared with non-Emiratis (3.2%) [109].
In the current RAK study which investigated IID rather than parasitic
infections, nationals were more likely to get IID than non-nationals (5.6% and 2.7%,
respectively, P≤0.05). While it is not possible to compare our results with the Sharjah
study, because the Sharjah study focused exclusively on the parasitic infections,
these two studies demonstrate that the prevalence of two different categories of
gastrointestinal infection is higher in native Emiratis.
In the current study, it is notable that there were no cases of the IID reported
from those who are living in group accommodation. Most of these individuals are
workers making a living through skilled or unskilled labour, and tend to live in
shared rooms that bring together 8 or more people under one roof. This finding is
unusual, since many studies found that those who are living in crowded conditions
are more susceptible to ID. Furthermore, most of the workers living together come
from endemic areas, therefore it would be expected that prevalence of IIDs is
comparable to, if not higher than, "native Emiratis" [115, 117]. It is possible that
these workers feared that reporting any kind of illness might be taken against them
and affect their work status, and therefore denied having any symptoms. If that is the
case, this would have ethical implications. The other possibility is that these
individuals come from a relatively low socioeconomic status and as a result they
have a higher tolerance to conditions such as transient fever, intestinal cramps and
diarrhea.
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In developing Countries
The RAK study is comparable with other developing countries that measured
the prevalence of the IIDs. A Chinese cross-sectional study conducted reported a
prevalence of 4.2% of IID in individuals from all age groups (N=39686) [99].
Similar to what was found with GCC countries, many of the studies done on
other developing countries focused on parasitic infections rather than intestinal
infections. For example, in Ethiopia, a cross sectional survey conducted from April
to June 2012 involving students from grade 1-8 (N=326) found the prevalence of
intestinal parasitic infection to be 34.2% [103]. Another cross-sectional survey
conducted in West Africa (Burkina Faso) in students aged 8-14 years (N=385)
reported that more than three quarters of the participants had intestinal parasitic
infections (86.2%) [100]. In Iran, a cross sectional survey conducted from October
2010 to March 2011 with 800 students (age 8-12 years) reported a prevalence of
intestinal parasitic infections of 28.8% [95].
Since parasitic infections are considered a subset of IIDs, it may be expected
that prevalence of IIDs in those populations is even higher and hence several-fold
more than the prevalence reported in my study.
Furthermore, many of the developing countries have been involved in wars in
the past decade, which is accompanied by a heavy burden of both communicable and
non-communicable disease, both in those who remain in the disaster-struck
deteriorated environments, as well as the thousands of refugees who are displaced
into unfavorable living conditions that are crowded and lack hygiene and good
sanitation [119]. As such, comparison of prevalence of disease in those populations,
with others living under stable conditions would not be on equal grounds.
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In developed countries
In several developed countries, the prevalence of IID was comparable with
our study. For example, in the US, a retrospective cross-sectional telephone based
survey conducted for 12 months reported a 6% prevalence of IID in the previous 4week period prior to the interview in their sample of 12075 participants of all ages
[43].
In Canada, prevalence of IID in the previous 4 weeks of the interview in a
retrospective cross-sectional telephone based survey conducted for 12 months with
participants from all age groups (N=3496) was 10% [54].
In Italy, a retrospective cross-sectional telephone based study conducted from
July 2008 to June 2009 with 3490 participants from all age groups reported
prevalence of 8.9% of the IID in the previous 4-week of the interview [90].
It is not clear why our prevalence is lower than what was found in studies in
developed countries, although it is possible that the selection bias due to language
barriers reported in those studies may account for the relatively higher prevalence as
compared to our study.
4.1.2 Comparison of participants interviewing methods
4.1.2.1 Effect on response rate
Different methods of interviewing research participants have been compared
extensively, with the aim of determining the easiest, most cost-effective method
without compromising the quality of the data [120].
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Response rate with telephone based method
Some studies found the response rate to be higher in face to face studies than
those using telephone surveys [121]. In RAK, a cross-sectional telephone based
method was used and found a low response rate of 31.7%. However, this “low”
response rate was in the same range as studies done in Western countries, where
there is generally much more public awareness about research.
Similarly, low response rates were found in several studies that used
telephone survey as a method to interview their participants. For example; a study
conducted in the Netherlands used a telephone survey found a response rate of 32.9%
[50]. Another study conducted in Canada using telephone survey found the response
rate of 36.6% [54]. It is interesting that the UAE study that was used as the basis for
the sample size calculation had a higher response rate (65%) than all the studies
mentioned above, possibly because the telephone base method in that study was
preceded by an initial recruitment step that happened face to face.
Response rate with face to face method
Response rates have varied with the face to face interview method. Some
studies showed a high response rate and others showed low response rate. For
example, in Barbados, a cross-sectional study in which interviews were conducted
face to face method reported a high response rate of 84%, and prevalence of IID
4.9% [27].
In a community setting in Pakistan, the response rate in a cross-sectional
study to study the prevalence of intestinal parasitic infections in children aged 1 to 5
years reported a response rate of 62.3% and prevalence of infection 52.8% [102].
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While in Iran (Tehran), a cross-sectional study conducted from January to
December 2014 on study participants from all age groups from the community using
the face to face method, reported a prevalence of 32.7% of intestinal parasitic
infections. This study had a low response rate of 25.4%. In this study the authors
mentioned that the reason for getting a low response rate is for some cultural reason,
where the participants found it embarrassing to pass the stool samples to others [97].
Generally speaking, the response rate appears to be affected by the method
used in interviewing the participants. Furthermore, it has been suggested that where
the study is conducted can have a higher influence on response rate than method of
interview. Studies that are conducted in a facility rather than a community seem to be
associated with a higher response rate, and conversely, community based studies
yield lower response rates regardless of the interviewing method (telephone and face
to face) used [54, 97].
4.1.2.2 Effect on outcome measures
Telephone based method vs. Face to face method
This RAK study is the first study to use a telephone based survey to study the
prevalence of IIDs in the UAE. This method was chosen, because the UAE culture is
not familiar with research surveys and the telephone based method was considered to
be less intrusive, and therefore more acceptable to potential participants, as well as
being more cost effective [122].
Several population based studies investigated the IID using telephone based
method. For example, a cross-sectional study conducted in Australia used a
telephone based method to interview the participants (N=6087) from all age groups.
The study found prevalence of IID in the previous 4 weeks prior to the interview to
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be 6.4% [93]. In Malta, a cross sectional study conducted using a telephone based
survey for one year involving 3504 participants from all age groups found prevalence
of IID to be 3.18% [91].
For some studies, the only option is to use face to face method. For example,
in communities where access to a telephone is not available for the entire population,
if the telephone were used then it will bias the study because those who do not have a
telephone would be excluded. It is not surprising, therefore, that the most common
method used in the majority of developing countries is the face to face method to
interview. It is important that the person conducting the interview does not influence
the responses and thereby affect the results. In studies were the result is determined
by laboratory testing, this kind of bias is eliminated. For example, a study in West
Africa (Burkina Faso) reported that 86.2% of children had infection [100]. Although,
the face to face method was used in the interview, it did not influence the results in
that study because the outcome (parasitic infection) was confirmed through
laboratory testing. In KSA, a face to face method was used to interview the
participants. The prevalence of intestinal parasitic infections was found to be 32.2%
[123].
Prevalence of IID in our study is similar to other studies that have the
telephone interview method. For example; Malta reported 5% IIDs prevalence using
telephone method in interviewing the participants [56]. In our study, the research
assistants were trained on interview procedures and were specifically instructed to
read the questions from the questionnaire as it was written and if needed, to explain
the questions without influencing the participants by suggesting answers. Although
this is expected to reduce the likelihood that different interviewers were associated
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with different results, this can only be confirmed by kappa statistics to determine
inter-rater variation.
4.1.3 Factors associated with IID
It is important to understand the factors associated with IID, since these
factors will be the starting point to develop interventions to reduce prevalence.
Age
In RAK, children aged 5 years or below are more likely to have IID than
those who are 6 years or above. Younger age has been found to be associated with
IID in several studies. In the US, a retrospective cross-sectional telephone survey
conducted for 12 months reported prevalence of IID to be 6% in the previous 4
weeks of the interview, and found that the rate of IID is highest among children
below 5 years of age and lowest in those aged ≥ 65 years [43].
Similarly, in the Netherlands, a retrospective cross-sectional study conducted
over one year (N= 1975) reported the IID prevalence found in the previous 4 weeks
of the interview to be 7.4%. The factor significantly associated with community IID
was age below 5 years [50].
It is hard to compare prevalence according to the age factor with the
developing countries, since their focus was specific pathogens like parasites and in
RAK study the IID covers all pathogens causing the infection. However, it is of
interest that even in studies that restricted their outcome to parasites, children were
found to be more likely to be infected than adults. In KSA (Riyadh), a community
survey conducted reported a prevalence of 32.2% of intestinal parasitic infections in
all population and from their multivariable analysis found a prevalence among
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children under 12 years old (34.4%) [123]. One of the reasons suggested for infection
being more prevalent children being more infected than other age groups is that they
are not aware or lack education related to hand hygiene (education factor) [96]. In
China, a prevalence of 12.6% of the IID was found in children ages from 0-4 years
old and it was higher than all other age groups [99].
Monthly household income
In RAK, a middle range household income was positively associated with the
IID. This is in contrast with reports from Malaysia and China in which no association
was found between the monthly household income and the IID [98 and 99,
respectively]. On the other hand, in Barbados, in agreement with our results,
household income was positively associated with the IID, the reason for which was
suggested to be higher frequency of eating outside [27]. In our setting, this could be
due to eating outside the home, although further studies would be needed to confirm
that.
Gender
In RAK, prevalence of IID was higher in females as compared with males
(1.1% and 0.6% respectively). The current study findings are in agreement with those
from a cross sectional telephone survey conducted in Canada that found that the
prevalence of IID is higher in females than males. The higher IID prevalence in
females was postulated to be due to their exposure to food (kitchen service), since
they are the ones who cook for their families and kitchens are considered to be
reservoirs for many food-borne pathogens [54].
In contrast, a cross-sectional study using face to face survey conducted in
Barbados found that the prevalence of IID is higher in males than females. The
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higher prevalence in males was suggested to be because of their tendency to eat more
frequently outside the home, in a setting where food outside the home seems to be
more contaminated [27]. In a cross sectional study conducted in US using a
telephone survey, the prevalence of IID was found to be the same in the two genders
[43].
In RAK, females had the higher number of cases of IID. This may be due to
the fact that the females are more in contact with their children and taking care of
them. Furthermore, the role those females are playing in the home such as cooking
make them more susceptible to such infections.
Season
Seasonal variation is an important phenomenon that has been documented
for IIDs. Several studies have found that IID prevalence was higher during winter
months as compared with other seasons. In Malta, the factor associated with the
prevalence of the IID in the community is the winter season [91]. In Italy, the
prevalence of the IID peaks in (November-March) which considered as winter [90].
In the US, a higher prevalence of IID cases found during the winter season
(December, January, February) [43]. In contrast, a study conducted in the
Netherlands found that there were higher frequencies of IID during spring and
autumn; however, the results of this study refer to the month of interview rather than
the date of the event [50].
In the RAK study the prevalence of IID was not uniform throughout the study
period, although the number of participants was comparable in all the study months.
Highest prevalence was reported in the months of February, March and April, which
are considered as spring in UAE. When evaluating studies for the effect of seasonal
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variations on IID, it is important to note whether the month reported is the month of
the interview or the month of the event. In most studies that collect data about the 4week period prior to the interview, events described will be in the previous month.
Furthermore, although the overall study duration was reduced by three months, the
total target sample size was reached.
One way to ensure that the data obtain relate to a single month it is to conduct
the interview during the last two days of the month, which ensures that any
occurrences reported happened during that month. In the current study the interviews
were allowed to be conducted throughout the month on any day in that month.
However, participants who reported symptoms that were consistent with IID were
requested to provide the date (s) of the beginning of their symptom (diarrhea), so that
the results can be documented according to the exact month of infection and not the
month of the interview. In our research, changing the study duration from 12 months
to 9 months means that data from 3 months was omitted, spanning across two
seasons. This omission means that any variations specific to those months will not be
captured. In the UAE, October is associated with a significant 20 degree drop from
the scorching 50 degree Celsius temperatures recorded in August. If it were
hypothesized that drastic change in temperature may be associated with an increase
in IID, then it might be expected to observe a higher prevalence of IID in November,
because temperature during this month drop considerably. If that is the case, then
inclusion of that data may cause increase of overall prevalence of IID. However, in
the absence of supportive data, this cannot be confirmed.
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In the current study data from different months were not grouped together,
nor were the seasons discussed, because in the UAE there aren’t four distinct
seasons. Most of the year is quite hot, with temperatures above 30 degrees from
April to October.
4.1.4 Underestimation of IID
It is of concern that underestimation in community studies is not uncommon.
In the current study, the possibility that the prevalence of IID of 4.2% that is reported
is in fact an underestimation of the real magnitude of the problem cannot be ruled
out. Several factors have been associated with under-reporting [43].
Migrants
In RAK, there were no cases of the self-reported IID from those who are
living in non-family accommodation. It has been previously found that there is
lower reporting of IDs in migrants compared to natives [115]. Our finding that there
were no reported cases of IID in the migrant population was unexpected. Most of
these migrants have come to the UAE seeking job opportunities. Often the jobs are
unskilled labour. Reporting an illness may be perceived as being a threat to their job
security. One way to overcome this issue is to collect the data in the form of a selfadministered questionnaire that is completed anonymously by participants, with all
forms (completed and blank) being returned to a box to be collected by the research
team.
Cultural issues
In our culture, certain issues are embarrassing, especially if they are discussed
outside healthcare facilities. For example; some participants refused to complete the
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questionnaire even after taking the initial consent from them. This refusal came after
going through some questions like when asking them about skin diseases.
Language barriers
The existence of language barriers is one of the reasons for under-reporting.
Many surveys are prepared in one language and do not consider potential participants
living in the same area and having a different language than the native people
language [120]. For example, in Canada, many participants were excluded from their
study, because these participants did not understand the survey language [54].
It is important to include those foreign participants in community studies,
since they are part of the community that is being studied and their exclusion would
introduce selection bias.
In RAK, the survey tool was produced in three languages to make sure that
those who excluded are not because of the language barrier.
4.1.5 Comparison of respiratory infections with IID
Comparison between studies investigating the factors associated with the
respiratory infection is difficult possibly due to the differences in the methodology.
For example, definition of respiratory infection has varied from one study to another.
Presence of several symptoms concurrently (as such fever, cough and nasal
discharge) has been considered to be necessary by some researchers [124], in
contrast with a single symptom such as cough by others [125]. In the current study a
very broad definition was used whereby a positive report of any one of the symptoms
was taken to be indicative of upper or lower respiratory infection, provided it was not
a chronic condition.
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On review of the literature, very few community studies on respiratory
infections around the world were found to have included participants from all ages.
The prevalence of respiratory infections of 14.2% from all age groups in the current
study is lower when compared with the prevalence of 19.85% from all age groups in
the Australian study [126].
The study populations can have a significant effect on the reported respiratory
infections, particularly with respect to age groups included, since children are
generally more susceptible. When drawing a comparison between our study and
other published studies, it is important to bear in mind the differences in
methodology and the impact that these differences may have on the outcome.
Many of the published studies of respiratory infection in the community have
focused on children. The discussion which follows is based on our calculation of
prevalence of respiratory infection in the sub group of our study sample compared
with other studies.
Age
In RAK, those aged ≥ 60 years old were less likely to get respiratory
infections than those who were 5 years old or below. Similarly, in the Australian
study, those of age group over 60 years old were less likely to experience respiratory
infections than children less than 5 years of age [126]. Although the underlying
reasons were not explored, this difference is possibly due to the life style of the
elderly people who tends to be more conservative in terms of their social habits or
eating habits that may impact immunity.
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The plethora of studies on respiratory infections in children has reported
prevalence's ranging from 7% to 52% [127,128]. In RAK, the prevalence of
respiratory infection in children aged 0-5 years old is found to be 34.8%, which may
be under estimating the actual prevalence in children in our community, because only
one child is selected from each household, while it is likely that in a household with
many children, more than one child would be affected.
An exhaustive and comprehensive search of the published and unpublished
literature (country health reports) and to the best of my knowledge there are no
studies in the prevalence of respiratory infections in the Middle East. Below is the
comparison of the current study results with few studies that considered to be closest
to the current study in terms of methodology (the definition of the respiratory
infection and the recall period during the study on which the participants had to
provide information).
A similar cross-sectional population-based study conducted in Malawi
reported a prevalence of respiratory infections of 32.6% in children 0-59 months was
comparable to the current study results [129].
In India, lower prevalence's of respiratory infections was found compared
with our study. For example; in Lucknow (India), a cross-sectional study conducted
in children under age of 5 years. The prevalence of ARI in this age group was 23%
[130].
Another cross-sectional study conducted in Gujarat (India) reported that the
prevalence of ARI in children under 5 years old is 22% [131].
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In the current it was found that the community infections, both respiratory
and intestinal appear to be more prevalent in younger children.
Monthly household income
In RAK, a middle range household income was positively associated with the
respiratory infections. Studies found that low income is associated with respiratory
infections. For example; in Madagascar, low income was found to be a risk factor for
many respiratory infections in children under age of 5 years [132].
Similarly, lower socioeconomic status was found to be a significant factor
associated with the ARI in a cross-sectional study conducted in India in children
under 5 years of age [128]. On the other hand, a cross-sectional population study
conducted in Indonesia found that there is no significant association between the
household income and the incidence of ARI in children [133].
Living conditions
The prevalence of respiratory infections in those living with spouses is lower
than those who are living alone. This could be related to the nature of the job of
people living alone or to the fact that those who are married generally have better
living accommodation in the UAE.
It is difficult to compare this factor with published studies, because living
conditions (with reference to who the study participant is living with) is unique to
our region. Workers accommodation is a facility that has been introduced in our
region to cope with the high influx of unskilled labourers that are employed by
companies such as building contractors, cleaning services and others. With regards
living together, only married couples can legally live together. Whereas in many
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other countries the marital status could be single, while at the same time they are
living together as a married couple.
Season
In the current study, during the colder months there was a higher prevalence
of respiratory infection. Seasonal variation is an important phenomenon that has been
documented for respiratory infections.
Several studies have found that respiratory infections prevalence was higher
during winter months than other season. In the Middle East there are large areas
covered with desert and in summer the weather is very hot and humid, but in winter
the temperature drops significantly [134].
Another study conducted in KSA investigating respiratory infections found
that the respiratory infections peaked in winter months [135].
A study conducted in Australia found that during winter, people were at
highest risk to get ARI and less likely to get ARI in summer, while there were no
significant difference was seen between autumn and spring [126]. Similarly, in the
current study, the respiratory infections peaked in colder months.
4.2 Infectious disease surveillance system in RAK
4.2.1 Structure and core function
In this study, the ID surveillance system in RAK was described, one of the
seven emirates making up the UAE, at two levels (district, hospitals). The building
blocks required for a potentially good ID surveillance system were in place and this
is consistent with the standard of health services in the country, which are
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comparable with international standards [136]. However, the way that different parts
of the system function individually and collectively are crucial in determining the
effectiveness and quality of the system as a whole, as will be discussed in the
following section.
The PMD is the higher-level authority in RAK which oversees the ID
surveillance system at the hospitals. However, it also has additional responsibility of
performing the ID screening that is mandatory for all visitors applying for residence
permits in the UAE. This situation seems to be unique to the UAE, since globally it
is unusual for higher authorities to be directly involved in clinical work. More
commonly, it is the hospitals and clinics that carry out the clinical tasks related to
infectious diseases.
For example, in the state of Maharashtra in India, the higher levels (National
surveillance unit, State surveillance unit and the District surveillance unit) are
responsible for the administrative work such as receiving data and giving feedback,
while lower levels are responsible for the clinical work [137]. Similarly, in Korea,
the lower levels report ID cases after performing all clinical tasks related to the case,
such as sample analysis, confirmation and investigation. The higher levels in turn
receive the reports and pursue with administrative tasks such as data analysis and
feedback [57].
It is possible that in RAK, having this extra clinical role at the higher level may
impact other duties. This would be likely, considering that the same personnel carry
out duties on both divisions of the PMD.
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4.2.1.1 Surveillance programs
The WHO health profile of the UAE (2015) report specifies several ID
programs that the country is working with. These are HIV and Hepatitis, TB,
malaria, neglected tropical diseases and vaccine preventable diseases [138].
Collectively, in the PMD, there was awareness of all of the programs that the UAE is
working on, although most personnel were focused only on one or two programs
with which they were directly involved. In contrast, at the hospital level, all ID
management was done within the framework of the clinical work, with limited
reference to surveillance programs. A study in Khartoum (Sudan) found that all the
staff at different levels working in the ID surveillance system knew the diseases
under surveillance [139]. It seems that training of staff at all levels is a priority in
their settings. In Qatar, training of their staff was found to improve the quality of
notification this is probably because of increased awareness about ongoing
surveillance programs and diseases for which notification is necessary [78].
4.2.1.2 Guidelines
The WHO considers the availability of a guideline for each disease to be a
basic element in any surveillance system [138]. Public health agencies at the national
level should have the responsibility to make an effective policy on reporting and
controlling IDs that the country reports to WHO [34]. In the UAE, guidelines are
prepared centrally at the main Ministry of Health headquarters. These are passed on
to the surveillance systems at the district/ emirate level, and from there, further down
to the hospitals. The district and hospital levels are not involved in preparation of the
guidelines however; if necessary they are able to tailor the guidelines to meet their
specific needs.
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Similarly, in KSA, the MoH is the authority that is responsible for making
policies, following up and evaluating infectious disease programs, through the
central Infectious Disease Department [140]. In Egypt, the Ministry of Health and
Population (MoH) is responsible of developing guidelines and providing feedback to
other lower levels. A subdivision of the MoH, the Central Epidemiology Surveillance
Unit, works on establishing the ID surveillance system [141]. By contrast, in the US
and Australia, the formulation of the procedures for the notifiable diseases
surveillance system is done by the contributions of both the regional and the
government organizations [29]. Only one of the three facilities included in this study
had guidelines for IDs. It is interesting to note that this same hospital has Joint
Commission International (JCI) accreditation. Furthermore, even for diseases for
which the guidelines exist, these guidelines are primarily used by PCIC members and
are not used by the other health professionals in their surveillance activities.
The guidelines that the district and hospital levels receive from MoHAP cover
the IDs with regards diagnosis, management and reporting. However, no clear
instructions were found about specimen transportation to reference laboratories.
Recently, laboratories in government hospitals have been taken over by a private
company. It is not clear what could be the impact of the new privatization of the
laboratories in these facilities on the ID surveillance system. However, what is
certain is that collaboration between the new administration and the MoHAP is
necessary to develop laboratory guidelines that should be part of the surveillance
system.
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Case definition
For IDs case detection, definition of the case is vital in order to ensure that data
from around the globe can be compared [139]. In the current study, the guidelines
were available for specific diseases such as TB, HIV, AFP/Poliomyelitis. Although
the guidelines were clear with case definitions, their limited distribution, particularly
at the lowest levels, indicates that they are not used in routine identification and
reporting of cases. At the lower levels there is no manual for ID case definitions,
since the ID management is done from a clinical perspective, health professionals
seem to find it easier to refer to the built-in information that is part of its electronic
health information system.
Similarly, in Khartoum (Sudan), the health facilities did not have a manual for
ID case definitions; to deal with possible errors that could occur due to this issue,
frequent supervision visits were conducted at different levels to confirm that cases
were properly defined. The unavailability of a case definition reference affects the
quality of case detection and increases the workloads for those who conduct the
supervision visits [139].
4.2.1.3 Notification
The WHO requires member states to report to it health emergencies with a
potential of international concern [21]. IDs are considered to be a health issue of
concern, for which it is mandatory to report to WHO all diseases listed on the
notifiable disease list. Compilation of the list is left to the discretion of the country
[29].
In the UAE, the list of the notifiable IDs is prepared by MoHAP, which
ensures that the same list is circulated and is unified across all the 16 government
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hospitals and other private hospitals under the MoHAP. The other health authorities
(Health Authority Abu Dhabi and Dubai Health Authority) in the UAE use the same
list as MoHAP and expand on it, resulting in their own longer list.
Most countries have developed their list of notifiable diseases, although the
number of diseases in the list differs from one country to another. Each country
decides which diseases to include in its list based on public health issues that are
considered to be issues of concern [28]. Countries have differed as to how many
diseases to include on their list, although the three diseases specified by WHO
(yellow fever, cholera, plague) are found on lists from all countries.
For example, China has a list of 39 notifiable diseases unified for the entire
country, and healthcare personnel use a standard and unified format to enter the ID
notifiable cases information [38, 142]. In the Netherlands, the list of 43 notifiable
IDs is used across the country [38].
In Egypt, the surveillance system is developed to be able to collect 26
notifiable diseases [141], while Oman has a unified notifiable IDs list (29 notifiable
IDs) [143] and KSA has a unified notifiable IDs list (47 notifiable IDs). This list is
provided by their MoH, the notifiable cases reported from the lower levels to the
health sector which then reports to the regional health affairs – public health, which
then reports the cases to the MoH [140]. In Sri Lanka, the ID notifiable list consists
of 27 diseases that should be notified [69], while Pakistan needs to notify any of the
46 IDs on its list [67].
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Updating the notifiable list
The list of notifiable diseases should not be static, but rather should be updated
as new health concerns emerge. It is necessary to update the list of notifiable IDs to
avoid issues related to reporting [34]. For example, in Khartoum (Sudan), their ID
notifiable form was not updated since its establishment, and as a result this weakened
the system and reduced the data accuracy [139].
Since in RAK the original ID notifiable form has been used for many years,
emerging diseases such as Middle East Respiratory Syndrome (MERS) which make
the headlines in local newspapers [144] are reported as an added item on the
notification form.
4.2.1.4 Reporting
Following case identification and confirmation, reporting is the next major step
in ID surveillance systems. Many different issues have been reported regarding
surveillance systems around the world; the most important of these problems will be
discussed below.
Under-reporting
Under-reporting of IDs has been well-documented in the published literature.
Reporting rates have not been assessed in this study.
However, the marked differences in number of reports coming from the
government and private sectors, and specifically the low number of ID reports
coming from the latter seem to indicate that there was under-reporting. This is
similar to a study in Pakistan (Gilgit – Baltistan), where the electronic ID
surveillance system that was introduced in that area did not include the private
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sectors, which resulted in exclusion of about 80% of their private healthcare
facilities [71].
In Mumbai (India), the private health sector serves nearly 70% of the
population. However, the surveillance data (notification system activities) collected
by public health does not include the private health sector, possibly because it is
under a separate agency/authority and is not controlled by the MoH [68].
This is in contrast with the KSA, where the reporting rate for the notifiable
cases from the private sectors is relatively higher (87%) as compared with the public
sector (74%) [145]. However, it is important to note that in that study a large number
of notification forms received from government hospitals were incomplete, and so
were excluded, resulting in an apparently higher reporting rate from the private
sector.
The surveillance system does not fulfill its purpose if the private health sector
is not included, so it is important to have systems that include all stakeholders,
coupled with regular communication, to avoid issues related to reporting the cases
[68]. In order to increase rate of reporting, the surveillance system in the UAE needs
to take measures to include both government and private health sectors in a single
system.
The completeness of ID notifiable forms
The completeness of the notification form was evaluated in several studies in
other countries by assessing a sample of notification forms. In RAK, there seems to
be an issue with completeness of forms that was understood through the information
provided through the interviews. However, this is rectified at the district level by
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PMD personnel, in order to ensure that the final forms that are sent to the central
MoHAP are complete. As a result of this practice, degree of completeness of forms
would give different results depending on where they were assessed – at the district
level prior to any steps by the PMD personnel to complete the messing information,
or at the central MoHAP level after receiving checked forms from the district level.
Similarly, in a KSA study, although reporting rate was relatively high for the
notification step, the documents were commonly found incomplete in sections related
to vaccination history of the case [145].
Qatar has the issue of incomplete forms of the notifiable diseases. The missing
information has been attributed to the presence of a language barrier when
communicating with the high number of expatriates with IDs [146].
Zero reporting
According to WHO, zero reporting is recommended, which is reporting of the
absence of disease cases which are under the surveillance. This is important to make
sure that all notifiable diseases have been counted, and that diseases for which the
count is zero are because there are no cases rather than neglected cases that have not
been counted [30]. In South Africa, the zero reporting by the lower levels is not
mandatory and not required in their national diseases surveillance system. As a
result, many positive cases were not reported. For example, the number of positive
results of Meningococcal meningitis reported from the laboratories was 230, while
only 105 notifications were received [39].
In Jeddah (KSA), there are 4 sectors that provide health services, all of which
receive zero weekly reports that are completed and sent from all health centers and
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hospitals [145]. Similarly, in RAK, all the lower levels send their zero weekly reports
(AFP, Measles and Meningitis) to their higher level. Although it is not mandatory by
WHO, zero reporting is recommended is to ensure that all the positive cases were
reported and to serve as a reminder for all who notify.
4.2.1.5 Method of reporting
Reporting is considered to be the basis of health surveillance systems [147].
Different methods of reporting have been used in different surveillance systems, such
as paper-based methods, electronic methods and, in some circumstances, a
combination of both. Each method of reporting has its advantages and disadvantages.
Below is a discussion of some of the problems that have been described with each
method.
Paper
Using paper forms is the simplest method that can be used in most settings and
does not require electronic equipment. Countries with limited resources such as SriLanka depend on a paper based reporting in their ID surveillance system. All the
activities in their system from registering to reporting are performed manually and
they have noticed that an additional filtration process (which is time consuming) is
necessary to avoid duplication [69].
In India, data collected on paper causes many operational issues such as
inaccurate or incomplete data, duplication of efforts and delays in detection of
outbreaks which leads to a delay in the response for the intervention [21].
Likewise, in RAK, the data is collected on paper and transported physically to
different premises (the PMD), which may potentially delay disease notification.
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Future work that assesses the timing of different steps in the reporting pathway is
needed to further explore this point.
Electronic
According to the WHO, timeliness (interval between two steps) should be
assessed fully from the time of infection to the reporting. Timeliness is particularly
important during epidemics, and can have a significant impact on the spread of
disease. Issues with reporting have been documented in surveillance systems across
the world. Introduction of electronic reporting into ID surveillance systems has
improved timeliness [148]. For example, moving to electronic methods in reporting
have been shown to be beneficial in Ghana, where the ID surveillance system
initially relied on paper; when internet base reporting was introduced, the
completeness and timeliness of the data increased [73].
The introduction of electronic resources like e-notification, e-mail, electronic
system and phones enhanced the ID surveillance system in Indonesia, providing a
faster, more efficient and cost-effective tool for collecting data. Using these tools
reduces the time of reporting the cases [149, 150]. Furthermore, a study carried out in
China found a significant increase in the reporting speed after introducing online
notification [38].
The Netherlands uses the electronic communications mechanisms for
reporting, and found that it is important for the surveillance system in controlling the
ID outbreaks, since time is of the essence in such emergency situations [38].
In Qatar, the notification for their IDs improved because of introducing new
technological facilities such as a fax machine which was used for the notification
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over 24 hours. This led to a reduction of the reporting time from figures over 2.5
days in 2012 to 1.5 days in 2013 [78].
However electronic systems do not always enhance ID surveillance.
Problems could arise if the infrastructure needed to support the advanced technology
is not available. For example, in Maharashtra (India), 97% of the 34 districts receive
the notification data from the settings (46 facilities and 25 laboratories) in paper
based formats; some of these districts experience regular problems with internet
connectivity, leading them to shift back to the paper based formats in reporting [137].
At the level of RAK, the PMD converts the data on paper to an electronic
form which is sent to MoHAP. Since there is no electronic system integrating the
surveillance reporting at different levels, the existing resources (time and personnel)
are further drained in order to complete the necessary task.
4.2.1.6 Other reporting issues
Another reporting issue documented in US, was the failure of healthcare
providers to report many ID cases, either in order to protect the patients’ privacy or
because there is no motivation or rewards for reporting [58].
According to the law in UAE it is mandatory to notify any ID that mentioned is
in their ID notifiable list [151].
In RAK, although physicians are the only health personnel authorized and
obligated to report ID cases, at the same time they have no active role in the
surveillance program as a whole. For example, they are not involved in developing
the guidelines at any stage, nor do they have tailored training programs that prepare
them for fulfilling their reporting duties as per the guidelines. ID training for
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physicians should be a mandatory component of continuous professional
development.
Expanding the responsibility of reporting to include not just the physicians, but
also the laboratories has improved reporting in some settings. This has been shown to
be essential to improve the reporting and the timeliness as in Netherlands study [66]
and other developed countries such as New Zealand where electronic reporting is
done by laboratories as well as physicians [152]. In Sweden, the ID surveillance
system improved by the double electronic reporting from both physicians and
laboratories. It was concluded that using this combined reporting made their ID
reporting system highly sensitive in their settings [153].
Similarly, in Oman, laboratories have an essential role in reporting, alongside
physicians. Laboratory staff must notify any positive results related to priority
diseases or an unusual organism through their electronic reporting system [143]. A
study in Qatar mentioned that the physicians are the ones who notify ID cases while
laboratories’ role is restricted to confirmation of the cases [78]. This is in contrast
with RAK (lower levels), where the laboratories’ role in the ID surveillance system
does not extend beyond running the clinical test. The full responsibility of reporting
these diseases relies on the physicians. Using electronic methods coupled with other
forms of communication as needed with the ICD.
4.2.1.7 Laboratories resources
The laboratory plays a central role in both detection of ID cases and
confirmation [154]. In Khartoum (Sudan), the laboratories at any level have no
written guidelines for the sample collection and transport, although this is done
through institutionally-established routine practice. Furthermore, the majority of
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district hospitals, health centers and facilities were unable to perform culture testing
for any of their notifiable diseases. Functioning laboratories were found in almost all
healthcare facilities with the ability to collect blood, stool and urine, however very
few of these laboratories were able to collect sputum specimens [139].
This could possibly be due to the fact that sputum collection required specific
procedure and the sample should be examined under the microscope (by a
microbiologist) as an initial step prior to sending to further analysis.
In RAK an important gap is the absence of standard guidelines for handling
and transportation of samples, since many of the samples need to be transported to
the reference laboratories in other emirates for further testing (such as TB culturing).
This could be expected to prolong the process timeline in the ID surveillance
pathway, especially in the absence of standardized procedures. The lower level
laboratories are able to perform culture for some of their notifiable diseases, in
contrast to the higher level laboratories in RAK, where it is not possible to perform
any type of culture. All RAK laboratories are functioning and are able to collect
blood, stool, urine and sputum specimens.
4.2.1.8 Data management /analysis
The surveillance system and reporting the IDs should provide information on
the prevalence and incidence of the disease, and allow quick identification and rapid
response to disease outbreaks [34]. However, in many developing countries this is
not the case. For example, in Ghana, the paper based forms are sent from the lower
level to the district health directorate, which enters these forms by health information
officers into electronic form [73]. In Sudan, the data analysis of the ID surveillance
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system was not done in all the lower levels of health facilities. It was done only by
few facilities in the lower level which had computers for their data analysis [139].
In our setting, the data management from ID notification forms is carried out
by the PMD. However, this does not include performing a detailed analysis and
looking for trends. As a result, it is difficult to predict outbreaks or understand
changes in disease patterns, such as re-emergence of certain diseases.
The central MoHAP is the only authority that receives data from all the 7
emirates and pools it to report national ID surveillance statistics. It is their
responsibility to have information about disease patterns, resistance patterns and
trends, because it is necessary in planning and ensuring that the services available
meet the local needs. It is still important at the level of individual hospitals to
perform this analysis to estimate increases in the number of ID cases in order to plan
for better management (improved facilities and services).
At the PMD level, it is important to know about the increases in the cases of
the IDs, to plan and to upgrade the resources to ensure they meet the needs. For
example, isolation rooms in healthcare facilities are important not only to manage
existing cases, but also contain spread of disease.
4.2.1.9 Epidemic /outbreak response
The WHO surveillance guidelines mention the rapid response team as one of
the indicators to assess the core function of the surveillance system [30]. In
Maharashtra (India), it was reported that all of their districts had a rapid response
team and the majority of these districts had a clear defined epidemic management
committee [137]. In contrast to Sudan, where none of their lower levels knew about

149
the number of the cases on the outbreaks (acute watery diarrhea in 2006 and Rift
Valley fever in 2007) and the outbreaks were managed centrally, because the lower
levels have no functioning epidemic managements committee. Furthermore, no
established rapid response team was available; instead, when needed, the team was
formed and activated [139].
In RAK, a team will be formed to deal with any outbreaks or emergencies only
when there is a need, which may be time consuming. Having a trained team which is
ready for such crises may reduce the time for containing such situations.
It is understandable that the highest medical authority in RAK, medical
authority in RAK (medical district), gets involved in times of ID outbreaks.
However, getting it involve in a more regular basis is likely to make it easier
to fulfill its role to form a team by mobilizing experts from different specialties to
deal with the situation. Ongoing involvement of RAK medical district in the PMD
surveillance system through regular meetings and initiation of activities at the district
level and continuous quality improvement programs are expected to enhance both
emergency and non-emergency function of the surveillance system.
4.2.1.10 Quality monitoring (feedback)
The feedback that the higher level in RAK (PMD) receives from MoHAP
about their work is valuable in making improvements. This would be even more
effective in bringing about change if there was a before and after assessment for any
intervention.
In contrast to Oman, the department of the surveillance distributes
electronically a weekly feedback report to all concerned on notified IDs, with the
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goal of the improving the efficiency of the surveillance that it is essential for their
surveillance system and without which the surveillance system will not function
efficiently (poor motivation) [143]. In Ghana, the healthcare facilities do not have
regular feedback from their higher level; the only feedback they got is during
irregular meetings in their facilities with their head of units in the lower levels [72].
The surveillance system evaluation should be regular to ensure that the
system is performing its duties efficiently [153]. In Pakistan, regular monitoring for
the surveillance system existed and was performed by district personnel and field
program officers [71].
Similarly, in RAK, the PMD performs the monitoring ID surveillance system
for their lower levels, but excludes the private health facilities, because of the
complicated administrative procedures required to enter their facilities.
There is a general kind of monitoring. However, it is not well structured in
terms of steps (analysis, feedback, implementation of plan and follow up).
Furthermore, the elements of the monitoring plan should follow those outlined by
WHO [28] such as timelines, flexibility, usefulness and sensitivity. This would make
it easier to compare with other WHO data.
4.2.1.11 Supervision
The surveillance system will not be complete without supervision, because, as
mentioned in the WHO guidelines, supervision is one of the elements of the support
function which is used to evaluate a surveillance system. Supervision is the process
in which the healthcare personnel in the lower level is guided and supported by the
higher levels [30].
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In my study, the senior personnel in the PMD supervise the performance of the
other personnel in the PMD and in the lower level as well, by visiting the hospitals or
answering their questions by phone regarding any issue related to the ID notification.
This supervision helps in improving the surveillance system performance. In Ghana,
the supervision of the ID surveillance system is absent or irregular, because of the
lack of interest of the surveillance activities and of other resources (transport
between the different levels and lack of human resources) [72]. Lack of supervision
may lead to lack of the motivation which leads to a lower number of notifiable
reports received from the lower level personnel (under-reporting).
4.2.1.12 Training
Training is a key element of the surveillance system [143]. Insufficient training
of the healthcare personnel could have a negative impact on the overall work
performance [13].
The MoHAP offers programs of core topics related to IDs such as hand
hygiene, sterilization and antibiotic resistance. The training on the specific ID
programs that the UAE is working on is usually offered for the personnel who are
working on it. Other healthcare personnel who are involved in the ID surveillance
system (physicians, nurses, laboratory technicians) need to get the training in the
context of the surveillance program, so that they can be more proactive in making
these programs achieve their goals. Developing a (train the trainer program) may be
suggested as a way of increasing ID training at the level of the hospitals.
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4.2.2 Putting it together
4.2.2.1 Collaborative efforts
In RAK, most parts of the surveillance system seem to be fulfilling the tasks
that are assigned for their specific departments. However, looking at the bigger
picture, gaps can be identified in the surveillance system.
A main reason for this is that the efforts are not concerted. The obstacles may
be different in different parts of the system, resulting in a fragmented surveillance
pathway. All parts of the ID surveillance system and related activities should be
integrated into one system in which there is transparency and open communication in
all directions.
4.2.2.2 Optimization of resources
Lack of human resources is a common complaint that echoes not only in the
UAE surveillance system, but in other parts of healthcare in the UAE and other
countries. Whenever there is a lack of resources, whatever those may be,
optimization of the existing resources becomes imperative in order to get the best
outcome. Using a single unified system for the healthcare services in UAE and using
whatever resources that it has in the most effective way would certainly improve the
current surveillance system.
4.3 Recommendations for further progress
Several suggestions are made to move forward and further develop our
surveillance system.
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4.3.1 Structure of surveillance system
Ensure the distribution of the guidelines to all healthcare personnel including
practical and clinical details that including clear case definitions, laboratory
confirmation criteria and an updated notifiable list with clear instructions about cases
reporting.
Establish a mechanism to connect and involve stakeholders at different levels
in the preparation of the ID surveillance system with their feedback to establish an
effective continuous quality improvement program.
Unify the electronic system and connect it with MoHAP and include the
private sectors in this system. Furthermore, the involvement and cooperation of the
laboratories in this system is vital.
It is important to have multilingual personnel working on the ID surveillance
system, to be able to communicate with the different nationalities.
Targeted training of health professionals, using customized material that is
based on WHO training and tailored to local needs.
4.3.2 Future research in the community
For studying IID in a community like RAK, it is important to think about a
mechanism to get more response from the workers group. Furthermore, these types
of surveys (health related) should be supported by an authority, so the participants
will feel comfortable to share their information and health concern.
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When selecting the samples from a community, it is important to make sure
that it is pooled from the latest updated database. Thus it is important for those
authorities to update their databases to support better research.
4.4 Strengths and limitations
This study provides the first prevalence estimates for IID from a
representative sample of the RAK (UAE) population. Despite the strengths of the
study design, there are a number of potential limitations that need to be discussed.
Recall bias (where the participants telescope their illness events in the past into the
observation period) is one of the potential limitations that is frequently found in selfreported IID studies and may lead to an overestimation of IID prevalence [44, 56].
However, the participants were asked about the exact date of their symptoms in order
to minimize this issue. There is also the possibility that the results in fact underestimate the true prevalence. With this being a population-based study investigating
IID, and in view of the fact that in UAE culture discussing issues related to the
bathroom and excretion outside the clinical setting is considered embarrassing, it is
possible that some participants did not admit to having had an IID in order to avoid
an uncomfortable conversation with the interviewer. Furthermore, it is notable that
there were zero cases of IID reported from participants living in group
accommodation. Most of these individuals are male expatriate workers who have
come to the UAE from countries endemic for infectious diseases, to make a living
through skilled or unskilled labour. This finding is unusual, since many studies have
found that those who are living in high-density shared accommodation are more
susceptible to IID [115,117].
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It is plausible that these workers feared that reporting any kind of illness
might be taken against them and affect their work status and job security. In addition,
it is possible that collecting such data from the migrant population using anonymous
data collection methods might overcome deliberate underreporting in future studies.
A final possibility is that these individuals have a relatively low socioeconomic
status and as a result they have a higher tolerance to conditions such as transient
fever, intestinal cramps, and diarrhoea. One point to consider is whether the study
recruitment method introduced any selection bias or underrepresentation of
individuals from large households. The primary aim of the sampling and recruitment
strategy was to recruit a representative sample of the general population in RAK.
Previous population-based telephone surveys performed by our research group in the
UAE [155] found that the telephone number and billing for a household is usually
linked to a male head of the household. This is primarily due to the social
hierarchical structure in the UAE population [155]. In consideration of this
phenomenon, it was aimed to recruit one male, one female, and one child from each
household. This recruitment strategy was developed to minimize the likelihood of
recruiting a predominantly male sample and to maximize the possibility of recruiting
a representative sample of males, females, and children.
We did not collect data on the number of people living in each household,
only whether the respondent lived alone, with a spouse, family, or non-family. It
would be prudent for future population-based cross-sectional studies in the Gulf
region to collect data on the number of individuals living within a household and to
explore the relationship between household occupancy and the prevalence of IID.
Some households in the UAE employ expatriate domestic workers to help with
childcare and/or food preparation. We did not collect information on whether a
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household employed a domestic worker, the number of domestic workers, or the
duties performed by the domestic workers. The presence of an expatriate domestic
worker within a household may potentially increase or decrease the prevalence
estimates of IID in the UAE. Future studies may want to consider including these
members of the household in their sampling and recruitment strategy, or at least
collect information on the number of domestic workers and their role within the
household.
Many surveys are prepared in one language and do not consider potential
participants living in the same area and speaking a different language to the native
language [120]. For example, the telephone survey in Canada was only conducted in
English and 9% (n = 568) of the 6047 people did not participate due to language
problems [54]. In the present study, the survey tool was produced in three languages
to minimize selection bias (i.e., excluding participants due to a language barrier) and
maximize the recruitment of a representative sample of the RAK population, which
is a multi-national population.
It was not possible to present prevalence estimates weighted or standardized
by the population composition of RAK. Accurate and reliable population estimates
and composition (e.g., by nationality or by UAE national and non-national) of the
RAK population are not publicly available. The UAE Government reports that RAK
is the fourth largest emirate with an estimated total population of 300 000 [156]. The
last publicly available census data for the UAE is from 2005, which estimated the
total population of RAK to be 210 063 (61.6% male; 41.8% UAE national) [157].
The population sampled in 2017 was 57.3% male and 41.8% UAE national.
However, it is not possible to gauge the true representativeness of the sample without
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recent data on the population growth of the UAE national and non-national
populations in RAK over the past 12 years. Finally, the prevalence estimates reported
in this study can only be generalized to the RAK population. There are considerable
differences in population size and composition across the seven emirates that may
influence the epidemiology of IID within different emirates. Based on the last 2005
census data, Ras Al Khaimah had the fourth largest population (n = 210 063) and the
second highest proportion (41.8%) of UAE nationals compared to the emirates of
Abu Dhabi (n = 1 399 484; 25.0% UAE nationals), Dubai (n = 1 321 453; 10.4%
UAE nationals), and Sharjah (n = 793 573; 17.4% UAE nationals), which had larger
populations with a greater proportion of expatriates [157].
4.4.1 Challenges in choosing the method for contacting the participants
Face to face
One of the challenges associated with community based studies is being able
to reach a target population and getting a response from them. This challenge is
magnified in the communities that lack in awareness and acceptance of these kinds of
studies.
Face to face method may be more accepted if the research personnel come
from a healthcare facility. While this may be the preferred method to collect data
from participants at health institutions or schools for example, access of researchers
to participants at their home is problematic. In the UAE culture, it would not be
acceptable for researchers to ring the bell and enter the home of the potential
participants and so it was expected that this method may result in a lower response
rate.
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Email
Another way to reach the participants is by e-mail. However, because of the
simple nature of our community in which the research has been done and the fact that
not all have access to the e-mail may exclude many potential participants.
Telephone method
Accessing the participants by phone was the best method for the current
study, although it was still considered an acceptable to ask detailed health related
questions over the phone by someone who was not affiliated with a health facility or
was treating the patients.
4.5 Limitation in the ID surveillance system
The findings from this study are not representative of the overall health system
in the UAE, because it was conducted in one emirate only. Furthermore, it did not
include the highest authority (MoHAP).
This part of the study cannot be generalized to all other emirates, because in
each emirate not only is the population different, but also the healthcare system [85]
and hence the surveillance system that existing within it. The surveillance system
would be expected to be the same with regards basic structure and function, while
being tailored to the needs and requirements of each emirate.
In this study, the quality issues of the ID surveillance system in RAK were
not examined. This study only focused on the structure, core and support functions of
this system.
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There has never been published evaluation of the ID surveillance system in
the UAE. The fact that at the time of doing the study the researcher was considered
to be an outsider to the system that was being assessed, made it more challenging to
get the information needed.
In conclusion, IID at the population level remains largely undetected through
many surveillance methods. In this population-based study, the prevalence of IID
was estimated to be 4.2% in a representative sample of the RAK population. The
factors associated with IID were being female and age below 6 years. Since this is
the first population-based telephone survey of IID in the UAE, it is possible that the
prevalence reported is a conservative estimate. Future IID studies in the UAE may
want to target specific high-risk groups such as expatriate workers living in shared
accommodation, who may have a higher prevalence of IID.
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Appendices
Appendix 1: Questionnaire in Arabic
استبيان األمراض المعدية في رأس الخيمة
رقم الهاتف
يوم المقابلة

مجري المقابلة
تاريخ المقابلة
معرف المكالمة
اسم المشارك في االستبيان
رقم الهوية
هل المشارك في االستبيان
طفل
لو كان المشارك طفالً،
يرجى ذكر اسم وعالقة
الشخص الذي يجيب على
األسئلة

 نعم

 ال

المحاوالت
المحاولة
1
2
3
4
•

التاريخ

الوقت (البداية)

تم إجراء االتصال

الموافقة ،المقابلة

السالم عليكم .اسمى ---------------------------وأتصل بالنيابة عن إدارة الصحة العامة التابعة لقسم

الصحة .هل يمكنني من فضلك التحدث إلى (المشارك في االستبيان).
•

نود التعرف على األمراض المعدية التي عانيت منها على مدار األسابيع األربعة الماضية.

• سنكون في غاية االمتنان إذا تفضلت باإلجابة على استبيان قصير لن يستغرق أكثر من  10دقائق
"هل توافق على المشاركة؟"
 نعم
 ال

"جميع المعلومات التي تقدمها مجهولة الهوية وسوف يتم التعامل معها بسرية تامة".
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القسم أ :خصائص المنزل
أ .1ما هو نوع المنزل/اإلقامة التي لديك؟ ____________________
أ .2كم عدد األفراد الذين يعيشون في المنزل عادةً؟ ____________________
يعيش بمفرده
مع الزوج/الزوجة
مع األسرة
كم عدد من دون  18عا ًما؟
كم عدد من تجاوز  18عا ًما؟
الخادم منزلي
كم عدد االشخاص؟
في مدينة جامعية أو بيئة مجتمعية
كم عدد األشخاص؟
أ .3إذا كان المشارك في االستبيان أقل من  18عا ًما ،هل وافق أحد الوالدين على إجراء المقابلة مع الطفل:
هل وافق أحد الوالدين؟

 ال [تتوقف المقابلة في حالة عدم الموافقة]

 نعم

القسم ب :المعلومات الديموغرافية الخاصة بالمشارك في االستبيان
[اشرح أن السبب الوحيد وراء طلب هذه المعلومات هو تقييم ما إذا كان األشخاص المشاركون في هذا
االستبيان الهاتفي ممثلين لمجموع السكان .جميع اإلجابات ستظل مجهولة الهوية].
ب .1العمر باألعوام______ :
ب .2النوع

 ذكر

 أنثى

ب .3الجنسية

 إماراتي

 غير إماراتي (حدد)______ :

ب .4ما هي وظيفتك الحالية أو آخر وظيفة عملت بها؟ __________________________
ب .5ما هي حالتك الوظيفية الحالية؟ __________________________
 =1في العمل
 =2بال عمل
 =3طالب
 =4متقاعد
 =5أقوم باالعتناء بالبيت أو األسرة
 =6مريض مرضًا طويالً أو من ذوي االحتياجات الخاصة
 =7غير ذلك
 =77ال أعلم/لست متأكدًا
 =99أرفض اإلجابة
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ب .6هل لديك اتصال بالحيوانات في العمل أو المنزل؟
 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى ج]1

 نعم

ب[ .7إذا كانت اإلجابة بنعم] ،أين ______________________ نوع الحيوانات
_________________
طبيعة االتصال__________________________
القسم ج :آخر مرة تعرضت فيها لإلسهال و/أو القيء
ج .1على مدار األسابيع األربعة األخيرة ،هل شعرت (أو طفلك) بأي من األعراض التالية؟ يرجى وضع
عالمة على جميع ما ينطبق على حالتك.
األعراض

نعم

غير متأكد

ال

عدد األيام
[إذا كانت اإلجابة بنعم،
كم عدد األيام التي استمرت فيها هذه
األعراض؟ اكتب عدد األيام في
الخانة المقابلة لألعراض]

إسهال (براز مائي
رخو)
إسهال مصحوب بدم
قيء (مع الشعور
بالمرض)
[أجب عن األعراض الثانوية فقط إذا تم وضع عالمة على أي من األعراض المذكورة أعاله ،في حالة عدم
وجود أعراض ،يتم االنتقال مباشرة إلى د]1
األعراض الثانوية

نعم

ال

غير متأكد

غثيان (مع الشعور
بالمرض)
ألم بالبطن (ألم بالمعدة)
فقدان الشهية
درجة حرارة مرتفعة
(الرعشة والعرق)
سعال ورشح وانسداد
األنف والتهاب الحلق
صداع
ج .2هل ال يزال أي من هذه األعراض موجودًا؟ يرجى وضع عالمة في المربع المناسب
األعراض
اإلسهال (براز مائي رخو)
إسهال مصحوب بدم
قيء (مع الشعور
بالمرض)

نعم

ال

غير متأكد
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ج .3في أي يوم (يوم/شهر/عام) بدأ اإلسهال و/أو القيء؟
___ ________ / ____ /
ج[ .4إذا كانت اإلجابة بنعم على الشعور باإلسهال في السؤال ج ،]1كم مرة دخلت (دخل طفلك) الحمام في
أكثر يوم ( 24ساعة) شعرت فيه بهذا المرض؟
عدد المرات ________________غير متأكد_________________
ج[ .5إذا كانت اإلجابة بنعم على الشعور بالقيء في السؤال ج ،]1كم مرة تقيأت (أو طفلك) في أكثر يوم (24
ساعة) شعرت فيه بهذا المرض؟
عدد المرات ________________غير متأكد_________________
[مالحظة – ال تدفع المشارك لإلجابة بعدم التأكد – سنحاول دائ ًما الحصول على تقدير لعدد المرات]
ج .6هل ذهبت (أو أخذت طفلك) للطبيب بخصوص هذا المرض؟
 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى ج]9
 نعم
ج[ .7إذا كانت اإلجابة بنعم] ،في أي يوم (يوم/شهر/عام) ذهبت (أو أخذت طفلك) للطبيب ألول مرة
بخصوص هذه األعراض؟
___ ________ / ____ /
ج[ .8إذا قمت باستشارة طبيبك الممارس العام] ،هل كان الغرض الحصول على التشخيص والعالج أم بسبب
طلبك الحصول على شهادة طبية للعمل؟
 شهادة طبية للعمل
 التشخيص والعالج
ج .9هل قمت بالتواصل مع أي خدمات أخرى أثناء فترة مرضك (أو طفلك)؟
مقدم خدمات خارج ساعات العمل
المراكز الصحية التي ال تشترط الحصول على موعد مسبق
المشورة من أحد الصيادلة
المواقع اإللكترونية المرتبطة بالصحة
النقاش مع ممرضة ممارسة
ال يوجد
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شدة المرض:
ج .10هل منعك مرضك (أو مرض طفلك) من ممارسة أنشطتك اليومية العادية؟
 غير متأكد
 ال
 نعم
ج .11هل منعك مرضك (أو مرض طفلك) من الذهاب إلى العمل أو المدرسة؟
 غير متأكد
 ال
 نعم
[إذا كانت اإلجابة بنعم] ،كم عدد األيام؟ ____________________
ج .12هل تأثر شخص آخر بمرضك (أو مرض طفلك)؟
 ال
 نعم
[إذا كانت اإلجابة بنعم] ،اذكر التفاصيل
__________________________________
األدوية المستخدمة:
ج .13هل تناولت (أو طفلك) أي أدوية لهذه األعراض؟
 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى ج]17
 نعم
ج[ .14إذا كانت اإلجابة بنعم] ،هل تناولت أدوية بدون وصفة أم بوصفة طبية؟
(أ) بدون وصفة طبية  :نعم

 ال

 نعم

 ال

(ب) بوصفة طبية:

(ج) غير ذلك ،يرجى التحديد ________________________________
ج .15اسم الدواء (األدوية)؟ ____________________________________
ج .16على مدار كم يوم تناولت األدوية؟ _______________________
دخول المستشفى:
ج .17هل ذهبت (أو أخذت طفلك) إلى أي قسم من أقسام المستشفى بسبب هذه األعراض؟
 ال
 نعم
ج .18هل دخلت (أو طفلك) المستشفى؟
 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى ج]20
 نعم
ج .19كم يوم أمضيت (أو أمضى طفلك) في المستشفى _____________________(اكتب "صفر"
إذا كانت اإلجابة بالنفي)
التحليل:
ج .20هل ُ
ِب منك (أو من طفلك) تقديم عينة براز للتحليل؟
طل َ
 نعم

 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى ج22أ]

 غير متأكد
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ج[ .21إذا كانت اإلجابة بنعم] ،ماذا كانت نتيجة التحليل الخاص بك (أو بطفلك)؟
 =1السالمونيال
 =2العطيفة
 =3الشيغيلة
 =4اإلشريكية القولونية
 =5فيروس
 =6غير ذلك (يرجى التحديد)________________________
 =77ال أعلم/لست متأكدًا
 =99أرفض اإلجابة
ج22أ .هل تعاني (أو طفلك) من أي إسهال متكرر أو أي مرض مزمن آخر يرتبط باألمراض المعوية؟
 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى متالزمة القولون العصبي ]1
 نعم
ج22ب[ .إذا كانت اإلجابة بنعم] ،يرجى التحديد ______________________________
مرض/متالزمة القولون العصبي:
 .1هل تم إخبارك (أو طفلك) أنك تعاني من متالزمة القولون العصبي؟
 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى ج23أ]
 نعم
[ .2إذا كانت اإلجابة بنعم] ،ما طول المدة التي عانيت (أو طفلك) منها؟ ______________
 .3من أخبرك بأنك (أو طفلك) تعاني من متالزمة القولون العصبي؟
 تشخيص ذاتي
 غيره من الطاقم الطبي
 الطبيب

 غير ذلك

 .4هل عانيت (أو طفلك) من أعراض متالزمة القولون العصبي في الشهر الماضي؟
 ال
 نعم
ج23أ .هل أجريت (أو طفلك) جراحة في المعدة أو األمعاء ،والتي ربما قد سببت اإلسهال نتيجة لها في
 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى ج]24
 نعم
األشهر الستة الماضية؟
ج23ب[ .إذا كانت اإلجابة بنعم] ،يرجى التحديد
___________________________________________
ج .24ماذا تعتقد أنه مسئول عن مرضك (أو مرض طفلك)؟
ج27أ .الطعام [يعتقد الشخص المشارك في االستبيان أن العدوى من الطعام]
ج27أ .المياه [يعتقد الشخص المشارك في االستبيان أن العدوى من المياه]
ج27ب .عدوى – انتقال العدوى من شخص آلخر
ج27ج .غثيان الصباح
ج27د .خمار
ج27هـ .انسداد في الحلق (يسبب القيء)
ج27و .مرض مزمن (مثل متالزمة القولون العصبي أو داء كرون)
ج27ز .جراحة حديثة في المعدة/األمعاء
ج27ح .تناول أدوية
ج27ط .غير ذلك
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القسم د :حاالت العدوى األخرى
د .1هل أصبت (أو طفلك) بأي عدوى أخرى في األسابيع األربعة األخيرة؟
 نعم

 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى هـ]1

د .2طبيعة العدوى
 عدوى الجهاز التنفسي
 عدوى الجلد

 عدوى العين أو األذن أو األنف أو الفم
 عدوى أخرى

 عدوى المسالك البولية

د .3تاريخ البداية :يوم/شهر/عام ___ ________ / ____ /
د .4المدة:

______________________

د .5هل ذهبت (أو طفلك) للطبيب؟

نعم

 ال

د .6هل تناولت (أو طفلك) أدوية؟

 نعم

 ال

د .7هل دخلت (أو طفلك) المستشفى؟ نعم

 ال

د .8هل تلقيت (أو طفلك) عال ًجا آخر (جراحة)؟

 نعم

 ال

د .9ما هي "الجرثومة" التي سببت العدوى؟
 فيروس
 بكتيريا

 فطريات

 غير متأكد

القسم هـ :السفر للخارج في األسبوعين السابقين لبدء المرض
هـ : 1هل سافرت (أو طفلك) خارج دولة اإلمارات العربية المتحدة في األسبوعين الماضيين أو في األسبوعين
السابقين لبدء المرض؟
 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى و]1
 نعم
هـ[ .2إذا كانت اإلجابة بنعم] ،كم المدة باألسابيع ___________ ،كم المدة باأليام _____________
هـ .3ما هو تاريخ سفرك (أو طفلك) بالخارج؟
تاريخ البداية:

يوم/شهر/عام ___ ________ / ____ /

تاريخ االنتهاء:

يوم/شهر/عام ___ ________ / ____ /

هـ .4إذا أقمت (أو طفلك) بالخارج ،يرجى توضيح اسم الدولة/الدول _____________________
القسم و .بيانات شخصية إضافية
و .1أين تسكن في رأس الخيمة؟
و .2هل تعمل في رأس الخيمة؟

______________________
 نعم

 ال [إذا كانت اإلجابة بال ،يتم االنتقال إلى و]4

و[ .3إذا كانت اإلجابة بنعم] ،أين تعمل في رأس الخيمة؟ ______________________
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و .4ما هي حالتك االجتماعية؟
 =1أعزب
 =2متزوج
 =3منفصل/مطلق
 =4أرمل
 =77ال أعلم/لست متأكدًا
 =99أرفض اإلجابة

[يتم االنتقال إلى و]6

[يتم االنتقال إلى و]6
[يتم االنتقال إلى و]6

[إذا كانت اإلجابة عن السؤال و 4الخيار رقم  2أو  3أو  ،4يتم االنتقال إلى و]5
و .5هل لديك أطفال؟
 =1نعم
 =2ال
 =77ال أعلم/لست متأكدًا
 =99أرفض اإلجابة
و .6ما هو أعلى مستوى تعليمي وصلت إليه؟
 =1لم أذهب إلى مدرسة  /ال يوجد تعليم مدرسي رسمي
 =2أكملت المدرسة االبتدائية
 =3أكملت المدرسة اإلعدادية
 =4أكملت المدرسة الثانوية
 =5حصلت على شهادة جامعية
 =6حصلت على درجة الماجستير أو الدكتوراه
 =77ال أعلم/لست متأكدًا
 =99أرفض اإلجابة
و .7ما هو متوسط إجمالي الدخل الشهري ألسرتك بالدرهم اإلماراتي؟
 =1أقل من 5.000
 5.000 =2إلى 14.999
 15.000 =3إلى 24.999
 25.000 =4إلى 34.999
 =5أكثر من 35.000
 =77ال أعلم/لست متأكدًا
 =99أرفض اإلجابة
و .8إذا كنا بحاجة إلى طرح المزيد من األسئلة ،هل يمكننا االتصال بك مرة ثانية؟
 ال
 نعم
شكرا جزيالً على حسن تعاونكم! إذا كان لديكم استفسارات أو تعليقات ،يرجى االتصال بالشخص
ً
التالي:
فاطمة حمدان العلكيم الزعابي
052- 6009175 – 050- 4536444
تعليقات مجري المقابلة:
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Appendix 2: Questionnaire in English
Survey of Infectious Disease in Ras Al Khaimah
Interviewer

Telephone number

Date of interview

Day of interview

Call ID

Name of subject

Subject ID No.

Is subject a child

 Yes

 No

If subject is a child,
Name and relation of
person answering
questions
Attempts
Attempt

Date

Time (start)

Contact
made

Consent,
interview

1
2
3
4

•

Hello. My name is _____________

and I’m calling on behalf of the

Public Health Department of the Health Division. May I please speak
to (subject) or (parent in case of a child).
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•

We would like to find out about infectious illness experienced in the
four weeks.

•

We would be very grateful if you could answer a brief questionnaire,
which should take no longer than 10 minutes.
“Do you consent to take part?”
Yes
 No

All information you provide is anonymous and will be treated in strict
confidence”.

Section A: Household Characteristics
A1. What sort of house/accommodation do you have?
____________________
A2. How many people usually live in your household?
____________________
Alone
With spouse

With family
How many are under 18 years old?
How many are over 18 years old?
As domestic servant
How many persons?
In a dormitory or communal setting
How many persons?
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A3. If the subject of the survey is under 18 years, was parental consent given
to interview the child:
Was parental consent given?  Yes

 No [No consent, interview halts]

Section B. Demographic information on respondent
[Explain that we only require this information to assess whether the people
participating in this Telephone Survey are representative of the general
population. All responses will remain anonymous].
B1. Age in years: ______
B2. Sex:

 Male

 Female

B3. Nationality:

 Emirati

 Non-Emirati (specify): ______

B4. What is your current or most recent occupation?
__________________________
B5. What is the current employment status?
1= At work
2= Unemployed
3= Student
4= Retired
5= Looking after home or family
6= Long-term sick or disabled
7= Other
77= DK/NS
99= Refused
B6. Do you have contact with animals at work or home?
 Yes
 No [If “No” go to C1]
B7. [If “Yes”], Where_______________________ Type of
animals_________________
Nature of contact__________________________
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Section C: Recent experience with diarrhea and/or vomiting
C1. In the past four weeks have you (your child) experienced any of the
following symptoms? Please tick all that apply.
Symptom

Yes

No

Not
Sure

Number of Days

[If answered “Yes”
How many days did these
symptoms last? Write the
number of days in the box]
Diarrhea (loose
watery bowel
movements)
Diarrhea with blood in
it
Vomiting (being sick)
[Only answer secondary symptoms if one of above symptoms ticked, for no
symptoms go straight to D1]
Secondary Symptom

Nausea (feeling sick)
Abdominal pain (tummy pain)

Loss of appetite

High temperature (shivering and sweating)
Cough, runny/blocked nose, sore throat

Headache

Yes

No

Not Sure
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C2. Are any of these symptoms still present? Please tick
Symptom

Yes

No

Not Sure

Diarrhea (loose watery bowel movements)
Diarrhea with blood in it
Vomiting (being sick)
C3. On what date (DD/MM/YYYY) did the diarrhea and/or vomiting begin?
___ / ____ / ________
C4. [If you answered “Yes” to having diarrhea in Question C1], how many
times did you (your child) go to the toilet on the worst day (24 hours) of this
illness?
Number of times________________ Not sure_________________
C5. [If you answered “Yes” to vomiting in Question C1], how many times did
you (your child) vomit on the worst day (24 hours) of this illness?
Number of times________________ Not sure_________________
[NB – Do not prompt “Not Sure” as a response –we will always try to
get an estimate of frequency]
C6. Have you been (take your child) to see the doctor about this illness?
 Yes
 No [If “No” go to C9]
C7. [If “Yes”], on what date (DD/MM/YYYY) did you (your child) first see the
doctor about these symptoms?
___ / ____ / ________
C8. [If you consulted your doctor GP], was it to seek diagnosis and treatment
or because you required a medical certificate for work?
 Diagnosis & treatment

 Certificate for work

189
C9. Did you contact any other service during the course of your (your child’s)
illness?
Out of hours provider

Walk in centre

Advice from pharmacist

health related websites

Discuss with practice nurse

None

Severity of illness:
C10. Did your (your child’s) illness prevent you from going about your normal
daily activities?
 Yes
 No
 Not sure
C11. Did your (your child’s) illness stop you from going to work or to school?
 Yes
 No
 Not sure
[If “Yes”], how many days? ____________________
C12. Was anyone else affected by your (your child’s) illness?
 Yes
 No
[If “Yes”], details__________________________________
Medications used:
C13. Did you (your child) take any medications for the symptoms?
 Yes
 No [If “No” go to C17]
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C14. [If “Yes”], Did you get the medication over the counter or on
prescription?
(a) Over the counter:  Yes

 No

(b) On prescription:  Yes

 No

(c) Other, please specify________________________________
C15. Name of medication(s)? ____________________________________
C16. How many days were medications taken for?
_______________________
Hospitalization:
C17. Did you go (take your child) to any hospital department due to these
symptoms?
 Yes
 No
C18. Were you (was your child) admitted to hospital?
 Yes
 No [If “No” go to C20]
C19. How many days did you (your child) spend in
hospital_____________________ (enter ‘0’ if none)
Testing:
C20. Were you (your child) asked to submit a stool sample for testing?
 Yes
 No [If “No” go to C22A]
 Not Sure
C.21. [If “Yes”], what was the result of your (your child’s) test?
1=Salmonella
2=Campylobacter
3=Shigella
4=E. coli
5=Virus
6=Other (specify)________________________
77= DK/NS
99= Refused
C22A. Do you (your child) suffer from any relapsing diarrhea or other chronic
illness related to intestinal disease?
 Yes
 No [If “No” go to IBS1]
C22B. [If “Yes”], please specify ______________________________
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Irritable Bowel disease/syndrome:
IBS1. Have you (your child) ever been told you have IBS?
 Yes
 No [If “No” go to C23A]
IBS2. [If “Yes”], how long have you (your child) suffered from it?
__________________
IBS3. Who told you (your child), you had IBS?
 Doctor
 Other medical staff
 Self-diagnosed

Other

IBS4. Have you (your child) had your IBS symptoms in the past month?
 Yes
 No
C23A. Have you (your child) had any stomach or bowel surgery which may
have caused diarrheal illness as a consequence in the past six months?
 Yes
 No [If “No” go to C24]
C23B. [If “Yes”], please specify:
___________________________________________
C24. What do you think was responsible for your (your child) illness?
C24A. food [Subject thinks infection from food]
C24B. water [Subject thinks infection from water]
C24C. Infection - person to person spread
C24D. Morning sickness
C24E. Hangover
C24F. Obstruction in throat (causing vomiting)
C24G. Chronic illness (e.g. IBS, Crohns disease)
C24H. Recent stomach/bowel surgery
C24I. Medication
C24J. Other
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Section D: Other infections
D1. Have you (your child) had any other infection in the past 4 weeks?
 Yes
 No [If “No” go to E1]
D2. Nature of infection
Respiratory tract infections
Skin infections

Eye, Ear, Nose & Mouth infections

Urinary tract infections

Other infections

D3. Start date:

DD/MM/YYYY ___ / ____ / ________

D4. Duration:

______________________

D5. Did you (your child) see a doctor?

 Yes

D6. Did you (your child) take medication?

 No
 Yes

D7. Were you (your child) admitted to hospital?

 No
 Yes

 No

D8. Did you (your child) have any other treatment (surgery)?
 Yes
 No
D9. What was the “germ” causing this infection?
 Bacteria
 Virus
 Fungi

 Not sure

Section E. Foreign travel in the two weeks before your illness started
E1. Did you (your child) travel outside the UAE in the last two weeks, or in
the two weeks before you became ill?
 Yes
 No [If “No” go to F1]
E2. [If “Yes”], how long in weeks ______________, how long in days
_______________
E3. What dates were you (your child) away?
Start date:

DD/MM/YYYY___ / ____ / ________

End date:

DD/MM/YYYY___ / ____ / ________

E4. If you (your child) stayed aboard please state which country/countries
______________________________
Section F. Further personal details
F1. Where in RAK do you live?

______________________

F2. Do you work in RAK?

Yes

No [If “No” go to F4]

193
F3. [If “Yes”], Where in RAK do you work?
F4. What is your marital status?
1=Single
[go to F6]
2=Married
3=Separated/divorced
4=Widowed
77= DK/NS [go to F6]
99= Refused [go to F6]

______________________

[If CODED 2-4 at F4 go to F5]
F5. Do you have children?
1 = Yes
2 = No
77= DK/NS
99= Refused
F6. What is your highest education level?
1=Did not attend school /no formal schooling
2=Completed primary school
3=Completed intermediate school
4=Completed secondary school
5=Completed college or university
6=Completed Master or PHD
77= DK/NS
99= Refused
F7. What is the average total monthly income received by your household in
AED?
1=Less than 5,000
2=5,000 to 14,999
3=15,000 to 24,999
4= 25,000 to 34,999
5=Greater than 35,000
77= DK/NS
99= Refused
F8. If we need to ask further questions, may we contact you again?
 Yes

 No

Thank you very much for your cooperation! If you have questions or
comments, please contact the following persons:
Fatima Hamdan Al-Alkeem Al-Zaabi
050- 4536444, 052- 6009175
INTERVIEWER COMMENTS:
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Appendix 3: Questionnaire in URDU
Survey of Infectious Disease in Ras Al Khaimah
Interviewer

Telephone number

Date of interview

Day of interview

Call ID

Name of subject

Subject ID No.

Is subject a child

 Yes

 No

If subject is a child,
Name and relation of
person answering
questions
Attempts
Attempt

Date

Time (start)

Contact
made

Consent,
interview

1
2
3
4

•

Hello. Mera nam _____________

or mai Public Health Department

of the Health Division se tarafse. Aape se bat kar saktaho?
•

Hamlog apsi bochna chahrahaihi kya in char haftah me koi bemari
aai?
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•

We would be very grateful if you could answer a brief questionnaire,
which should take no longer than 10 minutes.
“Do you consent to take part?”
Ha
 Na

All information you provide is anonymous and will be treated in strict
confidence”.

Section A: Household Characteristics
A1. Aap kis tharah ke qar par rahthe ho?____________________
A2. Kitne log aap ke qar par rahthe ho?____________________
Akele ho
Beevi ke saath

Qarwalom ke saath
18 saal ki umr se kam kitne he?
18 saal ki umr se oopar kitne he?
Qar ki nokrani
kitne log saat me he?
Kamare mem ya logom ke beech mem
kitne log saat me he?
A3. Agar Aap ki umra athara (18) saal se kam hai, gharwalo ki ijazat li hai:
Ijazat li hai ?  Ha

 Na [No consent, interview halts]
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Section B. Demographic information on respondent
[Explain that we only require this information to assess whether the people
participating in this Telephone Survey are representative of the general
population. All responses will remain anonymous].
B1. Umra (saal): ______
B2. Sex:

 Male

 Female

B3. Nationality:
______

 Emirati

 Non-Emirati (Kaun se muluk se ho):

B4. Abhi kya kaam karthe ho /aakhiri kaam kon sa tha?
__________________
B5. Abhi aap kis position me kaam karthe ho? __________________
1= Nokari
2= koi kaam nahi
3= Padayi karthe
4= Avkaash
5= Qarwalom ko dekbhal karthe ho
6= Beemar ho ya vikalang ho
7= koi aor karan
77= DK/NS
99= Mana karna
B6. Qar ya kaam par koi jaanwar se sampark he?
 Ha
 Na [If “No” go to C1]
B7. [If “Yes”], kaha______________________ kis thrah
jaanwar_________________
kis thrah ka sampark_________________________
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Section C: Recent experience with diarrhea and/or vomiting
C1. Pichle chaar haphthom me aap (aapke bache) ko dast/ ya ulti? Please
tick all that apply.
Symptom

Ha

Nahi

Malum
nahi

Number of Days

[If answered “Yes”
How many days did these
symptoms last? Write the
number of days in the box]
Dast

Dast mem qoon
Ulti
[Only answer secondary symptoms if one of above symptoms ticked, for no
symptoms go straight to D1]
Secondary Symptom

Jee michlana
Pet dard
Bhook nahi lagana
Bhukar
Qansi, jukam, gale mem dard
Sar dard

Ha

Nahi

Nahi
maloom
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C2. Se sare lakshan abhi bhi he kya?
Symptom

Ha

Nahi

Nahi
maloom

Dast

Dast mem qoon

Ulti

C3. Kon si thareeq ko dasth, ulti, shuroo hua?
___ / ____ / ________
C4. [If you answered “Yes” to having diarrhea in Question C1], Kitni dafa
toilet gaye ho (24 qantah) is beemari sah?
Kitni bar ________________

Malum nahi _________________

C5. [If you answered “Yes” to vomiting in Question C1] , Kitni baar ulti kiya
(24 qantah) is beemari sah?
Kitni bar ________________

Malum nahi _________________

[NB – Do not prompt “Not Sure” as a response –we will always try to get an
estimate of frequency]
C6. Kya aap (aapke bache) ko doctor ko dikaya?
 Ha
 Na [If “No” go to C9]
C7. [If “Yes”], Kon si taarikh ko (DD/MM/YYYY) aap (aapke bache) pahli baar
docor ke pas gaye thay ?
___ / ____ / ________
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C8. Kisi doctor ke paas ilaj keliye gaye ya certificate keliye gaye?
 Ilaj keliye
 Certificate keliye
C9. Beemari ke samay aapne (aapke bache) kisi aur ki seva lee?
Kamka ke samay ke alava

Clinic me gaye

Pharmacy se salah leliye

Website pe search kiya

Kisi nurse ko puchha

Khoi nahi

Severity of illness
C10. Kya beemari ke karan aap (aapke bache) ko apna roj ka kaam nahi kar
sakthe thay?
 Ha
 Na
 Malum nahi

C11. Beemari ke vajah se aap (aapke bache) kaam par ya school nahi ja
sakthe thay?
 Ha
 Na
 Malum nahi
[If “Yes”], Kitni denh? ____________________

C12. Aap ki (aapke bache) beemari ka asar kisi aur par hua he kya ?
 Ha
 Na
 Malum nahi
[If “Yes”], Kiskoh__________________________________
Medications used
C13. Aapne koi dawa li is beemari ke liye?
 Ha
 Na [If “No” go to C17]
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C14. [If “Yes”], Aapne (aapke bache) dawa Dr ki parchi se li ya bina parchi
ke?
(a) Bina parchi ke:  Ha
(b) Parchi se:

 Ha

 Na
 Na

(c) Or koi tarike se, to batavo ________________________________
C15. Dawa ka naam ? ____________________________________
C16. Kitne dinom thak dawa li ? _______________________
C17. Hospitalization /Aap kisi hospital me gaye thay?
 Ha
 Na
C18. Hospital me bharthi huey thay ?
 Ha
 Na [If “No” go to C20]
C19. kitne din hospital me bharthi rahe (enter ‘0’ if none)
_________________
Testing
C20. Aapne apna (aapke bache) maal test kiya?
 Ha
 Na [If “No” go to C22A]

 Malum nahi

C.21. [If “Yes”], Natheeja kya tha mal test ka?
1=Salmonella
2=Campylobacter
3=Shigella
4=E. coli
5=Virus
6=Other (specify)________________________
77= DK/NS
99= Nahi batana chahri
C22A. Aap (aapke bache) ko bar bar pet ki taklif ya bimari (dast) hoti?
 Ha
 Na [If “No” go to IBS1]
C22B. [If “Yes”], or to batao ______________________________
Irritable Bowel disease/syndrome:
IBS1. Aap (aapke bache) ko Kesine pataya IBS hai?
 Ha
 Na [If “No” go to C23A]
IBS2. [If “Yes”], aap (aapke bache) ko yeh pemari kapsi hai?
______________
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IBS3. Aap (aapke bache) ko Kesne pataya IBS hai?
 Doctor
 Qoi our hospital si  Khod ko pata chala
nahi

Malum

IBS4. Aap (aapke bache) ko IBS alamat mahsoos hoa pechle maheni?
 Ha
 Na
C23A. Aap (aapke bache) ko koi pet ka operation kiya aur iske baad dast ka
problem hua chai mahine thak ?
 Ha
 Na [If “No” go to C24]
C23B. [If “Yes”], or to batao:
___________________________________________
C24. Aap (aapke bache) ko ye bemare kaise howe?
C24A. Kana [Subject thinks infection from food]
C24B. Panei [Subject thinks infection from water]
C24C. Infection – kese se lage
C24D. Supamai koch takleef
C24E. Benase
C24F. Gale ka takleef (causing vomiting)
C24G. Roos ka bemari (e.g. IBS, Crohns disease)
C24H. Pet ka koi operation
C24I. koi dawayiam kaatha he
C24J. Koi or tarike se
Section D. Other infections
D1. Aapk (aapke bache) ko koi aur beemari ya infection hai pichle chaar
hafthom meh?
 Ha
 Na [If “No” go to E1]
D2. kis tarah ka infection
 Sasqi bemare hai
 Aaq,Kan, Naq or Mo ka bemare
 Jeld ke bemare

 Beshab mai koi takleef hai

 Koi or bemare

D3. Shuroo kab hua:
DD/MM/YYYY ___ / ____ / ________
D4. kitne din: ______________________
D5. Aap (aapke bache) ko Dr ko dikaya?

 Ha

 Na
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 Ha

D6. Aap (aapke bache) ko dawa li?

 Na

D7. Aap (aapke bache) ko hospital meh bharthi huy kya?
 Ha
 Na
D8. Aap (aapke bache) ko koi aur ilaj kiya kya?  Ha
D9. Roganu kon sa tha?
 Bacteria

 Virus

 Fungi

 Na
 Maloom nahi

Section E. Foreign travel in the two weeks before your illness started
E1. Aap (aapke bache) ko beemari ke do haphthe pahle UAE ke bahar gaye
thay?
 Ha
 Na [If “No” go to F1]
ya thay
E2. [If “Yes”], kitne haphthe ke liye _____________, kitne din ke
liye____________
E3. Konsi taryek ko paher tai?
Taryek ka shoro:

DD/MM/YYYY___ / ____ / ________

Taryek ka khatam: DD/MM/YYYY___ / ____ / ________
E4. Aap (aapke bache) ko kon si country me tahare thay?
Section F. Further personal details
F1. RAK me kaha rahthe ho? ______________________
Na [If “No” go

F2. Kya aap RAK me kaam karthe ho kya?
to F4]

Ha

F3. [If “Yes”], RAK me kaha kaam kartha ho?

______________________

F4. Shaadi shuroo ho kya?
1=Nahi howi
[go to F6]
2=Shadi shoda hai
3=Separated/talaq
4=Widowed/baiwa
77= DK/NS [go to F6]
99= Nahi batana chahri
[go to F6]
[If CODED 2-4 at F4 go to F5]
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F5. Bache he kya?
1 = Ha
2 = Na
77= DK/NS
99= Nahi batana chahri
F6. Parayi kaha thak ki?
1=School nahi qaya
2=Completed primary school
3=Completed intermediate school
4=Completed secondary school
5=College ko qaya
6=Master ya PHD parleiah
77= DK/NS
99= Nahi batana chahri
F7. Mahina mem kitna income he AED me?
1= 5,000 se kam
2=5,000 to 14,999
3=15,000 to 24,999
4= 25,000 to 34,999
5= 35,000 se zeyada
77= DK/NS
99= Nahi batana chahri
F8. Aap se agar aur zyada jankari chahyie tho kya hum aap se baath kar
sakthe he kya?
 Ha

 Na

Thank you very much for your cooperation!
If you have questions or comments, please contact the following persons:
Fatima Hamdan Al-Alkeem Al-Zaabi
050- 4536444, 052- 6009175
INTERVIEWER COMMENTS:
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Appendix 4: RAK medical district approval
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Appendix 5: Infectious diseases case notification form
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Appendix 6: Weekly zero reporting form
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Appendix 7: Meningitis case investigation form
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Appendix 8: Cholera case investigation form
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